Contact Molecules for Homologous Proteins | ||||
[Full Bars] |
[SiteTable] |
|
[Back to Search Page] |
[Back to HOMCOS] |
[SupCon3D] |
[help] |
seq_id(%): [0] [30] [40] [50] [60] [70] [80] [90] [95] [100] | [show] [download] [help] |
PID | QueryLength | Homolgous Sequence in PDB | UniProt Query | TITLE |
3013484 | 359 | 500 | P30556(AGTR1_HUMAN) | RecName: Full=Type-1 angiotensin II receptor ;AltName: Full=AT1AR ;AltName: Full=AT1BR;AltName: Full=Angiotensin II type-1 receptor ; Short=AT1 receptor ; |
QUERYSEQ |
MILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCI IIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPL FYGFLGKKFKRYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSTKKPAPCFEVE |
359 | region | name | description |
1-359 | CHAIN | /note="Type-1 angiotensin II receptor" /id="PRO_0000069153" | |
1-25 | TOPO_DOM | /note="Extracellular" ECO:0000269|PubMed:26420482, ECO:0000269|PubMed:30639100, ECO:0000269|PubMed:32079768, ECO:0007744|PDB:4YAY, ECO:0007744|PDB:4ZUD, ECO:0007744|PDB:6DO1, ECO:0007744|PDB:6OS0, ECO:0007744|PDB:6OS1, ECO:0007744|PDB:6OS2" | |
26-55 | TRANSMEM | /note="Helical; Name=1" ECO:0000269|PubMed:26420482, ECO:0000269|PubMed:30639100, ECO:0000269|PubMed:32079768, ECO:0007744|PDB:4YAY, ECO:0007744|PDB:4ZUD, ECO:0007744|PDB:6DO1, ECO:0007744|PDB:6OS0, ECO:0007744|PDB:6OS1, ECO:0007744|PDB:6OS2" | |
56-61 | TOPO_DOM | /note="Cytoplasmic" ECO:0000269|PubMed:26420482, ECO:0000269|PubMed:30639100, ECO:0000269|PubMed:32079768, ECO:0007744|PDB:4YAY, ECO:0007744|PDB:4ZUD, ECO:0007744|PDB:6DO1, ECO:0007744|PDB:6OS0, ECO:0007744|PDB:6OS1, ECO:0007744|PDB:6OS2" | |
62-89 | TRANSMEM | /note="Helical; Name=2" ECO:0000269|PubMed:26420482, ECO:0000269|PubMed:30639100, ECO:0000269|PubMed:32079768, ECO:0007744|PDB:4YAY, ECO:0007744|PDB:4ZUD, ECO:0007744|PDB:6DO1, ECO:0007744|PDB:6OS0, ECO:0007744|PDB:6OS1, ECO:0007744|PDB:6OS2" | |
90-98 | TOPO_DOM | /note="Extracellular" ECO:0000269|PubMed:26420482, ECO:0000269|PubMed:30639100, ECO:0000269|PubMed:32079768, ECO:0007744|PDB:4YAY, ECO:0007744|PDB:4ZUD, ECO:0007744|PDB:6DO1, ECO:0007744|PDB:6OS0, ECO:0007744|PDB:6OS1, ECO:0007744|PDB:6OS2" | |
99-125 | TRANSMEM | /note="Helical; Name=3" ECO:0000269|PubMed:26420482, ECO:0000269|PubMed:30639100, ECO:0000269|PubMed:32079768, ECO:0007744|PDB:4YAY, ECO:0007744|PDB:4ZUD, ECO:0007744|PDB:6DO1, ECO:0007744|PDB:6OS0, ECO:0007744|PDB:6OS1, ECO:0007744|PDB:6OS2" | |
126-141 | TOPO_DOM | /note="Cytoplasmic" ECO:0000269|PubMed:26420482, ECO:0000269|PubMed:30639100, ECO:0000269|PubMed:32079768, ECO:0007744|PDB:4YAY, ECO:0007744|PDB:4ZUD, ECO:0007744|PDB:6DO1, ECO:0007744|PDB:6OS0, ECO:0007744|PDB:6OS1, ECO:0007744|PDB:6OS2" | |
142-165 | TRANSMEM | /note="Helical; Name=4" ECO:0000269|PubMed:26420482, ECO:0000269|PubMed:30639100, ECO:0000269|PubMed:32079768, ECO:0007744|PDB:4YAY, ECO:0007744|PDB:4ZUD, ECO:0007744|PDB:6DO1, ECO:0007744|PDB:6OS0, ECO:0007744|PDB:6OS1, ECO:0007744|PDB:6OS2" | |
166-190 | TOPO_DOM | /note="Extracellular" ECO:0000269|PubMed:26420482, ECO:0000269|PubMed:30639100, ECO:0000269|PubMed:32079768, ECO:0007744|PDB:4YAY, ECO:0007744|PDB:4ZUD, ECO:0007744|PDB:6DO1, ECO:0007744|PDB:6OS0, ECO:0007744|PDB:6OS1, ECO:0007744|PDB:6OS2" | |
191-216 | TRANSMEM | /note="Helical; Name=5" ECO:0000269|PubMed:26420482, ECO:0000269|PubMed:30639100, ECO:0000269|PubMed:32079768, ECO:0007744|PDB:4YAY, ECO:0007744|PDB:4ZUD, ECO:0007744|PDB:6DO1, ECO:0007744|PDB:6OS0, ECO:0007744|PDB:6OS1, ECO:0007744|PDB:6OS2" | |
217-239 | TOPO_DOM | /note="Cytoplasmic" ECO:0000269|PubMed:26420482, ECO:0007744|PDB:4YAY, ECO:0007744|PDB:4ZUD" | |
240-268 | TRANSMEM | /note="Helical; Name=6" ECO:0000269|PubMed:26420482, ECO:0007744|PDB:4YAY, ECO:0007744|PDB:4ZUD" | |
269-278 | TOPO_DOM | /note="Extracellular" ECO:0000269|PubMed:26420482, ECO:0007744|PDB:4YAY, ECO:0007744|PDB:4ZUD" | |
279-304 | TRANSMEM | /note="Helical; Name=7" ECO:0000269|PubMed:26420482, ECO:0007744|PDB:4YAY, ECO:0007744|PDB:4ZUD" | |
305-359 | TOPO_DOM | /note="Cytoplasmic" ECO:0000269|PubMed:26420482, ECO:0007744|PDB:4YAY, ECO:0007744|PDB:4ZUD" | |
335-359 | REGION | /note="Disordered" | |
335-351 | COMPBIAS | /note="Polar residues" | |
15-15 | BINDING | /ligand="angiotensin II" /ligand_id="ChEBI:CHEBI:58506" ECO:0007744|PDB:6DO1" | |
17-17 | BINDING | /ligand="angiotensin II" /ligand_id="ChEBI:CHEBI:58506" ECO:0000305|PubMed:32079768, ECO:0007744|PDB:6DO1, ECO:0007744|PDB:6OS0" | |
167-167 | BINDING | /ligand="angiotensin II" /ligand_id="ChEBI:CHEBI:58506" ECO:0000305|PubMed:32079768, ECO:0007744|PDB:6DO1, ECO:0007744|PDB:6OS0" | |
182-182 | BINDING | /ligand="angiotensin II" /ligand_id="ChEBI:CHEBI:58506" ECO:0000305|PubMed:32079768, ECO:0007744|PDB:6DO1, ECO:0007744|PDB:6OS0" | |
183-183 | BINDING | /ligand="angiotensin II" /ligand_id="ChEBI:CHEBI:58506" ECO:0000305|PubMed:32079768, ECO:0007744|PDB:6DO1, ECO:0007744|PDB:6OS0" | |
184-184 | BINDING | /ligand="angiotensin II" /ligand_id="ChEBI:CHEBI:58506" ECO:0000305|PubMed:32079768, ECO:0007744|PDB:6DO1, ECO:0007744|PDB:6OS0" | |
199-199 | BINDING | /ligand="angiotensin II" /ligand_id="ChEBI:CHEBI:58506" ECO:0000305|PubMed:32079768, ECO:0007744|PDB:6DO1, ECO:0007744|PDB:6OS0" | |
355-355 | LIPID | /note="S-palmitoyl cysteine" | |
1-359 | DISORDER | predicted by DISOPRED |
MONOMER | |||||||
359 | |||||||
pdb_id | a1 | identity[%]2 | description | ||||
7f6g | A | 99.4 | Angiotensin receptor AT1R | ||||
1.a1:asym_id for the homologue. 2.identity[%]2:sequence identity between the query and the homologue. |
HETERO | |||||||
359 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
7f6g[1] | B | SAR1-AngII[8 aa] | A | 100.0 /99.4 |
23 /23 |
Angiotensin receptor AT1R | |
6do1[1] | E | Nanobody Nb.AT110i1[58 aa] | A | 100.0 /98.7 |
3 /3 |
AGTR1_HUMAN C562_ECOLX AGTR1_HUMAN Type-1 angiotensin II receptor,Soluble cytochrome .. | |
6do1[5] | C | Nanobody Nb.AT110i1[125 aa] | A | 100.0 /98.7 |
21 /21 |
AGTR1_HUMAN C562_ECOLX AGTR1_HUMAN Type-1 angiotensin II receptor,Soluble cytochrome .. | |
6jod[1] | B | Angiotensin II[8 aa] | A | 52.2 /38.2 |
23 /24 |
AGTR2_HUMAN Type-2 angiotensin II receptor | |
6os0[1] | C | ANGT_HUMAN Angiotensinogen[8 aa] | A | 100.0 /94.8 |
20 /26 |
AGTR1_HUMAN C562_ECOLX AGTR1_HUMAN Type-1 angiotensin II receptor,Soluble cytochrome .. | |
6os1[1] | C | TRV023 peptide[8 aa] | A | 100.0 /94.8 |
16 /23 |
AGTR1_HUMAN C562_ECOLX AGTR1_HUMAN Type-1 angiotensin II receptor,Soluble cytochrome .. | |
6os2[1] | C | TRV026 peptide[8 aa] | A | 100.0 /94.8 |
20 /27 |
AGTR1_HUMAN C562_ECOLX AGTR1_HUMAN Type-1 angiotensin II receptor,Soluble cytochrome .. | |
5xjm[2] | B | FabH[220 aa] | A | 21.4 /38.4 |
14 /18 |
AGTR2_HUMAN C562_ECOLX AGTR2_HUMAN Type-2 angiotensin II receptor,Soluble cytochrome .. | |
5xjm[2] | C | FabL[212 aa] | A | 50.0 /38.4 |
2 /5 |
AGTR2_HUMAN C562_ECOLX AGTR2_HUMAN Type-2 angiotensin II receptor,Soluble cytochrome .. | |
6jod[1] | C | C562_ECOLX C562_ECOLX Soluble cytochrome b562,Soluble cytochrome b562[59.. | A | 33.3 /38.2 |
3 /4 |
AGTR2_HUMAN Type-2 angiotensin II receptor | |
5vbl[1] | A | agonist peptide[17 aa] | B | 52.4 /37.6 |
21 /26 |
APJ_HUMAN RUBR_CLOPA APJ_HUMAN Apelin receptor,Rubredoxin,Apelin receptor Chimera.. | |
6knm[1] | B | Single domain antibody JN241[129 aa] | A | 26.9 /37.6 |
26 /32 |
APJ_HUMAN RUBR_CLOPA APJ_HUMAN Apelin receptor,Rubredoxin,Apelin receptor | |
7sqo[1] | B | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 66.7 /37.3 |
6 /13 |
OX2R_HUMAN Orexin receptor type 2 | |
7sk3[5] | B | SDF1_HUMAN Stromal cell-derived factor 1[68 aa] | A | 28.6 /34.0 |
21 /30 |
ACKR3_HUMAN Atypical chemokine receptor 3 | |
8u4o[1] | E | SDF1_HUMAN Stromal cell-derived factor 1[65 aa] | A | 15.8 /37.1 |
19 /19 |
CXCR4_HUMAN C-X-C chemokine receptor type 4 | |
8u4n[4] | A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | D | 45.0 /38.4 |
20 /20 |
CXCR4_HUMAN C-X-C chemokine receptor type 4 | |
8u4q[1] | A | REGN7663 Fab light chain[219 aa] | C | 0.0 /37.1 |
4 /4 |
CXCR4_HUMAN C-X-C chemokine receptor type 4 | |
8u4q[1] | B | REGN7663 Fab heavy chain[219 aa] | C | 19.0 /37.1 |
21 /21 |
CXCR4_HUMAN C-X-C chemokine receptor type 4 | |
7sk7[1] | D | CID25 Fab heavy chain[211 aa] | A | 33.3 /37.0 |
9 /12 |
ACKR3_HUMAN Atypical chemokine receptor 3 | |
7ykd[1] | A | RARR2_HUMAN Retinoic acid receptor responder protein 2[9 aa] | B | 17.4 /36.9 |
23 /23 |
CML1_HUMAN Chemerin-like receptor 1 | |
8sg1[1] | E | Chemerin 9[9 aa] | A | 23.5 /36.9 |
17 /18 |
CML1_HUMAN Chemerin-like receptor 1 | |
8sg1[1] | D | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 39.1 /36.9 |
23 /23 |
CML1_HUMAN Chemerin-like receptor 1 | |
5xjm[2] | D | Sar1, Ile8-angiotensin II[8 aa] | A | 58.3 /38.4 |
12 /22 |
AGTR2_HUMAN C562_ECOLX AGTR2_HUMAN Type-2 angiotensin II receptor,Soluble cytochrome .. | |
6do1[2] | H | Angiotensin-like peptide S1I8[8 aa] | A | 100.0 /98.7 |
26 /26 |
AGTR1_HUMAN C562_ECOLX AGTR1_HUMAN Type-1 angiotensin II receptor,Soluble cytochrome .. | |
7euo[2] | B | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 26.7 /35.9 |
15 /15 |
FPR1_HUMAN fMet-Leu-Phe receptor | |
8k2x[1] | A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | D | 27.3 /36.9 |
22 /24 |
C562_ECOLX CXCR3_HUMAN LUCI_OPLGR Soluble cytochrome b562,C-X-C chemokine receptor t.. | |
8k2x[1] | F | CXL10_HUMAN C-X-C motif chemokine 10[8 aa] | D | 28.6 /36.9 |
14 /17 |
C562_ECOLX CXCR3_HUMAN LUCI_OPLGR Soluble cytochrome b562,C-X-C chemokine receptor t.. | |
7vl9[2] | D | CCL15_HUMAN CCL15(26-92)[65 aa] | E | 34.5 /36.8 |
29 /35 |
CCR1_HUMAN C-C chemokine receptor type 1 | |
8u4r[8] | A | REGN7663 Fab light chain[111 aa] | C | 0.0 /36.4 |
6 /6 |
CXCR4_HUMAN C-X-C chemokine receptor type 4 | |
8u4t[4] | D | REGN7663 Fab light chain[112 aa] | C | 0.0 /36.6 |
2 /3 |
CXCR4_HUMAN C-X-C chemokine receptor type 4 | |
8u4r[8] | B | REGN7663 Fab heavy chain[125 aa] | C | 16.7 /36.4 |
24 /24 |
CXCR4_HUMAN C-X-C chemokine receptor type 4 | |
6lfm[2] | A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | F | 33.3 /36.5 |
21 /21 |
CXCR2_HUMAN C-X-C chemokine receptor type 2 | |
6wwz[1] | B | CCL20_HUMAN C-C motif chemokine 20[66 aa] | F | 18.8 /36.3 |
16 /25 |
CCR6_HUMAN C-C chemokine receptor type 6,C-C chemokine recept.. | |
8k2w[1] | A | Nb6[101 aa] | B | 20.0 /36.2 |
10 /11 |
C562_ECOLX CXCR3_HUMAN OPRK_HUMAN CXCR3_HUMAN Soluble cytochrome b562,C-X-C chemokine receptor t.. | |
8xzg[1] | A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | E | 46.7 /36.1 |
15 /17 |
APJ_HUMAN Apelin receptor | |
8xzg[1] | D | APEL_HUMAN Apelin-13[13 aa] | E | 44.4 /36.1 |
27 /27 |
APJ_HUMAN Apelin receptor | |
8feg[1] | F | ACE-TYR-ALA-DTY-THR-THR-CYS-THR-DPN-XT9[10 aa] | E | 17.4 /35.9 |
23 /23 |
OPRK_HUMAN Kappa-type opioid receptor | |
7vfx[1] | F | Peptide agonist fMIFL[4 aa] | A | 33.3 /35.9 |
15 /16 |
FPR1_HUMAN fMet-Leu-Phe receptor | |
7vl8[6] | A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | D | 42.1 /37.6 |
19 /19 |
CCR1_HUMAN C-C chemokine receptor type 1 | |
8xzf[1] | B | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 26.1 /35.9 |
23 /23 |
APJ_HUMAN Apelin receptor | |
8xzf[1] | F | WN561[14 aa] | A | 48.1 /35.9 |
27 /27 |
APJ_HUMAN Apelin receptor | |
8xzh[1] | F | MM07[13 aa] | A | 40.0 /35.9 |
25 /25 |
APJ_HUMAN Apelin receptor | |
8xzj[1] | F | WN353[13 aa] | A | 39.1 /35.9 |
23 /24 |
APJ_HUMAN Apelin receptor | |
7euo[1] | F | Peptide Agonist fMLF[3 aa] | A | 41.7 /35.9 |
12 /13 |
FPR1_HUMAN fMet-Leu-Phe receptor | |
7wvu[1] | E | FME-LEU-PHE[3 aa] | A | 40.0 /35.7 |
10 /11 |
FPR1_HUMAN fMet-Leu-Phe receptor | |
7wvu[1] | B | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 27.8 /35.7 |
18 /18 |
FPR1_HUMAN fMet-Leu-Phe receptor | |
7w0n[4] | H | ELA_HUMAN Apelin receptor early endogenous ligand[15 aa] | D | 50.0 /35.6 |
18 /18 |
C562_ECOLX APJ_HUMAN Soluble cytochrome b562,Apelin receptor | |
7w0o[2] | A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | E | 18.2 /35.6 |
11 /12 |
C562_ECOLX APJ_HUMAN Soluble cytochrome b562,Apelin receptor | |
7wvw[1] | A | FME-TYR-PHE-ILE-ASN-ILE-LEU-THE-LEU[7 aa] | B | 42.1 /35.7 |
19 /21 |
C562_ECOLX FPR2_HUMAN Soluble cytochrome b562,N-formyl peptide receptor .. | |
7wvx[1] | A | HUNIN_HUMAN Humanin[15 aa] | B | 35.0 /35.7 |
20 /23 |
C562_ECOLX FPR2_HUMAN Soluble cytochrome b562,N-formyl peptide receptor .. | |
7sk5[2] | B | CID24 Fab heavy chain[220 aa] | A | 14.8 /34.3 |
27 /29 |
ACKR3_HUMAN Atypical chemokine receptor 3 | |
7sk5[2] | D | CID24 Fab light chain[211 aa] | A | 0.0 /34.3 |
6 /6 |
ACKR3_HUMAN Atypical chemokine receptor 3 | |
7sk7[1] | C | CID25 Fab light chain[211 aa] | A | 50.0 /37.0 |
2 /2 |
ACKR3_HUMAN Atypical chemokine receptor 3 | |
7w0m[1] | A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | D | 46.2 /35.6 |
13 /14 |
C562_ECOLX APJ_HUMAN Soluble cytochrome b562,Apelin receptor | |
8dzr[1] | B | G alpha gustducin protein[205 aa] | A | 28.6 /35.6 |
21 /21 |
OPRK_HUMAN Kappa-type opioid receptor | |
3sn6[1] | B | GBB1_RAT Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | D | 0.0 /29.1 |
2 /2 |
ENLYS_BPT4 ADRB2_HUMAN Endolysin,Beta-2 adrenergic receptor | |
6lfm[2] | B | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | F | 0.0 /36.5 |
1 /1 |
CXCR2_HUMAN C-X-C chemokine receptor type 2 | |
6ni3[1] | B | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | D | 0.0 /29.6 |
1 /1 |
A0A097J809_BPT4 ADRB2_HUMAN Endolysin,Beta-2 adrenergic receptor chimera | |
6omm[11] | D | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | A | 0.0 /34.3 |
2 /2 |
FPR2_HUMAN N-formyl peptide receptor 2 | |
6vms[3] | B | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | E | 0.0 /28.5 |
1 /3 |
D9IEF7_BPT4 DRD2_HUMAN DRD2_HUMAN Endolysin,D(2) dopamine receptor,D(2) dopamine rec.. | |
7db6[6] | B | Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | E | 25.0 /27.1 |
4 /4 |
MTR1A_HUMAN Melatonin receptor type 1A | |
7eib[1] | D | GBB1_RAT Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | A | 0.0 /34.4 |
1 /1 |
BKRB1_HUMAN B1 bradykinin receptor | |
7euo[1] | C | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | A | 0.0 /35.9 |
1 /1 |
FPR1_HUMAN fMet-Leu-Phe receptor | |
7f1r[2] | C | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | A | 0.0 /34.6 |
1 /1 |
CCL5_HUMAN CCR5_HUMAN C-C motif chemokine 5,C-C chemokine receptor type .. | |
7f6i[2] | D | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | A | 0.0 /34.4 |
1 /1 |
Bradykinin receptor BK2R | |
7rkf[11] | B | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | F | 0.0 /29.5 |
2 /3 |
US28_HCMVA G-protein coupled receptor homolog US28 | |
7rkn[1] | B | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | F | 0.0 /29.5 |
2 /2 |
US28_HCMVA G-protein coupled receptor homolog US28 | |
7t2g[1] | B | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | D | 100.0 /35.1 |
1 /1 |
C562_ECOLX OPRM_MOUSE Soluble cytochrome b562,Mu-type opioid receptor | |
7t6s[3] | B | GBB1_RAT Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | E | 0.0 /34.3 |
2 /2 |
FPR2_HUMAN N-formyl peptide receptor 2 | |
7t6t[1] | B | GBB1_RAT Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | E | 0.0 /35.7 |
1 /1 |
FPR1_HUMAN fMet-Leu-Phe receptor | |
7vgy[2] | C | GBB1_RAT Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | A | 0.0 /28.2 |
1 /1 |
MTR1A_HUMAN Melatonin receptor type 1A | |
7vkt[1] | C | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | A | 0.0 /31.8 |
1 /1 |
LT4R1_HUMAN Leukotriene B4 receptor 1 | |
7w0m[3] | B | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | D | 50.0 /35.6 |
2 /2 |
C562_ECOLX APJ_HUMAN Soluble cytochrome b562,Apelin receptor | |
7w55[2] | B | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | F | 0.0 /30.4 |
1 /1 |
Neuromedin-U receptor 2 | |
7wj5[1] | B | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | E | 100.0 /33.3 |
2 /2 |
C562_ECOLX SSR2_HUMAN Soluble cytochrome b562,Somatostatin receptor type.. | |
7wq4[4] | D | GBB1_RAT Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | A | 0.0 /29.7 |
1 /1 |
GALR2_HUMAN Galanin receptor type 2 | |
7wvv[4] | D | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | B | 0.0 /34.6 |
1 /1 |
C562_ECOLX FPR2_HUMAN Soluble cytochrome b562,N-formyl peptide receptor .. | |
7x9b[1] | B | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | D | 0.0 /29.9 |
1 /1 |
NPY2R_HUMAN Neuropeptide Y receptor type 2 | |
7xav[1] | C | GBB1_BOVIN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | A | 100.0 /34.1 |
1 /1 |
SSR2_HUMAN Somatostatin receptor type 2,LargeBit | |
7xbd[1] | C | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | A | 0.0 /29.3 |
1 /1 |
GALR2_HUMAN Galanin receptor type 2 | |
7xbw[3] | B | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | D | 0.0 /35.6 |
1 /1 |
CX3C1_HUMAN CX3C chemokine receptor 1 | |
7xbx[1] | B | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | D | 0.0 /35.1 |
1 /1 |
X3CL1_HUMAN CX3C1_HUMAN Processed fractalkine,CX3C chemokine receptor 1 | |
7xjk[1] | C | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | F | 0.0 /29.7 |
3 /3 |
GALR2_HUMAN Galanin receptor type 2 | |
7xv3[1] | E | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | A | 0.0 /29.7 |
1 /1 |
GP174_HUMAN Probable G-protein coupled receptor 174 | |
7y89[2] | B | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | E | 0.0 /31.8 |
1 /1 |
GPR17_HUMAN Uracil nucleotide/cysteinyl leukotriene receptor | |
7ykd[1] | D | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | B | 100.0 /36.9 |
2 /3 |
CML1_HUMAN Chemerin-like receptor 1 | |
8ge1[11] | B | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | D | 0.0 /30.2 |
1 /1 |
ADRB2_HUMAN Beta-2 adrenergic receptor | |
8h2g[3] | C | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | A | 100.0 /24.5 |
1 /1 |
HCAR2_HUMAN Hydroxy-carboxylic acid receptor 2 | |
8i95[6] | B | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | E | 0.0 /32.1 |
1 /1 |
C3AR_HUMAN C3a anaphylatoxin chemotactic receptor | |
8izb[1] | B | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | E | 0.0 /29.5 |
1 /1 |
GP174_HUMAN Probable G-protein coupled receptor 174 | |
8j6q[1] | B | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | E | 100.0 /24.4 |
1 /1 |
HCAR2_HUMAN Hydroxycarboxylic acid receptor 2 | |
8jz7[1] | A | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | E | 100.0 /25.6 |
1 /1 |
HCAR2_HUMAN Hydroxycarboxylic acid receptor 2 | |
8kfx[1] | B | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | D | 100.0 /31.7 |
1 /2 |
CCR8_HUMAN C-C chemokine receptor type 8,Fusion protein | |
8sai[1] | D | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | A | 0.0 /30.1 |
1 /1 |
GPR34_HUMAN Probable G-protein coupled receptor 34 | |
8wrb[1] | B | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | E | 0.0 /30.8 |
1 /1 |
GPR34_HUMAN Probable G-protein coupled receptor 34,Tag | |
7w0l[2] | A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | E | 41.7 /35.6 |
12 /13 |
C562_ECOLX APJ_HUMAN Soluble cytochrome b562,Apelin receptor | |
6dde[2] | F | DAMGO[5 aa] | E | 26.7 /35.3 |
15 /15 |
OPRM_MOUSE Mu-type opioid receptor | |
7f2o[1] | A | G subunit q (Gi1-Gq chimeric)[230 aa] | D | 41.4 /35.3 |
29 /30 |
BKRB2_HUMAN B2 bradykinin receptor | |
7xa3[1] | B | CCL2_HUMAN C-C motif chemokine 2[69 aa] | A | 25.0 /35.3 |
20 /26 |
CCR2_HUMAN Isoform B of C-C chemokine receptor type 2 | |
7xa3[1] | C | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 41.2 /35.3 |
17 /17 |
CCR2_HUMAN Isoform B of C-C chemokine receptor type 2 | |
8efb[1] | B | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 25.0 /34.1 |
24 /24 |
OPRM_HUMAN Mu-type opioid receptor | |
8f7w[1] | C | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 36.8 /35.3 |
19 /20 |
OPRK_HUMAN Kappa-type opioid receptor | |
8f7w[1] | B | PDYN_HUMAN Dynorphin[8 aa] | A | 26.3 /35.3 |
19 /20 |
OPRK_HUMAN Kappa-type opioid receptor | |
8dzs[1] | B | GNAZ_HUMAN Guanine nucleotide-binding protein G(z) subunit al.. | A | 27.8 /35.2 |
18 /19 |
OPRK_HUMAN Kappa-type opioid receptor | |
8dzq[1] | D | GNAO_HUMAN Guanine nucleotide-binding protein G(o) subunit al.. | E | 28.6 /35.2 |
21 /21 |
OPRK_HUMAN Kappa-type opioid receptor | |
6dde[6] | A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | E | 28.6 /35.3 |
21 /22 |
OPRM_MOUSE Mu-type opioid receptor | |
7sbf[1] | A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | E | 28.6 /35.3 |
21 /21 |
C562_ECOLX OPRM_MOUSE Soluble cytochrome b562, Mu-type opioid receptor c.. | |
7y1f[1] | A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | C | 34.8 /35.1 |
23 /24 |
OPRK_HUMAN Kappa-type opioid receptor | |
7t2g[1] | A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | D | 30.8 /35.1 |
26 /27 |
C562_ECOLX OPRM_MOUSE Soluble cytochrome b562,Mu-type opioid receptor | |
7y1f[1] | B | Dynorphin[9 aa] | C | 17.4 /35.1 |
23 /24 |
OPRK_HUMAN Kappa-type opioid receptor | |
8qot[1] | B | Nanobody E (NbE)[125 aa] | A | 10.0 /35.1 |
20 /20 |
OPRM_MOUSE Mu-type opioid receptor | |
6lfm[2] | D | IL8_HUMAN Interleukin-8[71 aa] | F | 13.3 /36.5 |
15 /27 |
CXCR2_HUMAN C-X-C chemokine receptor type 2 | |
6lfm[1] | E | IL8_HUMAN Interleukin-8[67 aa] | F | 0.0 /36.5 |
2 /2 |
CXCR2_HUMAN C-X-C chemokine receptor type 2 | |
8ic0[1] | F | IL8_HUMAN Interleukin-8[69 aa] | A | 11.8 /35.0 |
17 /25 |
CXCR1_HUMAN C-X-C chemokine receptor type 1 | |
7ul4[1] | B | Megabody 6[65 aa] | A | 11.1 /35.0 |
9 /10 |
OPRM_MOUSE Mu-type opioid receptor | |
8ic0[1] | B | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 28.6 /35.0 |
21 /21 |
CXCR1_HUMAN C-X-C chemokine receptor type 1 | |
5c1m[2] | B | Nanobody 39[118 aa] | A | 34.8 /34.9 |
23 /23 |
OPRM_MOUSE Mu-type opioid receptor | |
6b73[2] | D | Nanobody[122 aa] | A | 55.0 /36.9 |
20 /21 |
C562_ECOLX OPRK_HUMAN Soluble cytochrome b562, kappa-type opioid recepto.. | |
7yit[1] | B | Nanobody39[109 aa] | A | 60.0 /37.3 |
15 /16 |
OPRK_HUMAN Kappa-type opioid receptor | |
7y27[1] | F | somatostatin-14[12 aa] | D | 7.7 /34.7 |
13 /13 |
SSR2_HUMAN Somatostatin receptor type 2 | |
3oe0[2] | B | Polyphemusin analog, CXC chemokine receptor antago.. | A | 19.2 /34.7 |
26 /26 |
CXCR4_HUMAN LYS_BPT4 CXCR4_HUMAN C-X-C chemokine receptor type 4, Lysozyme Chimera | |
8efq[1] | D | DAMGO[4 aa] | E | 23.1 /34.7 |
13 /13 |
OPRM_HUMAN Mu-type opioid receptor | |
7sk6[1] | B | SDF1_HUMAN Stromal cell-derived factor 1[59 aa] | A | 20.6 /34.6 |
34 /43 |
ACKR3_HUMAN Atypical chemokine receptor 3 | |
7t6t[1] | D | Synthetic peptide[5 aa] | E | 45.0 /35.7 |
20 /23 |
FPR1_HUMAN fMet-Leu-Phe receptor | |
7t6v[1] | F | Synthetic peptide[5 aa] | A | 33.3 /34.3 |
15 /17 |
FPR2_HUMAN N-formyl peptide receptor 2 | |
7wvv[1] | A | FME-LEU-PHE-ILE-ILE[5 aa] | B | 31.6 /34.6 |
19 /20 |
C562_ECOLX FPR2_HUMAN Soluble cytochrome b562,N-formyl peptide receptor .. | |
7wvv[3] | C | GNAI2_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | B | 31.6 /34.6 |
19 /19 |
C562_ECOLX FPR2_HUMAN Soluble cytochrome b562,N-formyl peptide receptor .. | |
7wvy[1] | A | B4DMD5_HUMAN Amyloid-beta A4 protein[16 aa] | B | 30.8 /34.6 |
26 /28 |
C562_ECOLX FPR2_HUMAN Soluble cytochrome b562,N-formyl peptide receptor .. | |
4rws[1] | B | VMI2_HHV8P Viral macrophage inflammatory protein 2[70 aa] | A | 28.0 /34.5 |
25 /26 |
CXCR4_HUMAN LYS_BPT4 CXCR4_HUMAN C-X-C chemokine receptor type 4/Endolysin chimeric.. | |
8ef5[1] | G | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | F | 38.9 /34.4 |
18 /19 |
OPRM_HUMAN Mu-type opioid receptor | |
8efl[1] | G | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | F | 46.7 /34.4 |
15 /16 |
OPRM_HUMAN Mu-type opioid receptor | |
8efo[1] | G | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | F | 36.8 /34.4 |
19 /20 |
OPRM_HUMAN Mu-type opioid receptor | |
8f7r[2] | B | endomorphin[5 aa] | A | 23.5 /34.4 |
17 /17 |
OPRM_HUMAN Mu-type opioid receptor | |
8f7r[1] | C | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 30.0 /34.4 |
20 /21 |
OPRM_HUMAN Mu-type opioid receptor | |
8f7r[1] | I | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | G | 47.1 /34.4 |
17 /18 |
OPRM_HUMAN Mu-type opioid receptor | |
7eib[1] | B | LYS-ARG-PRO-PRO-GLY-PHE-SER-PRO-PHE[9 aa] | A | 33.3 /34.4 |
24 /26 |
BKRB1_HUMAN B1 bradykinin receptor | |
7eib[1] | C | G subunit q (Gi1-Gq chimeric)[235 aa] | A | 50.0 /34.4 |
24 /25 |
BKRB1_HUMAN B1 bradykinin receptor | |
7f2o[1] | C | ARG-PRO-PRO-GLY-PHE-SER-PRO-PHE-ARG[9 aa] | D | 41.7 /35.3 |
24 /24 |
BKRB2_HUMAN B2 bradykinin receptor | |
7f6h[1] | B | Bradykinin[9 aa] | A | 40.0 /34.4 |
25 /25 |
Bradykinin receptor BK2R | |
7f6h[1] | C | GNAQ_HUMAN Guanine nucleotide-binding protein G(q) subunit al.. | A | 48.0 /34.4 |
25 /26 |
Bradykinin receptor BK2R | |
7f6i[1] | B | Kallidin[10 aa] | A | 35.7 /34.4 |
28 /29 |
Bradykinin receptor BK2R | |
7f6i[1] | C | GNAQ_HUMAN Guanine nucleotide-binding protein G(q) subunit al.. | A | 48.3 /34.4 |
29 /30 |
Bradykinin receptor BK2R | |
7y24[2] | E | Octreotide[8 aa] | F | 5.6 /33.7 |
18 /18 |
SSR2_HUMAN Somatostatin receptor type 2 | |
6lw5[1] | B | TRP-LYS-TYR-MET-VAL-QXV[6 aa] | A | 23.8 /35.3 |
21 /23 |
C562_ECOLX FPR2_HUMAN Soluble cytochrome b562,N-formyl peptide receptor .. | |
6omm[1] | B | Peptide agonist[6 aa] | A | 20.0 /34.3 |
15 /17 |
FPR2_HUMAN N-formyl peptide receptor 2 | |
6omm[1] | C | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 24.0 /34.3 |
25 /25 |
FPR2_HUMAN N-formyl peptide receptor 2 | |
7t6s[2] | A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | E | 25.0 /34.3 |
20 /20 |
FPR2_HUMAN N-formyl peptide receptor 2 | |
7t6t[1] | A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | E | 28.6 /35.7 |
21 /21 |
FPR1_HUMAN fMet-Leu-Phe receptor | |
7t6u[1] | A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | F | 27.3 /34.3 |
22 /22 |
FPR2_HUMAN N-formyl peptide receptor 2 | |
7t6u[1] | E | Synthetic peptide[8 aa] | F | 27.8 /34.3 |
18 /20 |
FPR2_HUMAN N-formyl peptide receptor 2 | |
7xmt[1] | B | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 25.0 /34.2 |
20 /20 |
SSR4_HUMAN Somatostatin receptor type 4 | |
6pt2[2] | C | Peptide agonist KGCHM07[5 aa] | A | 38.1 /32.5 |
21 /21 |
Delta opioid receptor | |
7xna[1] | B | CYN 154806[10 aa] | A | 20.0 /34.1 |
20 /23 |
SSR2_HUMAN XYNA_BACCI SSR2_HUMAN Somatostatin receptor type 2,Endo-1,4-beta-xylanas.. | |
7xat[3] | B | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 19.0 /33.5 |
21 /22 |
SSR2_HUMAN Somatostatin receptor type 2,LargeBit | |
7xau[1] | F | Octreotide[7 aa] | A | 15.8 /34.1 |
19 /19 |
SSR2_HUMAN Somatostatin receptor type 2,LargeBit | |
7xav[1] | F | Lanreotide[6 aa] | A | 6.7 /34.1 |
15 /15 |
SSR2_HUMAN Somatostatin receptor type 2,LargeBit | |
8ef5[4] | B | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 30.4 /34.4 |
23 /24 |
OPRM_HUMAN Mu-type opioid receptor | |
8f7q[1] | C | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 27.3 /34.1 |
22 /23 |
OPRM_HUMAN Mu-type opioid receptor | |
8f7q[1] | C | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | G | 0.0 /34.1 |
1 /1 |
OPRM_HUMAN Mu-type opioid receptor | |
8f7q[2] | B | COLI_HUMAN Beta-endorphin[21 aa] | A | 17.6 /34.1 |
17 /17 |
OPRM_HUMAN Mu-type opioid receptor | |
7sk3[3] | C | CID25 Fab light chain[105 aa] | A | 50.0 /34.0 |
2 /2 |
ACKR3_HUMAN Atypical chemokine receptor 3 | |
7sk3[4] | E | CID24 Fab light chain[106 aa] | A | 0.0 /34.0 |
6 /6 |
ACKR3_HUMAN Atypical chemokine receptor 3 | |
7sk3[3] | D | CID25 Fab heavy chain[123 aa] | A | 33.3 /34.0 |
12 /15 |
ACKR3_HUMAN Atypical chemokine receptor 3 | |
7sk3[4] | F | CID24 Fab heavy chain[125 aa] | A | 14.8 /34.0 |
27 /30 |
ACKR3_HUMAN Atypical chemokine receptor 3 | |
5nj6[1] | B | Fab3949 H[219 aa] | A | 33.3 /33.8 |
3 /13 |
PAR2_HUMAN C562_ECOLX PAR2_HUMAN Proteinase-activated receptor 2,Soluble cytochrome.. | |
5nj6[1] | C | Fab3949 L[213 aa] | A | 50.0 /33.8 |
2 /9 |
PAR2_HUMAN C562_ECOLX PAR2_HUMAN Proteinase-activated receptor 2,Soluble cytochrome.. | |
4rwa[4] | D | bifunctional peptide[5 aa] | A | 16.7 /34.3 |
12 /12 |
C562_ECOLX Soluble cytochrome b562,Delta-type opioid receptor.. | |
7t10[1] | E | SMS_HUMAN Somatostatin-14[14 aa] | A | 19.0 /33.1 |
21 /21 |
SSR2_HUMAN OPRK_HUMAN SSR2_HUMAN Somatostatin receptor type 2,Kappa-type opioid rec.. | |
7wic[1] | A | somatostatin-14[14 aa] | B | 17.4 /33.3 |
23 /23 |
SSR2_HUMAN Somatostatin receptor type 2 | |
7xmr[1] | E | SMS_HUMAN Somatostatin-14[14 aa] | A | 23.1 /33.5 |
26 /26 |
SSR2_HUMAN Somatostatin receptor type 2 | |
7xmr[1] | B | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 26.3 /33.5 |
19 /19 |
SSR2_HUMAN Somatostatin receptor type 2 | |
7t11[1] | E | Octreotide[8 aa] | F | 9.5 /33.0 |
21 /21 |
SSR2_HUMAN OPRK_HUMAN SSR2_HUMAN Somatostatin receptor type 2,Kappa-type opioid rec.. | |
7yae[1] | F | DPN-CYS-PHE-DTR-LYS-THR-CYS-THO[8 aa] | E | 6.2 /33.3 |
16 /16 |
SSR2_HUMAN Somatostatin receptor type 2 | |
7y65[1] | A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | F | 23.5 /29.7 |
17 /17 |
C5AR1_HUMAN C5a anaphylatoxin chemotactic receptor 1 | |
7yae[1] | A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | E | 27.8 /33.3 |
18 /19 |
SSR2_HUMAN Somatostatin receptor type 2 | |
8f7x[1] | B | PNOC_HUMAN Nociceptin[14 aa] | A | 18.2 /33.1 |
22 /22 |
OPRX_HUMAN Nociceptin receptor | |
8f7x[1] | C | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 31.6 /33.1 |
19 /19 |
OPRX_HUMAN Nociceptin receptor | |
7ul5[1] | B | Nanobody 6[86 aa] | A | 10.0 /33.1 |
10 /11 |
SSR2_HUMAN OPRK_HUMAN SSR2_HUMAN Somatostatin receptor type 2 | |
7wj5[1] | F | Somatostatin-14 (SST-14)[12 aa] | E | 18.2 /33.3 |
22 /22 |
C562_ECOLX SSR2_HUMAN Soluble cytochrome b562,Somatostatin receptor type.. | |
7xat[1] | F | SMS_HUMAN Somatostatin-14[12 aa] | A | 15.0 /33.5 |
20 /20 |
SSR2_HUMAN Somatostatin receptor type 2,LargeBit | |
7xms[1] | F | SMS_HUMAN Somatostatin-14[12 aa] | A | 10.5 /33.1 |
19 /19 |
SSR4_HUMAN Somatostatin receptor type 4 | |
7xms[1] | B | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 20.0 /33.1 |
20 /21 |
SSR4_HUMAN Somatostatin receptor type 4 | |
7t10[2] | B | GNAI3_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 30.8 /33.1 |
13 /13 |
SSR2_HUMAN OPRK_HUMAN SSR2_HUMAN Somatostatin receptor type 2,Kappa-type opioid rec.. | |
8tlm[1] | A | Fab heavy chain[215 aa] | C | 18.2 /32.8 |
11 /11 |
CCR8_HUMAN GFP_AEQVI C-C chemokine receptor type 8, Green fluorescent p.. | |
8tlm[1] | B | Fab light chain[215 aa] | C | 33.3 /32.8 |
3 /3 |
CCR8_HUMAN GFP_AEQVI C-C chemokine receptor type 8, Green fluorescent p.. | |
8i95[2] | F | EP54 ligand[9 aa] | E | 26.3 /32.1 |
19 /24 |
C3AR_HUMAN C3a anaphylatoxin chemotactic receptor | |
8i9a[1] | A | Guanine nucleotide-binding protein G(q) subunit al.. | E | 35.3 /32.6 |
17 /17 |
C3AR_HUMAN C3a anaphylatoxin chemotactic receptor | |
8ef6[1] | G | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | F | 44.4 /34.4 |
18 /19 |
OPRM_HUMAN Mu-type opioid receptor | |
8f7q[1] | I | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | G | 40.0 /34.1 |
15 /16 |
OPRM_HUMAN Mu-type opioid receptor | |
8f7s[1] | H | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | F | 46.7 /32.5 |
15 /15 |
OPRD_HUMAN Delta-type opioid receptor | |
8f7s[2] | B | DA2D_PHYBI deltorphin[8 aa] | A | 31.6 /32.5 |
19 /19 |
OPRD_HUMAN Delta-type opioid receptor | |
8f7s[1] | C | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 33.3 /32.5 |
21 /21 |
OPRD_HUMAN Delta-type opioid receptor | |
5uiw[1] | B | CCL5_HUMAN C-C motif chemokine 5[68 aa] | A | 18.9 /33.8 |
37 /40 |
CCR5_HUMAN RUBR_CLOPA CCR5_HUMAN C-C chemokine receptor type 5,Rubredoxin chimera | |
7o7f[1] | E | CCL5_HUMAN C-C motif chemokine 5[67 aa] | C | 23.3 /32.4 |
30 /31 |
CCR5_HUMAN C-C chemokine receptor type 5 | |
6meo[2] | A | Q70145_9HIV1 Envelope glycoprotein gp160[398 aa] | C | 16.0 /32.4 |
25 /35 |
CCR5_HUMAN C-C chemokine receptor type 5 | |
7o7f[1] | A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | C | 41.2 /32.4 |
17 /17 |
CCR5_HUMAN C-C chemokine receptor type 5 | |
7f6g[1] | C | GNAQ_HUMAN Guanine nucleotide-binding protein G(q) subunit al.. | A | 100.0 /99.4 |
20 /20 |
Angiotensin receptor AT1R | |
7w3z[1] | C | GNAQ_HUMAN Guanine nucleotide-binding protein G(q) subunit al.. | A | 50.0 /32.4 |
20 /26 |
A0A6D0N546_ECOLX GRPR_HUMAN Maltodextrin-binding protein,Gastrin-releasing pep.. | |
7w3z[1] | B | Gastrin Releasing Peptide PRGNHWAVGHLM(NH2)[13 aa].. | A | 45.8 /32.4 |
24 /34 |
A0A6D0N546_ECOLX GRPR_HUMAN Maltodextrin-binding protein,Gastrin-releasing pep.. | |
7w40[1] | B | GNAQ_HUMAN Guanine nucleotide-binding protein G(q) subunit al.. | A | 50.0 /32.4 |
18 /24 |
A0A6D0N546_ECOLX GRPR_HUMAN Maltodextrin-binding protein,Gastrin-releasing pep.. | |
7w40[1] | F | Bombesin[9 aa] | A | 38.9 /32.4 |
18 /28 |
A0A6D0N546_ECOLX GRPR_HUMAN Maltodextrin-binding protein,Gastrin-releasing pep.. | |
7xjj[1] | C | GALA_HUMAN Galanin[17 aa] | D | 11.8 /32.3 |
17 /18 |
GALR1_HUMAN Galanin receptor type 1 | |
8i9l[1] | F | CO3_HUMAN C3a anaphylatoxin[70 aa] | E | 23.5 /32.1 |
17 /21 |
C3AR_HUMAN C3a anaphylatoxin chemotactic receptor | |
8j6d[1] | D | EP141 peptide agonist[10 aa] | C | 12.5 /32.1 |
16 /19 |
C3AR_HUMAN C3a anaphylatoxin chemotactic receptor | |
7f1q[3] | B | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 45.5 /32.4 |
22 /22 |
CCL3_HUMAN CCR5_HUMAN C-C motif chemokine 3,C-C chemokine receptor type .. | |
7f1s[1] | B | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 31.6 /33.3 |
19 /19 |
CCR5_HUMAN C-C chemokine receptor type 5 | |
7vh0[1] | B | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 42.9 /33.2 |
14 /15 |
MTR1B_HUMAN Melatonin receptor type 1B | |
7wj5[1] | A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | E | 20.0 /33.3 |
15 /17 |
C562_ECOLX SSR2_HUMAN Soluble cytochrome b562,Somatostatin receptor type.. | |
7x9a[1] | B | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 35.3 /33.3 |
17 /18 |
NPY1R_HUMAN Neuropeptide Y receptor type 1 | |
7xbw[1] | A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | D | 41.4 /35.6 |
29 /29 |
CX3C1_HUMAN CX3C chemokine receptor 1 | |
7ykd[1] | C | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | B | 42.9 /36.9 |
21 /21 |
CML1_HUMAN Chemerin-like receptor 1 | |
7yoo[1] | A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | E | 30.8 /29.9 |
13 /16 |
NPY2R_HUMAN Neuropeptide Y receptor type 2 | |
8dzp[2] | B | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 26.1 /35.2 |
23 /23 |
OPRK_HUMAN Kappa-type opioid receptor | |
8hqe[4] | E | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | D | 33.3 /27.7 |
15 /16 |
C562_ECOLX GP132_HUMAN Soluble cytochrome b562,Probable G-protein coupled.. | |
8ia8[1] | C | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | B | 21.4 /31.8 |
14 /15 |
C3AR_HUMAN C3a anaphylatoxin chemotactic receptor | |
8ij3[4] | C | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 21.4 /24.5 |
14 /16 |
HCAR2_HUMAN Hydroxycarboxylic acid receptor 2 | |
8j6j[1] | A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | E | 17.6 /24.5 |
17 /17 |
HCAR2_HUMAN Hydroxycarboxylic acid receptor 2,hydroxycarboxyli.. | |
8u1u[1] | B | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 33.3 /31.9 |
18 /18 |
CCL1_HUMAN CCR8_HUMAN A0A6M5E0N3_ADE02 C-C motif chemokine 1,C-C chemokine receptor type .. | |
7y89[1] | A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | E | 40.0 /31.8 |
20 /21 |
GPR17_HUMAN Uracil nucleotide/cysteinyl leukotriene receptor | |
8hk2[1] | B | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 22.2 /31.8 |
18 /19 |
C3AR_HUMAN C3a anaphylatoxin chemotactic receptor | |
8hk2[1] | D | CO3_HUMAN C3a anaphylatoxin[73 aa] | A | 19.0 /31.8 |
21 /26 |
C3AR_HUMAN C3a anaphylatoxin chemotactic receptor | |
8hk3[1] | A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | C | 33.3 /31.8 |
18 /19 |
C3AR_HUMAN C3a anaphylatoxin chemotactic receptor | |
8ia8[1] | A | ALA-SER-LYS-LEU-GLY-LEU-ALA-ARG[8 aa] | B | 25.0 /31.8 |
16 /19 |
C3AR_HUMAN C3a anaphylatoxin chemotactic receptor | |
7vkt[1] | B | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 36.8 /31.8 |
19 /19 |
LT4R1_HUMAN Leukotriene B4 receptor 1 | |
8kfx[3] | A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | D | 32.0 /31.7 |
25 /25 |
CCR8_HUMAN C-C chemokine receptor type 8,Fusion protein | |
7xk8[1] | A | NMU_HUMAN Neuromedin-U-25[26 aa] | B | 14.3 /31.4 |
21 /24 |
NMUR2_HUMAN Neuromedin-U receptor 2 | |
7xk8[1] | C | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | B | 43.8 /31.4 |
16 /16 |
NMUR2_HUMAN Neuromedin-U receptor 2 | |
8h0p[1] | A | NMB30[10 aa] | B | 3.6 /31.3 |
28 /31 |
NMBR_HUMAN Neuromedin-B receptor | |
8h0p[1] | C | G-alpha q[213 aa] | B | 40.0 /31.3 |
20 /20 |
NMBR_HUMAN Neuromedin-B receptor | |
7wvx[1] | C | GNAI2_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | B | 23.5 /35.7 |
17 /17 |
C562_ECOLX FPR2_HUMAN Soluble cytochrome b562,N-formyl peptide receptor .. | |
7yj4[2] | D | GNAI2_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | E | 10.5 /31.3 |
19 /19 |
RL3R2_HUMAN Relaxin-3 receptor 2 | |
7yj4[1] | A | INSL5_HUMAN Insulin-like peptide INSL5 A chain[20 aa] | E | 0.0 /31.3 |
2 /2 |
RL3R2_HUMAN Relaxin-3 receptor 2 | |
7yj4[1] | B | INSL5_HUMAN Insulin-like peptide INSL5 B chain[20 aa] | E | 12.5 /31.3 |
16 /18 |
RL3R2_HUMAN Relaxin-3 receptor 2 | |
7yk7[1] | B | GNAI2_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | C | 10.0 /31.3 |
20 /20 |
RL3R2_HUMAN Relaxin-3 receptor 2 | |
7x9c[1] | B | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 13.0 /31.3 |
23 /24 |
NPY4R_HUMAN Neuropeptide Y receptor type 4 | |
7x9c[1] | E | PAHO_HUMAN Pancreatic hormone[36 aa] | A | 22.2 /31.3 |
27 /33 |
NPY4R_HUMAN Neuropeptide Y receptor type 4 | |
8efq[1] | A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | E | 35.0 /34.7 |
20 /21 |
OPRM_HUMAN Mu-type opioid receptor | |
8j6i[1] | B | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 18.8 /24.4 |
16 /18 |
HCAR2_HUMAN Hydroxycarboxylic acid receptor 2 | |
8k4n[1] | A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | E | 40.0 /31.2 |
10 /15 |
GPR34_HUMAN Probable G-protein coupled receptor 34 | |
8geh[1] | A | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit al.. | D | 50.0 /31.0 |
8 /12 |
ADRB2_HUMAN Beta-2 adrenergic receptor | |
7trs[1] | D | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | E | 28.6 /29.9 |
14 /14 |
ACM4_HUMAN ACM4_HUMAN Muscarinic acetylcholine receptor M4 | |
8wrb[1] | A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | E | 33.3 /30.8 |
12 /16 |
GPR34_HUMAN Probable G-protein coupled receptor 34,Tag | |
7l1u[1] | F | OREX_HUMAN Orexin[10 aa] | E | 21.1 /30.7 |
19 /21 |
Q548Y0_HUMAN Hypocretin receptor type 2 | |
8xbh[1] | A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | D | 31.6 /30.6 |
19 /23 |
GPR34_HUMAN Probable G-protein coupled receptor 34 | |
8gei[1] | A | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit al.. | D | 28.6 /30.5 |
7 /9 |
ADRB2_HUMAN Beta-2 adrenergic receptor | |
7vgx[1] | B | NPY_HUMAN Neuropeptide Y[22 aa] | A | 23.8 /30.5 |
21 /26 |
NPY1R_HUMAN Neuropeptide Y receptor type 1 | |
7vgx[1] | C | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 35.7 /30.5 |
14 /14 |
NPY1R_HUMAN Neuropeptide Y receptor type 1 | |
7w55[1] | A | Guanine nucleotide-binding protein G(q) subunit al.. | F | 38.5 /30.4 |
26 /29 |
Neuromedin-U receptor 2 | |
7w55[1] | C | NMU_HUMAN Neuromedin-U-25[9 aa] | F | 20.8 /30.4 |
24 /27 |
Neuromedin-U receptor 2 | |
4mqs[2] | B | Nanobody 9-8[121 aa] | A | 25.0 /30.1 |
12 /12 |
ACM2_HUMAN ACM2_HUMAN Muscarinic acetylcholine receptor M2 | |
7bz2[1] | A | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit al.. | E | 35.3 /30.3 |
17 /18 |
Beta2 adrenergic receptor | |
7dhr[1] | A | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit al.. | E | 27.8 /30.3 |
18 /19 |
ADRB2_HUMAN Beta-2 adrenergic receptor | |
7y67[1] | A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | D | 20.0 /30.3 |
20 /20 |
C5AR1_HUMAN C5a anaphylatoxin chemotactic receptor 1 | |
7y67[1] | F | C089 peptide[6 aa] | D | 0.0 /30.3 |
16 /16 |
C5AR1_HUMAN C5a anaphylatoxin chemotactic receptor 1 | |
6ni3[1] | A | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit al.. | D | 40.0 /29.6 |
15 /20 |
A0A097J809_BPT4 ADRB2_HUMAN Endolysin,Beta-2 adrenergic receptor chimera | |
7dhi[33] | A | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit al.. | E | 33.3 /30.2 |
21 /24 |
ADRB2_HUMAN Beta-2 adrenergic receptor | |
8ge8[1] | A | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit al.. | D | 41.7 /30.2 |
12 /17 |
ADRB2_HUMAN Beta-2 adrenergic receptor | |
8gea[1] | A | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit al.. | D | 46.2 /30.2 |
13 /16 |
ADRB2_HUMAN Beta-2 adrenergic receptor | |
8ged[2] | A | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit al.. | D | 36.4 /30.2 |
11 /15 |
ADRB2_HUMAN Beta-2 adrenergic receptor | |
8gef[1] | A | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit al.. | D | 45.5 /30.2 |
11 /16 |
ADRB2_HUMAN Beta-2 adrenergic receptor | |
8geg[1] | A | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit al.. | D | 30.8 /30.2 |
13 /18 |
ADRB2_HUMAN Beta-2 adrenergic receptor | |
8gg5[1] | A | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit al.. | D | 38.5 /30.2 |
13 /19 |
ADRB2_HUMAN Beta-2 adrenergic receptor | |
8gg6[1] | A | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit al.. | D | 62.5 /30.2 |
8 /14 |
ADRB2_HUMAN Beta-2 adrenergic receptor | |
8gg8[1] | A | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit al.. | D | 54.5 /30.2 |
11 /16 |
ADRB2_HUMAN Beta-2 adrenergic receptor | |
8gg9[1] | A | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit al.. | D | 50.0 /30.2 |
10 /13 |
ADRB2_HUMAN Beta-2 adrenergic receptor | |
8uo1[1] | A | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit al.. | D | 62.5 /30.2 |
8 /13 |
ADRB2_HUMAN Beta-2 adrenergic receptor | |
8unp[1] | A | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit al.. | D | 36.4 /30.2 |
11 /16 |
ADRB2_HUMAN Beta-2 adrenergic receptor | |
8unq[1] | A | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit al.. | D | 62.5 /30.2 |
8 /13 |
ADRB2_HUMAN Beta-2 adrenergic receptor | |
8unr[1] | A | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit al.. | D | 41.7 /30.2 |
12 /16 |
ADRB2_HUMAN Beta-2 adrenergic receptor | |
8uns[1] | A | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit al.. | D | 55.6 /30.2 |
9 /12 |
ADRB2_HUMAN Beta-2 adrenergic receptor | |
8uny[1] | A | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit al.. | D | 66.7 /30.2 |
9 /13 |
ADRB2_HUMAN Beta-2 adrenergic receptor | |
8uo2[1] | A | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit al.. | D | 42.9 /30.2 |
7 /12 |
ADRB2_HUMAN Beta-2 adrenergic receptor | |
7w57[1] | A | Guanine nucleotide-binding protein G(q) subunit al.. | F | 33.3 /30.2 |
24 /25 |
Neuromedin-U receptor 2 | |
7w57[1] | C | NMS_HUMAN Neuromedin-S[12 aa] | F | 15.4 /30.2 |
26 /29 |
Neuromedin-U receptor 2 | |
8sai[1] | C | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 50.0 /30.1 |
10 /14 |
GPR34_HUMAN Probable G-protein coupled receptor 34 | |
5jqh[2] | D | Nanobody60, Nb60[120 aa] | A | 18.2 /29.8 |
22 /25 |
ENLYS_BPT4 ADRB2_HUMAN Endolysin,Beta-2 adrenergic receptor | |
4xt1[1] | C | nanobody 7[116 aa] | A | 26.1 /30.1 |
23 /23 |
US28_HCMVA G-protein coupled receptor homolog US28 | |
7trk[4] | E | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 31.2 /30.0 |
16 /17 |
ACM4_HUMAN ACM4_HUMAN Muscarinic acetylcholine receptor M4 | |
7y65[1] | D | C5apep peptide[6 aa] | F | 15.8 /29.7 |
19 /19 |
C5AR1_HUMAN C5a anaphylatoxin chemotactic receptor 1 | |
8hpt[1] | B | MEA-LYS-PRO-ZAL-ALC-DAR[6 aa] | A | 8.3 /30.0 |
12 /12 |
C5AR1_MOUSE C5a anaphylatoxin chemotactic receptor 1 | |
7x9a[1] | E | NPY_HUMAN Neuropeptide Y[36 aa] | A | 31.4 /33.3 |
35 /42 |
NPY1R_HUMAN Neuropeptide Y receptor type 1 | |
7x9b[1] | E | NPY_HUMAN Neuropeptide Y[36 aa] | D | 21.1 /29.9 |
19 /22 |
NPY2R_HUMAN Neuropeptide Y receptor type 2 | |
7x9b[1] | A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | D | 27.8 /29.9 |
18 /20 |
NPY2R_HUMAN Neuropeptide Y receptor type 2 | |
7yon[1] | A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | E | 18.2 /29.9 |
11 /14 |
NPY2R_HUMAN Neuropeptide Y receptor type 2 | |
7yon[1] | D | PYY_HUMAN Peptide YY(3-36)[25 aa] | E | 28.6 /29.9 |
21 /23 |
NPY2R_HUMAN Neuropeptide Y receptor type 2 | |
7yoo[1] | D | NPY_HUMAN Neuropeptide Y[29 aa] | E | 28.0 /29.9 |
25 /28 |
NPY2R_HUMAN Neuropeptide Y receptor type 2 | |
6c1q[2] | B | PMX53[7 aa] | A | 18.2 /29.9 |
22 /22 |
C562_ECOLX C5AR1_HUMAN Soluble cytochrome b562, C5a anaphylatoxin chemota.. | |
4gbr[1] | B | LYS_BPT4 Lysozyme[162 aa] | A | 50.0 /29.9 |
2 /7 |
ADRB2_HUMAN Beta-2 adrenergic receptor | |
7xxh[1] | B | Guanine nucleotide-binding protein G(11) subunit a.. | A | 32.1 /29.8 |
28 /28 |
P2RY1_HUMAN P2Y purinoceptor 1 | |
7xxi[1] | B | GNAI2_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 38.1 /29.7 |
21 /21 |
P2Y12_HUMAN P2Y purinoceptor 12 | |
7wq4[1] | B | GALA_HUMAN Galanin[13 aa] | A | 9.1 /29.7 |
22 /22 |
GALR2_HUMAN Galanin receptor type 2 | |
7wq4[1] | C | Engineered Guanine nucleotide-binding protein G(q).. | A | 42.9 /29.7 |
21 /21 |
GALR2_HUMAN Galanin receptor type 2 | |
7xv3[1] | C | Engineered G protein subunit S (mini-Gs)[234 aa] | A | 17.9 /29.7 |
28 /28 |
GP174_HUMAN Probable G-protein coupled receptor 174 | |
6wwz[1] | D | GNAO_HUMAN GNAO_HUMAN Guanine nucleotide-binding protein G(o) subunit al.. | F | 58.8 /36.3 |
17 /18 |
CCR6_HUMAN C-C chemokine receptor type 6,C-C chemokine recept.. | |
7w2z[1] | A | A0A1W2PS82_HUMAN GNAO_HUMAN Guanine nucleotide-binding protein G(o) subunit al.. | B | 50.0 /27.9 |
14 /16 |
GHSR_HUMAN Growth hormone secretagogue receptor type 1 | |
7xjj[1] | A | A0A1W2PRJ7_HUMAN A0A1W2PP38_HUMAN GNAO_HUMAN G protein subunit alpha o1,Guanine nucleotide-bind.. | D | 30.0 /32.3 |
20 /21 |
GALR1_HUMAN Galanin receptor type 1 | |
7y24[1] | A | GNAO_HUMAN GNAO_HUMAN GNAO_HUMAN Guanine nucleotide-binding protein G(o) subunit al.. | F | 35.7 /33.7 |
14 /15 |
SSR2_HUMAN Somatostatin receptor type 2 | |
8hpt[4] | C | GNAO_HUMAN GNAO_HUMAN Guanine nucleotide-binding protein G(o) subunit al.. | A | 11.1 /30.0 |
18 /18 |
C5AR1_MOUSE C5a anaphylatoxin chemotactic receptor 1 | |
8i95[5] | A | GNAO_HUMAN GNAO_HUMAN Guanine nucleotide-binding protein G(o) subunit al.. | E | 25.0 /32.1 |
16 /17 |
C3AR_HUMAN C3a anaphylatoxin chemotactic receptor | |
8iy9[5] | A | GNAO_HUMAN GNAO_HUMAN Guanine nucleotide-binding protein G(o) subunit al.. | E | 28.6 /24.2 |
21 /21 |
ACM4_HUMAN HCAR2_HUMAN Hydroxycarboxylic acid receptor 2 | |
7wq3[2] | F | GALA_HUMAN Galanin[16 aa] | A | 5.9 /29.7 |
17 /18 |
GALR1_HUMAN Galanin receptor type 1 | |
7xbd[1] | F | GALA_HUMAN Galanin[16 aa] | A | 0.0 /29.3 |
16 /17 |
GALR2_HUMAN Galanin receptor type 2 | |
7xjl[1] | A | spexin[14 aa] | F | 21.1 /29.7 |
19 /19 |
GALR2_HUMAN Galanin receptor type 2 | |
7y64[2] | A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | E | 10.5 /29.7 |
19 /19 |
C5AR1_HUMAN C5a anaphylatoxin chemotactic receptor 1 | |
7y64[2] | F | CO5_HUMAN C5a anaphylatoxin[74 aa] | E | 10.3 /29.7 |
29 /34 |
C5AR1_HUMAN C5a anaphylatoxin chemotactic receptor 1 | |
8hqc[3] | D | CO5_HUMAN C5a anaphylatoxin[74 aa] | A | 8.3 /29.0 |
12 /14 |
C5AR1_MOUSE C5a anaphylatoxin chemotactic receptor 1 | |
7y66[1] | F | BM213 peptide[9 aa] | E | 10.0 /29.7 |
20 /20 |
C5AR1_HUMAN C5a anaphylatoxin chemotactic receptor 1 | |
8hk5[1] | C | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 19.0 /29.7 |
21 /21 |
C5AR1_HUMAN C5a anaphylatoxin chemotactic receptor 1 | |
7vla[2] | A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | E | 42.9 /36.8 |
14 /14 |
CCR1_HUMAN C-C chemokine receptor type 1 | |
7wic[2] | C | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | B | 22.2 /33.3 |
18 /19 |
SSR2_HUMAN Somatostatin receptor type 2 | |
6ibb[4] | B | Nanobody6[133 aa] | A | 28.6 /32.0 |
14 /16 |
SUCR1_RAT Succinate receptor 1 | |
6mxt[1] | B | nanobody Nb71[122 aa] | A | 25.0 /29.6 |
20 /25 |
D9IEF7_BPT4 ADRB2_HUMAN ADRB2_HUMAN Endolysin, Beta-2 adrenergic receptor chimera | |
4xt1[6] | B | X3CL1_HUMAN Fractalkine[68 aa] | A | 20.8 /30.1 |
24 /34 |
US28_HCMVA G-protein coupled receptor homolog US28 | |
7rkf[1] | A | GNA11_HUMAN Guanine nucleotide-binding protein subunit alpha-1.. | F | 37.5 /29.5 |
16 /16 |
US28_HCMVA G-protein coupled receptor homolog US28 | |
7rkm[1] | A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | F | 33.3 /29.5 |
21 /21 |
US28_HCMVA G-protein coupled receptor homolog US28 | |
7rkn[1] | A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | F | 37.5 /29.5 |
24 /24 |
US28_HCMVA G-protein coupled receptor homolog US28 | |
7l1u[2] | A | Engineered Guanine nucleotide-binding protein subu.. | E | 46.7 /30.7 |
15 /16 |
Q548Y0_HUMAN Hypocretin receptor type 2 | |
7sr8[1] | A | a modified Guanine nucleotide-binding protein G(q).. | E | 66.7 /37.0 |
9 /19 |
Q548Y0_HUMAN Hypocretin receptor type 2 | |
7xbd[1] | B | Guanine nucleotide-binding protein G(q) subunit al.. | A | 45.0 /29.3 |
20 /20 |
GALR2_HUMAN Galanin receptor type 2 | |
7xjk[2] | B | Guanine nucleotide-binding protein G(q)[226 aa] | F | 47.6 /29.7 |
21 /21 |
GALR2_HUMAN Galanin receptor type 2 | |
7y26[2] | B | Engineered Guanine nucleotide-binding protein G(q).. | E | 38.5 /34.4 |
13 /13 |
SSR2_HUMAN Somatostatin receptor type 2 | |
8izb[1] | A | GNAS2_HUMAN GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit al.. | E | 20.0 /29.5 |
35 /35 |
GP174_HUMAN Probable G-protein coupled receptor 174 | |
8kh5[1] | B | GNAS2_HUMAN GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit al.. | A | 20.0 /29.4 |
35 /35 |
GP174_HUMAN Probable G-protein coupled receptor 174 | |
6vms[1] | A | GNAI1_RAT Guanine nucleotide-binding protein G(i) subunit al.. | E | 35.3 /28.5 |
17 /22 |
D9IEF7_BPT4 DRD2_HUMAN DRD2_HUMAN Endolysin,D(2) dopamine receptor,D(2) dopamine rec.. | |
7tuz[1] | B | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 22.7 /29.3 |
22 /23 |
GP183_HUMAN G-protein coupled receptor 183 | |
4lde[5] | B | Camelid Antibody Fragment[120 aa] | A | 35.3 /29.3 |
17 /20 |
LYS_BPT4 ADRB2_HUMAN ADRB2_HUMAN Lysozyme, Beta-2 adrenergic receptor | |
8unx[1] | A | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit al.. | D | 45.5 /29.3 |
11 /15 |
ADRB2_HUMAN Beta-2 adrenergic receptor | |
3sn6[1] | A | GNAS2_BOVIN Guanine nucleotide-binding protein G(s) subunit al.. | D | 40.0 /29.1 |
20 /25 |
ENLYS_BPT4 ADRB2_HUMAN Endolysin,Beta-2 adrenergic receptor | |
7l1v[1] | F | Synthetic nanobody 51 (Sb51)[111 aa] | E | 5.6 /29.1 |
18 /20 |
Q548Y0_HUMAN Hypocretin receptor type 2 | |
8hs3[2] | A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | D | 23.5 /27.3 |
17 /17 |
C562_ECOLX GPR20_HUMAN Soluble cytochrome b562,G-protein coupled receptor.. | |
8hsc[1] | E | heavy chain of Fab046[122 aa] | F | 20.0 /28.5 |
5 /12 |
C562_ECOLX GPR20_HUMAN Soluble cytochrome b562,G-protein coupled receptor.. | |
7xwo[1] | D | G324[229 aa] | A | 58.3 /28.3 |
12 /15 |
C562_ECOLX NK2R_HUMAN Soluble cytochrome b562,Substance-K receptor | |
7xwo[1] | F | HIS-LYS-THR-ASP-SER-PHE-VAL-GLY-LEU-MET-NH2[11 aa].. | A | 0.0 /28.3 |
11 /17 |
C562_ECOLX NK2R_HUMAN Soluble cytochrome b562,Substance-K receptor | |
7f9y[2] | A | Engineered G-alpha-q subunit[228 aa] | F | 44.4 /28.0 |
18 /18 |
Soluble cytochrome b562 | |
7f9y[1] | C | GHRL_HUMAN Ghrelin-28[15 aa] | F | 21.4 /28.0 |
14 /17 |
Soluble cytochrome b562 | |
7na7[2] | A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | E | 37.5 /27.3 |
16 /18 |
GHSR_HUMAN Growth hormone secretagogue receptor type 1 | |
7w2z[1] | F | GHRL_HUMAN Appetite-regulating hormone[16 aa] | B | 18.2 /27.9 |
22 /26 |
GHSR_HUMAN Growth hormone secretagogue receptor type 1 | |
8hs2[1] | A | heavy chain of Fab046[218 aa] | C | 33.3 /27.6 |
3 /10 |
C562_ECOLX GPR20_HUMAN Soluble cytochrome b562,G-protein coupled receptor.. | |
7srs[1] | A | Anti-5HT2BR Fab light chain[107 aa] | C | 25.0 /27.5 |
4 /4 |
5-hydroxytryptamine receptor 2B | |
7srs[1] | B | Anti-5HT2BR Fab heavy chain[127 aa] | C | 22.2 /27.5 |
9 /9 |
5-hydroxytryptamine receptor 2B | |
7srs[1] | D | ARRB1_HUMAN Isoform 1B of Beta-arrestin-1[355 aa] | C | 6.7 /27.5 |
15 /22 |
5-hydroxytryptamine receptor 2B | |
7vgy[2] | B | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 35.0 /28.2 |
20 /20 |
MTR1A_HUMAN Melatonin receptor type 1A | |
8ihb[5] | B | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 23.1 /24.5 |
13 /16 |
C562_ECOLX HCAR2_HUMAN Soluble cytochrome b562,Hydroxycarboxylic acid rec.. | |
7na7[1] | F | GHRL_HUMAN Ghrelin-27[12 aa] | E | 18.2 /27.3 |
22 /25 |
GHSR_HUMAN Growth hormone secretagogue receptor type 1 | |
6ko5[1] | B | Fab7881 Heavy Chain[218 aa] | A | 0.0 /27.0 |
8 /10 |
C562_ECOLX GHSR_HUMAN Chimera of Soluble cytochrome b562 and Growth horm.. | |
6ko5[1] | C | Fab7881 Light Chain[219 aa] | A | 0.0 /27.0 |
2 /2 |
C562_ECOLX GHSR_HUMAN Chimera of Soluble cytochrome b562 and Growth horm.. | |
6vi4[3] | D | Nanobody 6[117 aa] | A | 18.2 /36.0 |
11 /13 |
OPRK_HUMAN Kappa opioid receptor | |
7ymj[1] | B | Nb6[116 aa] | A | 12.5 /27.8 |
8 /9 |
alpha1A-adrenergic receptor | |
8hn1[1] | A | 3SI1A_DENAN Toxin AdTx1[65 aa] | B | 18.2 /26.6 |
22 /22 |
ADA1A_HUMAN Alpha-1A adrenergic receptor | |
8jbf[1] | E | Senktide[8 aa] | A | 4.5 /26.3 |
22 /24 |
NK3R_HUMAN Neuromedin-K receptor | |
8jbf[1] | F | Guanine nucleotide-binding protein Gq subunit alph.. | A | 44.4 /26.3 |
18 /19 |
NK3R_HUMAN Neuromedin-K receptor | |
7db6[1] | A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | E | 31.6 /27.1 |
19 /20 |
MTR1A_HUMAN Melatonin receptor type 1A | |
8iy5[1] | A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | E | 20.0 /25.8 |
25 /27 |
Endothelin type B receptor | |
8iy5[1] | F | EDN1_HUMAN Endothelin-1[21 aa] | E | 12.9 /25.8 |
31 /34 |
Endothelin type B receptor | |
7xk2[1] | A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | C | 16.7 /25.6 |
18 /20 |
HCAR2_HUMAN Hydroxycarboxylic acid receptor 2 | |
7yac[1] | A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | D | 26.3 /33.3 |
19 /19 |
SSR2_HUMAN Somatostatin receptor type 2 | |
8jhy[3] | C | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | E | 15.4 /25.6 |
13 /14 |
HCAR2_HUMAN Hydroxycarboxylic acid receptor 2 | |
8jil[1] | C | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | E | 18.8 /25.6 |
16 /16 |
HCAR2_HUMAN Hydroxycarboxylic acid receptor 2 | |
8jz7[1] | C | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | E | 20.0 /25.6 |
15 /16 |
HCAR2_HUMAN Hydroxycarboxylic acid receptor 2 | |
8h8j[1] | A | GNA13_HUMAN Guanine nucleotide-binding protein subunit alpha-1.. | C | 32.0 /25.0 |
25 /27 |
GPR35_HUMAN G-protein coupled receptor 35 | |
8h2g[1] | B | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 20.0 /24.5 |
15 /16 |
HCAR2_HUMAN Hydroxy-carboxylic acid receptor 2 | |
8i7v[1] | B | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 18.8 /24.5 |
16 /18 |
HCAR2_HUMAN Human hydroxycarboxylic acid receptor 2,Hydroxycar.. | |
8i7w[1] | B | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 14.3 /24.5 |
14 /15 |
HCAR2_HUMAN Human hydroxycarboxylic acid receptor 2,Hydroxycar.. | |
8j6p[3] | A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | E | 19.0 /24.4 |
21 /21 |
HCAR2_HUMAN Hydroxycarboxylic acid receptor 2 | |
8j6l[1] | A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | E | 10.0 /24.3 |
20 /20 |
HCAR2_HUMAN Hydroxycarboxylic acid receptor 2,hydroxycarboxyli.. | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
COMPOUND | |||||||
359 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
4yay[1] | B |
ZD7
5,7-diethyl-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl.. |
A | 100.0 /99.7 |
14 /14 |
C562_ECOLX AGTR1_HUMAN Soluble cytochrome b562,Type-1 angiotensin II rece.. | |
4zud[1] | B |
OLM
Olmesartan[33 atoms] |
A | 100.0 /99.6 |
13 /13 |
C562_ECOLX AGTR1_HUMAN AGTR1_HUMAN Chimera protein of Soluble cytochrome b562 and Typ.. | |
6rz4[1] | B |
KNT
pranlukast[36 atoms] |
A | 33.3 /40.0 |
6 /21 |
CLTR1_HUMAN C562_ECOLX CLTR1_HUMAN Cysteinyl leukotriene receptor 1,Soluble cytochrom.. | |
6rz5[3] | C |
ZLK
zafirlukast[41 atoms] |
A | 50.0 /38.5 |
8 /18 |
CLTR1_HUMAN C562_ECOLX CLTR1_HUMAN Cysteinyl leukotriene receptor 1,Soluble cytochrom.. | |
5unh[2] | C |
8EM
N-[(furan-2-yl)methyl]-N-(4-oxo-2-propyl-3-{[2'-(2.. |
A | 39.1 /38.6 |
23 /23 |
C562_ECOLX AGTR2_HUMAN Soluble cytochrome b562,Type-2 angiotensin II rece.. | |
7jni[2] | C |
VFD
Olodanrigan[38 atoms] |
A | 52.9 /38.5 |
17 /17 |
C562_ECOLX AGTR2_HUMAN Soluble cytochrome b562,Type-2 angiotensin II rece.. | |
7jni[1] | K |
HEZ
HEXANE-1,6-DIOL[8 atoms] |
A | 0.0 /38.5 |
1 /5 |
C562_ECOLX AGTR2_HUMAN Soluble cytochrome b562,Type-2 angiotensin II rece.. | |
6rz9[1] | B |
KO5
(2~{S})-8-[[4-[4-(5-fluoranyl-2-methyl-phenyl)buto.. |
A | 28.6 /38.4 |
14 /19 |
CLTR2_HUMAN C562_ECOLX CLTR2_HUMAN Cysteinyl leukotriene receptor 2,Soluble cytochrom.. | |
3odu[9] | C |
ITD
(6,6-dimethyl-5,6-dihydroimidazo[2,1-b][1,3]thiazo.. |
A | 25.0 /36.2 |
12 /12 |
CXCR4_HUMAN LYS_BPT4 CXCR4_HUMAN C-X-C chemokine receptor type 4, Lysozyme Chimera | |
5unf[3] | C |
8ES
N-benzyl-N-(2-ethyl-4-oxo-3-{[2'-(2H-tetrazol-5-yl.. |
A | 45.0 /37.6 |
20 /20 |
C562_ECOLX AGTR2_HUMAN Chimera protein of Type-2 angiotensin II receptor .. | |
8u4p[1] | F |
VH6
Plerixafor[36 atoms] |
D | 30.0 /38.2 |
10 /10 |
CXCR4_HUMAN C-X-C chemokine receptor type 4 | |
6lfl[1] | B |
EBX
4-[[3,4-bis(oxidanylidene)-2-[[(1~{R})-1-(4-propan.. |
A | 50.0 /38.0 |
18 /18 |
CXCR2_HUMAN Q9V2J8_PYRAB CXCR2_HUMAN C-X-C chemokine receptor type 2,GlgA glycogen synt.. | |
6rz6[2] | B |
KNW
(2~{S})-8-[[4-[4-(2-chloranyl-5-fluoranyl-phenyl)b.. |
A | 23.5 /37.7 |
17 /22 |
CLTR2_HUMAN C562_ECOLX CLTR2_HUMAN Cysteinyl leukotriene receptor 2,Soluble cytochrom.. | |
7yit[1] | D |
IVB
nalfurafine[35 atoms] |
A | 21.1 /37.3 |
19 /19 |
OPRK_HUMAN Kappa-type opioid receptor | |
6b73[2] | E |
CVV
N-[(5alpha,6beta)-17-(cyclopropylmethyl)-3-hydroxy.. |
A | 33.3 /36.9 |
15 /15 |
C562_ECOLX OPRK_HUMAN Soluble cytochrome b562, kappa-type opioid recepto.. | |
6rz8[1] | B |
KNZ
(2~{S})-8-[[4-[4-[2,3-bis(fluoranyl)phenoxy]butoxy.. |
A | 26.1 /37.1 |
23 /26 |
CLTR2_HUMAN C562_ECOLX CLTR2_HUMAN Cysteinyl leukotriene receptor 2,Soluble cytochrom.. | |
7sqo[1] | J |
A6F
methyl (2R,3S)-3-[(methanesulfonyl)amino]-2-({[(1s.. |
A | 0.0 /37.3 |
8 /14 |
OX2R_HUMAN Orexin receptor type 2 | |
7sr8[1] | F |
A6F
methyl (2R,3S)-3-[(methanesulfonyl)amino]-2-({[(1s.. |
E | 12.5 /37.0 |
8 /13 |
Q548Y0_HUMAN Hypocretin receptor type 2 | |
6qzh[1] | C |
JLW
3-[[4-[[(1~{R})-2,2-dimethyl-1-(5-methylfuran-2-yl.. |
A | 44.4 /36.7 |
9 /16 |
CCR7_HUMAN NANA_STREE CCR7_HUMAN C-C chemokine receptor type 7,Sialidase A,C-C chem.. | |
6qzh[1] | E |
TAR
D(-)-TARTARIC ACID[10 atoms] |
A | 100.0 /36.7 |
1 /4 |
CCR7_HUMAN NANA_STREE CCR7_HUMAN C-C chemokine receptor type 7,Sialidase A,C-C chem.. | |
8u4s[7] | K |
D21
(2R)-1-(hexadecanoyloxy)-3-(phosphonooxy)propan-2-.. |
C | 20.0 /36.5 |
5 /5 |
CXCR4_HUMAN C-X-C chemokine receptor type 4 | |
8u4s[7] | N |
D21
(2R)-1-(hexadecanoyloxy)-3-(phosphonooxy)propan-2-.. |
C | 25.0 /36.5 |
4 /4 |
CXCR4_HUMAN C-X-C chemokine receptor type 4 | |
4dkl[2] | B |
BF0
methyl 4-{[(5beta,6alpha)-17-(cyclopropylmethyl)-3.. |
A | 0.0 /36.5 |
6 /14 |
OPRM_MOUSE LYS_BPT4 OPRM_MOUSE Mu-type opioid receptor, lysozyme chimera | |
4djh[3] | C |
JDC
(3R)-7-hydroxy-N-{(2S)-1-[(3R,4R)-4-(3-hydroxyphen.. |
A | 33.3 /39.0 |
15 /20 |
OPRK_HUMAN LYS_BPT4 OPRK_HUMAN Kappa-type opioid receptor, Lysozyme | |
6vi4[2] | E |
JDC
(3R)-7-hydroxy-N-{(2S)-1-[(3R,4R)-4-(3-hydroxyphen.. |
A | 38.5 /36.0 |
13 /13 |
OPRK_HUMAN Kappa opioid receptor | |
3vw7[1] | B |
VPX
ethyl [(1R,3aR,4aR,6R,8aR,9S,9aS)-9-{(E)-2-[5-(3-f.. |
A | 40.0 /36.4 |
5 /21 |
PAR1_HUMAN LYS_BPT4 PAR1_HUMAN Proteinase-activated receptor 1, Lysozyme | |
7k15[1] | B |
VRJ
N-(tert-butylsulfonyl)-4-fluoro-2-{(3S,4R)-4-hydro.. |
A | 18.2 /36.4 |
11 /18 |
LT4R1_HUMAN FLAV_DESVH LT4R1_HUMAN Leukotriene B4 receptor 1,Flavodoxin,Leukotriene B.. | |
7k15[1] | I |
2PE
NONAETHYLENE GLYCOL[28 atoms] |
A | 45.5 /36.4 |
11 /12 |
LT4R1_HUMAN FLAV_DESVH LT4R1_HUMAN Leukotriene B4 receptor 1,Flavodoxin,Leukotriene B.. | |
8k2w[1] | E |
LPC
[1-MYRISTOYL-GLYCEROL-3-YL]PHOSPHONYLCHOLINE[31 at.. |
B | 25.0 /36.2 |
8 /8 |
C562_ECOLX CXCR3_HUMAN OPRK_HUMAN CXCR3_HUMAN Soluble cytochrome b562,C-X-C chemokine receptor t.. | |
8k2w[1] | F |
FI6
N-[(1R)-1-[3-(4-ethoxyphenyl)-4-oxidanylidene-pyri.. |
B | 50.0 /36.2 |
8 /9 |
C562_ECOLX CXCR3_HUMAN OPRK_HUMAN CXCR3_HUMAN Soluble cytochrome b562,C-X-C chemokine receptor t.. | |
6gps[1] | C |
F7N
[(3~{S},4~{S})-3-methoxyoxan-4-yl]-[(1~{R},3~{S})-.. |
A | 21.4 /36.7 |
14 /17 |
CCR2_HUMAN RUBR_CLOPA CCR2_HUMAN C-C chemokine receptor type 2,Rubredoxin,C-C chemo.. | |
6gpx[2] | O |
F7N
[(3~{S},4~{S})-3-methoxyoxan-4-yl]-[(1~{R},3~{S})-.. |
A | 21.4 /36.8 |
14 /16 |
CCR2_HUMAN RUBR_CLOPA CCR2_HUMAN C-C chemokine receptor type 2,Rubredoxin,C-C chemo.. | |
5t1a[1] | B |
73R
(3S)-1-{(1S,2R,4R)-4-[methyl(propan-2-yl)amino]-2-.. |
A | 23.1 /35.9 |
13 /15 |
CCR2_HUMAN D9IEF7_BPT4 CCR2_HUMAN Chimera protein of CC chemokine receptor type 2 is.. | |
5t1a[1] | C |
VT5
(2~{R})-1-(4-chloranyl-2-fluoranyl-phenyl)-2-cyclo.. |
A | 64.3 /35.9 |
14 /14 |
CCR2_HUMAN D9IEF7_BPT4 CCR2_HUMAN Chimera protein of CC chemokine receptor type 2 is.. | |
7sk7[3] | F |
GJ9
(1R)-4-[7-(3-carboxypropoxy)-6-methylquinolin-8-yl.. |
A | 33.3 /37.0 |
15 /15 |
ACKR3_HUMAN Atypical chemokine receptor 3 | |
7sus[1] | C |
8EH
(1R,2S)-N-[4-(2,6-dimethoxyphenyl)-5-(6-methylpyri.. |
A | 31.2 /37.9 |
16 /16 |
APJ_HUMAN RUBR_CLOPA APJ_HUMAN Apelin receptor, with Rubredoxin insertion | |
7w0l[3] | G |
8EH
(1R,2S)-N-[4-(2,6-dimethoxyphenyl)-5-(6-methylpyri.. |
D | 46.2 /35.6 |
13 /13 |
C562_ECOLX APJ_HUMAN Soluble cytochrome b562,Apelin receptor | |
8xzi[1] | F |
A1D5N
(3~{S})-5-methyl-3-[[1-pentan-3-yl-2-(thiophen-2-y.. |
A | 37.5 /35.6 |
16 /16 |
APJ_HUMAN Apelin receptor | |
7scg[1] | F |
8RI
(2E)-N-[(2S)-2-(dimethylamino)-3-(4-hydroxyphenyl).. |
C | 20.0 /35.4 |
10 /10 |
OPRM_MOUSE Mu-type opioid receptor | |
7u2k[1] | E |
KZR
N-(6-carbamimidamidohexyl)-N-[1-(2-phenylethyl)pip.. |
C | 40.0 /35.4 |
15 /16 |
OPRM_MOUSE Mu-type opioid receptor | |
7u2l[1] | F |
L0X
N-(5-carbamimidamidopentyl)-N-[1-(2-phenylethyl)pi.. |
D | 29.4 /35.4 |
17 /18 |
OPRM_MOUSE Mu-type opioid receptor | |
7t2h[1] | F |
EID
Lofentanil[30 atoms] |
E | 30.8 /35.3 |
13 /13 |
OPRM_MOUSE Mu-type opioid receptor | |
8dzr[1] | F |
U9I
methyl (3R)-4-[(3,4-dichlorophenyl)acetyl]-3-[(pyr.. |
A | 27.3 /35.6 |
11 /11 |
OPRK_HUMAN Kappa-type opioid receptor | |
8dzs[1] | F |
U9I
methyl (3R)-4-[(3,4-dichlorophenyl)acetyl]-3-[(pyr.. |
A | 21.4 /35.2 |
14 /14 |
OPRK_HUMAN Kappa-type opioid receptor | |
8dzp[2] | F |
U99
methyl (2S,4aR,6aR,7R,9S,10aS,10bR)-2-(furan-3-yl).. |
A | 27.8 /35.2 |
18 /18 |
OPRK_HUMAN Kappa-type opioid receptor | |
7t2g[1] | E |
EIG
Mitragynine pseudoindoxyl[30 atoms] |
D | 30.8 /35.1 |
13 /13 |
C562_ECOLX OPRM_MOUSE Soluble cytochrome b562,Mu-type opioid receptor | |
7ul4[1] | C |
NG0
N-[(2S)-2-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimeth.. |
A | 30.0 /35.0 |
10 /10 |
OPRM_MOUSE Mu-type opioid receptor | |
5c1m[2] | I |
VF1
(2R,3S,3aR,5aR,6R,11bR,11cS)-3a-methoxy-3,14-dimet.. |
A | 16.7 /34.9 |
12 /14 |
OPRM_MOUSE Mu-type opioid receptor | |
6akx[2] | E |
A4R
N-[(1S)-3-{(3-exo)-3-[3-methyl-5-(propan-2-yl)-4H-.. |
A | 38.5 /34.8 |
13 /13 |
CCR5_HUMAN RUBR_CLOPA CCR5_HUMAN C-C chemokine receptor type 5,Rubredoxin,C-C chemo.. | |
7f83[2] | E |
1KQ
2-(2-methylimidazo[2,1-b][1,3]thiazol-6-yl)-1-[2-[.. |
A | 36.4 /34.7 |
11 /19 |
GHSR_HUMAN C562_ECOLX GHSR_HUMAN Growth hormone secretagogue receptor type 1,Solubl.. | |
7xn9[1] | C |
GI9
tert-butyl (2S)-6-azanyl-2-[[(2R,3S)-3-(1H-indol-3.. |
A | 26.1 /34.6 |
23 /23 |
SSR2_HUMAN XYNA_NIACI SSR2_HUMAN Somatostatin receptor type 2,Endo-1,4-beta-xylanas.. | |
4ea3[4] | C |
0NN
1-benzyl-N-[3-(1'H,3H-spiro[2-benzofuran-1,4'-pipe.. |
A | 25.0 /33.6 |
16 /16 |
C562_ECOLX OPRX_HUMAN Fusion protein of Nociceptin receptor and cytochro.. | |
5dhg[4] | C |
DGV
1-benzyl-N-{3-[4-(2,6-dichlorophenyl)piperidin-1-y.. |
A | 28.6 /33.6 |
14 /14 |
C562_ECOLX OPRX_HUMAN Soluble cytochrome b562,Nociceptin receptor | |
7sbf[1] | F |
8QY
N-[(2S)-2-(dimethylamino)-3-(4-hydroxyphenyl)propy.. |
E | 18.2 /35.3 |
11 /11 |
C562_ECOLX OPRM_MOUSE Soluble cytochrome b562, Mu-type opioid receptor c.. | |
8efo[2] | H |
8QY
N-[(2S)-2-(dimethylamino)-3-(4-hydroxyphenyl)propy.. |
A | 16.7 /34.4 |
12 /12 |
OPRM_HUMAN Mu-type opioid receptor | |
8ef5[2] | H |
7V7
N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propan.. |
A | 41.7 /34.4 |
12 /13 |
OPRM_HUMAN Mu-type opioid receptor | |
8ef6[2] | H |
MOI
(7R,7AS,12BS)-3-METHYL-2,3,4,4A,7,7A-HEXAHYDRO-1H-.. |
A | 0.0 /34.4 |
6 /6 |
OPRM_HUMAN Mu-type opioid receptor | |
8efl[2] | H |
WH9
5,6-dichloro-1-{1-[(4-chlorophenyl)methyl]piperidi.. |
A | 25.0 /34.4 |
12 /12 |
OPRM_HUMAN Mu-type opioid receptor | |
7t6s[1] | F |
FUI
N-(4-chlorophenyl)-N'-[1-methyl-3-oxo-2-phenyl-5-(.. |
E | 41.7 /34.3 |
12 /13 |
FPR2_HUMAN N-formyl peptide receptor 2 | |
7xmt[1] | F |
I8B
(2~{S})-2-[[(2~{S})-4-azanyl-2-[(4-methylnaphthale.. |
A | 13.3 /34.2 |
15 /15 |
SSR4_HUMAN Somatostatin receptor type 4 | |
5lwe[2] | C |
79K
Vercirnon[30 atoms] |
A | 40.0 /34.8 |
20 /20 |
CCR9_HUMAN C-C chemokine receptor type 9 | |
8efb[1] | F |
WH2
N-[(3-methoxythiophen-2-yl)methyl]-2-[(9R)-9-(pyri.. |
A | 28.6 /34.1 |
14 /15 |
OPRM_HUMAN Mu-type opioid receptor | |
7sk8[1] | L |
LMN
Lauryl Maltose Neopentyl Glycol[47 atoms] |
A | 40.0 /34.0 |
5 /5 |
ACKR3_HUMAN Atypical chemokine receptor 3 | |
4mbs[2] | C |
MRV
4,4-difluoro-N-[(1S)-3-{(3-exo)-3-[3-methyl-5-(pro.. |
A | 36.8 /34.0 |
19 /19 |
CCR5_HUMAN RUBR_CLOPA CCR5_HUMAN Chimera protein of C-C chemokine receptor type 5 a.. | |
6aky[1] | D |
A4X
4,4-difluoro-N-[(1S)-3-{(3-exo)-3-[3-methyl-5-(pro.. |
A | 31.6 /33.9 |
19 /19 |
CCR5_HUMAN RUBR_CLOPA CCR5_HUMAN C-C chemokine receptor type 5,Rubredoxin,C-C chemo.. | |
5dhh[3] | H |
DGW
(5S,7S)-7-{[4-(2,6-dichlorophenyl)piperidin-1-yl]m.. |
A | 25.0 /33.8 |
16 /16 |
C562_ECOLX OPRX_HUMAN Soluble cytochrome b562,Nociceptin receptor | |
5ndd[1] | B |
8TZ
(~{S})-(4-fluoranyl-2-propyl-phenyl)-(1~{H}-imidaz.. |
A | 33.3 /33.8 |
12 /14 |
D9IEF7_BPT4 PAR2_HUMAN C562_ECOLX PAR2_HUMAN Lysozyme,Proteinase-activated receptor 2,Soluble c.. | |
5ndz[1] | B |
8UN
2-(6-bromanyl-1,3-benzodioxol-5-yl)-~{N}-(4-cyanop.. |
A | 30.0 /33.8 |
10 /10 |
D9IEF7_BPT4 PAR2_HUMAN C562_ECOLX PAR2_HUMAN Lysozyme,Proteinase-activated receptor 2,Soluble c.. | |
4ej4[1] | B |
EJ4
(4bS,8R,8aS,14bR)-7-(cyclopropylmethyl)-5,6,7,8,14.. |
A | 0.0 /35.0 |
5 /12 |
OPRD_MOUSE LYS_BPT4 OPRD_MOUSE Delta-type opioid receptor, Lysozyme chimera | |
4n6h[1] | T |
EJ4
(4bS,8R,8aS,14bR)-7-(cyclopropylmethyl)-5,6,7,8,14.. |
A | 23.1 /33.3 |
13 /13 |
C562_ECOLX OPRD_HUMAN Soluble cytochrome b562, Delta-type opioid recepto.. | |
7yac[1] | F |
IUD
Paltusotine[34 atoms] |
D | 23.1 /33.3 |
13 /13 |
SSR2_HUMAN Somatostatin receptor type 2 | |
7db6[1] | F |
JEV
N-{2-[(8S)-1,6,7,8-tetrahydro-2H-indeno[5,4-b]fura.. |
E | 16.7 /27.1 |
12 /12 |
MTR1A_HUMAN Melatonin receptor type 1A | |
7vgz[1] | F |
JEV
N-{2-[(8S)-1,6,7,8-tetrahydro-2H-indeno[5,4-b]fura.. |
A | 7.1 /27.5 |
14 /14 |
MTR1A_HUMAN Melatonin receptor type 1A | |
7vh0[1] | F |
JEV
N-{2-[(8S)-1,6,7,8-tetrahydro-2H-indeno[5,4-b]fura.. |
A | 16.7 /33.2 |
12 /12 |
MTR1B_HUMAN Melatonin receptor type 1B | |
4py0[1] | B |
6AT
2-(methylsulfanyl)adenosine 5'-(tetrahydrogen trip.. |
A | 35.3 /33.2 |
17 /25 |
P2Y12_HUMAN C562_ECOLX P2Y12_HUMAN P2Y purinoceptor 12, Soluble cytochrome b562 | |
5zkq[2] | C |
9EU
4-ethynyl-3-{3-fluoro-4-[(2-methyl-1H-imidazo[4,5-.. |
A | 29.4 /32.5 |
17 /17 |
PTAFR_HUMAN ENLYS_BPT4 ENLYS_BPT4 PTAFR_HUMAN Platelet-activating factor receptor,Endolysin,Endo.. | |
7wig[1] | F |
9FI
~{N}-[(2~{R})-1-[[(1~{R},3~{S})-3-(aminomethyl)cyc.. |
A | 22.2 /32.8 |
9 /9 |
SSR2_HUMAN Somatostatin receptor type 2 | |
7ddz[1] | B |
H46
~{N}-[4-[4-[(1~{S})-2-(diethylamino)-2-oxidanylide.. |
A | 21.4 /32.8 |
14 /19 |
A0A097J809_BPT4 NPY2R_HUMAN FLAV_DESVH NPY2R_HUMAN Human Neuropeptide Y Y2 Receptor fusion protein | |
6pt3[2] | C |
OWY
4-[(R)-[(2S,5R)-4-benzyl-2,5-dimethylpiperazin-1-y.. |
A | 22.2 /32.5 |
18 /18 |
Delta opioid receptor | |
4ntj[1] | B |
AZJ
ethyl 6-{4-[(benzylsulfonyl)carbamoyl]piperidin-1-.. |
A | 27.3 /32.4 |
11 /16 |
P2Y12_HUMAN C562_ECOLX P2Y12_HUMAN P2Y purinoceptor 12,Soluble cytochrome b562,P2Y pu.. | |
7pp1[1] | B |
7Y5
Selatogrel[43 atoms] |
A | 20.0 /32.4 |
10 /17 |
P2Y12_HUMAN C562_ECOLX P2Y12_HUMAN P2Y purinoceptor 12,Soluble cytochrome b562,P2Y pu.. | |
5zkp[1] | B |
9ER
N1,N1-dimethyl-N2-[(pyridin-3-yl)methyl]-N2-{4-[2,.. |
A | 23.5 /32.4 |
17 /17 |
PTAFR_HUMAN FLAV_DESVH PTAFR_HUMAN Platelet-activating factor receptor,Flavodoxin,Pla.. | |
6ibb[1] | N |
H95
(2~{S},5~{R})-hexane-2,5-diol[8 atoms] |
A | 16.7 /32.0 |
6 /6 |
SUCR1_RAT Succinate receptor 1 | |
3ny8[1] | D |
JRZ
(2S,3S)-1-[(7-methyl-2,3-dihydro-1H-inden-4-yl)oxy.. |
A | 14.3 /31.9 |
7 /13 |
ADRB2_HUMAN LYS_BPT4 ADRB2_HUMAN Beta-2 adrenergic receptor, Lysozyme | |
6ps4[1] | B |
JRZ
(2S,3S)-1-[(7-methyl-2,3-dihydro-1H-inden-4-yl)oxy.. |
A | 12.5 /31.9 |
8 /14 |
ADRB2_HUMAN D9IEF7_BPT4 ADRB2_HUMAN Fusion protein of Beta-2 adrenergic receptor and T.. | |
3ny9[1] | D |
JSZ
ethyl 4-({(2S)-2-hydroxy-3-[(1-methylethyl)amino]p.. |
A | 7.7 /31.9 |
13 /20 |
ADRB2_HUMAN LYS_BPT4 ADRB2_HUMAN Beta-2 adrenergic receptor, Lysozyme | |
6ps3[1] | B |
CVD
(2S)-1-(8H-CARBAZOL-4-YLOXY)-3-[2-(2-METHOXYPHENOX.. |
A | 13.3 /31.9 |
15 /23 |
ADRB2_HUMAN D9IEF7_BPT4 ADRB2_HUMAN Fusion protein of Beta-2 adrenergic receptor and T.. | |
6ps5[1] | B |
SNP
1-(ISOPROPYLAMINO)-3-(1-NAPHTHYLOXY)-2-PROPANOL[19.. |
A | 11.1 /31.9 |
9 /15 |
ADRB2_HUMAN D9IEF7_BPT4 ADRB2_HUMAN Fusion protein of Beta-2 adrenergic receptor and T.. | |
5zbq[1] | B |
9AO
N~2~-(diphenylacetyl)-N-[(4-hydroxyphenyl)methyl]-.. |
A | 16.7 /31.9 |
18 /20 |
NPY1R_HUMAN A0A097J792_BPT4 Neuropeptide Y receptor type 1,T4 Lysozyme | |
4xnv[1] | D |
Y01
CHOLESTEROL HEMISUCCINATE[35 atoms] |
A | 30.0 /29.7 |
10 /10 |
P2RY1_HUMAN RUBR_CLOPA P2RY1_HUMAN P2Y purinoceptor 1, Rubredoxin, P2Y purinoceptor 1.. | |
4xnv[1] | E |
Y01
CHOLESTEROL HEMISUCCINATE[35 atoms] |
A | 16.7 /29.7 |
12 /12 |
P2RY1_HUMAN RUBR_CLOPA P2RY1_HUMAN P2Y purinoceptor 1, Rubredoxin, P2Y purinoceptor 1.. | |
4xnv[1] | F |
Y01
CHOLESTEROL HEMISUCCINATE[35 atoms] |
A | 20.0 /29.7 |
10 /10 |
P2RY1_HUMAN RUBR_CLOPA P2RY1_HUMAN P2Y purinoceptor 1, Rubredoxin, P2Y purinoceptor 1.. | |
7vkt[1] | G |
Y01
CHOLESTEROL HEMISUCCINATE[35 atoms] |
A | 42.9 /31.8 |
7 /7 |
LT4R1_HUMAN Leukotriene B4 receptor 1 | |
7vkt[1] | H |
Y01
CHOLESTEROL HEMISUCCINATE[35 atoms] |
A | 50.0 /31.8 |
2 /3 |
LT4R1_HUMAN Leukotriene B4 receptor 1 | |
7vkt[1] | I |
Y01
CHOLESTEROL HEMISUCCINATE[35 atoms] |
A | 20.0 /31.8 |
5 /5 |
LT4R1_HUMAN Leukotriene B4 receptor 1 | |
7vkt[1] | J |
Y01
CHOLESTEROL HEMISUCCINATE[35 atoms] |
A | 14.3 /31.8 |
7 /7 |
LT4R1_HUMAN Leukotriene B4 receptor 1 | |
7vkt[1] | F |
LTB
LEUKOTRIENE B4[24 atoms] |
A | 30.8 /31.8 |
13 /13 |
LT4R1_HUMAN Leukotriene B4 receptor 1 | |
7vkt[1] | K |
8IO
[(2R)-2-[(Z)-hexadec-9-enoyl]oxy-3-[oxidanyl-[(2S,.. |
A | 33.3 /31.8 |
15 /15 |
LT4R1_HUMAN Leukotriene B4 receptor 1 | |
7tuy[1] | E |
KKF
8-[(2E)-3-(4-chlorophenyl)prop-2-enoyl]-3-[(3,4-di.. |
D | 22.2 /31.7 |
9 /14 |
GP183_HUMAN GP183_HUMAN G-protein coupled receptor 183,Soluble cytochrome .. | |
8kfx[1] | F |
OS9
8-[[3-(2-methoxyphenoxy)phenyl]methyl]-1-(2-phenyl.. |
D | 26.7 /31.7 |
15 /15 |
CCR8_HUMAN C-C chemokine receptor type 8,Fusion protein | |
8kfy[1] | F |
OXF
2-[2-[4-[(3-phenoxyphenyl)methyl]piperazin-1-yl]et.. |
D | 33.3 /31.7 |
12 /12 |
CCR8_HUMAN C-C chemokine receptor type 8,Fusion protein | |
7yk6[1] | F |
IYF
1-[2-(4-chlorophenyl)ethyl]-3-[(7-ethyl-5-oxidanyl.. |
C | 11.1 /31.3 |
9 /9 |
RL3R2_HUMAN Relaxin-3 receptor 2 | |
7yk7[1] | F |
IYM
[(1S)-7-ethoxy-6-methoxy-1-[2-(5-methoxy-1H-indol-.. |
C | 15.4 /31.3 |
13 /15 |
RL3R2_HUMAN Relaxin-3 receptor 2 | |
2rh1[5] | I |
CAU
(2S)-1-(9H-Carbazol-4-yloxy)-3-(isopropylamino)pro.. |
A | 10.0 /31.2 |
10 /17 |
ADRB2_HUMAN LYS_BPT4 ADRB2_HUMAN beta-2-adrenergic receptor/T4-lysozyme chimera | |
4gbr[1] | C |
CAU
(2S)-1-(9H-Carbazol-4-yloxy)-3-(isopropylamino)pro.. |
A | 18.8 /29.9 |
16 /16 |
ADRB2_HUMAN Beta-2 adrenergic receptor | |
5jqh[2] | E |
CAU
(2S)-1-(9H-Carbazol-4-yloxy)-3-(isopropylamino)pro.. |
A | 17.6 /29.8 |
17 /17 |
ENLYS_BPT4 ADRB2_HUMAN Endolysin,Beta-2 adrenergic receptor | |
6ps0[1] | B |
CAU
(2S)-1-(9H-Carbazol-4-yloxy)-3-(isopropylamino)pro.. |
A | 10.0 /31.2 |
10 /16 |
ADRB2_HUMAN D9IEF7_BPT4 ADRB2_HUMAN Fusion protein of Beta-2 adrenergic receptor and T.. | |
3pds[1] | B |
ERC
8-hydroxy-5-[(1R)-1-hydroxy-2-({2-[3-methoxy-4-(3-.. |
A | 25.0 /31.2 |
12 /21 |
ADRB2_HUMAN LYS_BPT4 ADRB2_HUMAN Fusion protein Beta-2 adrenergic receptor/Lysozyme.. | |
5x7d[1] | F |
8VS
4-carbamoyl-N-[(2R)-2-cyclohexyl-2-phenylacetyl]-L.. |
A | 60.0 /31.2 |
5 /16 |
ADRB2_HUMAN D9IEF7_BPT4 ADRB2_HUMAN Chimera protein of Beta-2 adrenergic receptor and .. | |
6oba[1] | E |
M3J
6-bromo-N~2~-phenylquinazoline-2,4-diamine[19 atom.. |
A | 28.6 /31.2 |
7 /7 |
ADRB2_HUMAN D9IEF7_BPT4 ADRB2_HUMAN Beta-2 adrenergic receptor,Lysozyme,Beta-2 adrener.. | |
8iyx[1] | B |
S6R
1-[4-(3-chlorophenyl)phenyl]carbonyl-4-[2-(4-pheny.. |
A | 35.7 /31.2 |
14 /14 |
GPR34_HUMAN GPR34_HUMAN Probable G-protein coupled receptor 34,YL-365 | |
8k4n[1] | F |
VF0
(2R)-2-azanyl-3-[oxidanyl-[(2R)-2-oxidanyl-3-tetra.. |
E | 27.3 /31.2 |
11 /11 |
GPR34_HUMAN Probable G-protein coupled receptor 34 | |
6me8[1] | C |
JEY
N-[2-(5-methoxy-2-phenyl-1H-indol-3-yl)ethyl]aceta.. |
A | 18.8 /31.2 |
16 /19 |
C562_ECOLX MTR1B_HUMAN RUBR_CLOPA MTR1B_HUMAN Soluble cytochrome b562,Melatonin receptor type 1B.. | |
3nya[2] | D |
JTZ
(2S)-1-[(1-methylethyl)amino]-3-(2-prop-2-en-1-ylp.. |
A | 11.1 /31.9 |
9 /15 |
ADRB2_HUMAN LYS_BPT4 ADRB2_HUMAN Beta-2 adrenergic receptor, Lysozyme | |
6prz[2] | B |
JTZ
(2S)-1-[(1-methylethyl)amino]-3-(2-prop-2-en-1-ylp.. |
A | 9.1 /31.2 |
11 /17 |
ADRB2_HUMAN D9IEF7_BPT4 ADRB2_HUMAN Fusion protein of Beta-2 adrenergic receptor and T.. | |
8jjo[1] | B |
JTZ
(2S)-1-[(1-methylethyl)amino]-3-(2-prop-2-en-1-ylp.. |
A | 14.3 /31.2 |
7 /13 |
ADRB2_HUMAN ADRB2_HUMAN Beta-2 adrenergic receptor,Beta-2 adrenergic recep.. | |
7bz2[1] | F |
H98
~{N}-[5-[(1~{R})-2-[[(2~{R})-1-(4-methoxyphenyl)pr.. |
E | 16.7 /30.3 |
12 /12 |
Beta2 adrenergic receptor | |
8jj8[1] | B |
H98
~{N}-[5-[(1~{R})-2-[[(2~{R})-1-(4-methoxyphenyl)pr.. |
A | 16.7 /31.2 |
12 /20 |
ADRB2_HUMAN C562_ECOLX ADRB2_HUMAN Beta-2 adrenergic receptor,Soluble cytochrome b562.. | |
8jjl[1] | B |
DZQ
Olodaterol[28 atoms] |
A | 14.3 /31.2 |
14 /22 |
ADRB2_HUMAN C562_ECOLX ADRB2_HUMAN Beta-2 adrenergic receptor,Soluble cytochrome b562.. | |
3d4s[1] | B |
TIM
(2S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,.. |
A | 10.0 /31.9 |
10 /17 |
ADRB2_HUMAN LYS_BPT4 ADRB2_HUMAN Beta-2 adrenergic receptor/T4-lysozyme chimera | |
6ps1[2] | B |
TIM
(2S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,.. |
A | 10.0 /31.9 |
10 /17 |
ADRB2_HUMAN D9IEF7_BPT4 ADRB2_HUMAN Fusion protein of Beta-2 adrenergic receptor and T.. | |
2rh1[258] | M |
CLR
CHOLESTEROL[28 atoms] |
A | 11.1 /31.2 |
9 /9 |
ADRB2_HUMAN LYS_BPT4 ADRB2_HUMAN beta-2-adrenergic receptor/T4-lysozyme chimera | |
3pds[1] | C |
CLR
CHOLESTEROL[28 atoms] |
A | 12.5 /31.2 |
8 /8 |
ADRB2_HUMAN LYS_BPT4 ADRB2_HUMAN Fusion protein Beta-2 adrenergic receptor/Lysozyme.. | |
4ntj[1] | C |
CLR
CHOLESTEROL[28 atoms] |
A | 0.0 /32.4 |
1 /5 |
P2Y12_HUMAN C562_ECOLX P2Y12_HUMAN P2Y purinoceptor 12,Soluble cytochrome b562,P2Y pu.. | |
4pxz[1] | C |
CLR
CHOLESTEROL[28 atoms] |
A | 37.5 /33.2 |
8 /8 |
P2Y12_HUMAN C562_ECOLX P2Y12_HUMAN P2Y purinoceptor 12, Soluble cytochrome b562 | |
5jqh[2] | F |
CLR
CHOLESTEROL[28 atoms] |
A | 25.0 /29.8 |
4 /4 |
ENLYS_BPT4 ADRB2_HUMAN Endolysin,Beta-2 adrenergic receptor | |
6b73[2] | F |
CLR
CHOLESTEROL[28 atoms] |
A | 42.9 /36.9 |
7 /7 |
C562_ECOLX OPRK_HUMAN Soluble cytochrome b562, kappa-type opioid recepto.. | |
6drz[1] | B |
CLR
CHOLESTEROL[28 atoms] |
A | 66.7 /30.2 |
3 /6 |
5HT2B_HUMAN C562_ECOLX 5HT2B_HUMAN 5HT2B receptor, BRIL chimera | |
6lw5[1] | C |
CLR
CHOLESTEROL[28 atoms] |
A | 33.3 /35.3 |
3 /3 |
C562_ECOLX FPR2_HUMAN Soluble cytochrome b562,N-formyl peptide receptor .. | |
6pt2[1] | E |
CLR
CHOLESTEROL[28 atoms] |
A | 50.0 /32.5 |
6 /6 |
Delta opioid receptor | |
7f6g[1] | G |
CLR
CHOLESTEROL[28 atoms] |
A | 100.0 /99.4 |
11 /11 |
Angiotensin receptor AT1R | |
7f6g[1] | H |
CLR
CHOLESTEROL[28 atoms] |
A | 100.0 /99.4 |
9 /9 |
Angiotensin receptor AT1R | |
7f6g[1] | I |
CLR
CHOLESTEROL[28 atoms] |
A | 100.0 /99.4 |
7 /7 |
Angiotensin receptor AT1R | |
7f6g[1] | J |
CLR
CHOLESTEROL[28 atoms] |
A | 100.0 /99.4 |
9 /9 |
Angiotensin receptor AT1R | |
7f6g[1] | K |
CLR
CHOLESTEROL[28 atoms] |
A | 100.0 /99.4 |
7 /7 |
Angiotensin receptor AT1R | |
7f6g[1] | L |
CLR
CHOLESTEROL[28 atoms] |
A | 100.0 /99.4 |
2 /2 |
Angiotensin receptor AT1R | |
7f6h[2] | F |
CLR
CHOLESTEROL[28 atoms] |
A | 37.5 /34.4 |
8 /8 |
Bradykinin receptor BK2R | |
7f6h[2] | G |
CLR
CHOLESTEROL[28 atoms] |
A | 25.0 /34.4 |
4 /5 |
Bradykinin receptor BK2R | |
7f6i[1] | H |
CLR
CHOLESTEROL[28 atoms] |
A | 20.0 /34.4 |
10 /10 |
Bradykinin receptor BK2R | |
7f9y[1] | I |
CLR
CHOLESTEROL[28 atoms] |
F | 22.2 /28.0 |
9 /9 |
Soluble cytochrome b562 | |
7sk3[3] | G |
CLR
CHOLESTEROL[28 atoms] |
A | 0.0 /34.0 |
3 /3 |
ACKR3_HUMAN Atypical chemokine receptor 3 | |
7t2g[1] | F |
CLR
CHOLESTEROL[28 atoms] |
D | 33.3 /35.1 |
9 /9 |
C562_ECOLX OPRM_MOUSE Soluble cytochrome b562,Mu-type opioid receptor | |
7t2g[1] | G |
CLR
CHOLESTEROL[28 atoms] |
D | 40.0 /35.1 |
10 /10 |
C562_ECOLX OPRM_MOUSE Soluble cytochrome b562,Mu-type opioid receptor | |
7wq3[1] | G |
CLR
CHOLESTEROL[28 atoms] |
A | 50.0 /29.7 |
4 /4 |
GALR1_HUMAN Galanin receptor type 1 | |
7wq3[2] | K |
CLR
CHOLESTEROL[28 atoms] |
A | 37.5 /29.7 |
8 /8 |
GALR1_HUMAN Galanin receptor type 1 | |
7wq4[1] | H |
CLR
CHOLESTEROL[28 atoms] |
A | 33.3 /29.7 |
3 /4 |
GALR2_HUMAN Galanin receptor type 2 | |
7yae[1] | H |
CLR
CHOLESTEROL[28 atoms] |
E | 0.0 /33.3 |
3 /3 |
SSR2_HUMAN Somatostatin receptor type 2 | |
8f7s[1] | V |
CLR
CHOLESTEROL[28 atoms] |
F | 0.0 /32.5 |
6 /6 |
OPRD_HUMAN Delta-type opioid receptor | |
8f7w[1] | G |
CLR
CHOLESTEROL[28 atoms] |
A | 14.3 /35.3 |
7 /7 |
OPRK_HUMAN Kappa-type opioid receptor | |
8f7w[1] | I |
CLR
CHOLESTEROL[28 atoms] |
A | 33.3 /35.3 |
3 /3 |
OPRK_HUMAN Kappa-type opioid receptor | |
8hk2[1] | G |
CLR
CHOLESTEROL[28 atoms] |
A | 33.3 /31.8 |
6 /6 |
C3AR_HUMAN C3a anaphylatoxin chemotactic receptor | |
8hk2[1] | H |
CLR
CHOLESTEROL[28 atoms] |
A | 25.0 /31.8 |
4 /4 |
C3AR_HUMAN C3a anaphylatoxin chemotactic receptor | |
8hk2[1] | J |
CLR
CHOLESTEROL[28 atoms] |
A | 40.0 /31.8 |
5 /5 |
C3AR_HUMAN C3a anaphylatoxin chemotactic receptor | |
8hk2[1] | K |
CLR
CHOLESTEROL[28 atoms] |
A | 14.3 /31.8 |
7 /7 |
C3AR_HUMAN C3a anaphylatoxin chemotactic receptor | |
8izb[1] | I |
CLR
CHOLESTEROL[28 atoms] |
E | 37.5 /29.5 |
8 /8 |
GP174_HUMAN Probable G-protein coupled receptor 174 | |
8u4t[4] | BA |
CLR
CHOLESTEROL[28 atoms] |
C | 100.0 /36.6 |
1 /1 |
CXCR4_HUMAN C-X-C chemokine receptor type 4 | |
8u4t[4] | Q |
CLR
CHOLESTEROL[28 atoms] |
C | 80.0 /36.6 |
5 /5 |
CXCR4_HUMAN C-X-C chemokine receptor type 4 | |
8wrb[1] | F |
CLR
CHOLESTEROL[28 atoms] |
E | 50.0 /30.8 |
4 /4 |
GPR34_HUMAN Probable G-protein coupled receptor 34,Tag | |
8izb[1] | F |
UBL
[(2R)-2-oxidanyl-3-phosphonooxy-propyl] (Z)-octade.. |
E | 22.2 /29.5 |
18 /18 |
GP174_HUMAN Probable G-protein coupled receptor 174 | |
8wrb[1] | H |
UBL
[(2R)-2-oxidanyl-3-phosphonooxy-propyl] (Z)-octade.. |
E | 25.0 /30.8 |
12 /12 |
GPR34_HUMAN Probable G-protein coupled receptor 34,Tag | |
8izb[1] | G |
SER
SERINE[7 atoms] |
E | 0.0 /29.5 |
7 /8 |
GP174_HUMAN Probable G-protein coupled receptor 174 | |
8wrb[1] | G |
SER
SERINE[7 atoms] |
E | 28.6 /30.8 |
7 /7 |
GPR34_HUMAN Probable G-protein coupled receptor 34,Tag | |
8xbh[2] | F |
KW3
(2~{S})-2-azanyl-3-[[(2~{R})-1-ethoxy-3-[3-[2-[(3-.. |
D | 21.7 /30.6 |
23 /23 |
GPR34_HUMAN Probable G-protein coupled receptor 34 | |
4mqt[1] | D |
2CU
3-amino-5-chloro-N-cyclopropyl-4-methyl-6-[2-(4-me.. |
A | 9.1 /30.3 |
11 /11 |
ACM2_HUMAN ACM2_HUMAN Muscarinic acetylcholine receptor M2 | |
7dhr[1] | F |
5FW
ISOPRENALINE[15 atoms] |
E | 12.5 /30.3 |
8 /8 |
ADRB2_HUMAN Beta-2 adrenergic receptor | |
4mqs[5] | C |
IXO
4-(4,5-dihydro-1,2-oxazol-3-yloxy)-N,N,N-trimethyl.. |
A | 28.6 /30.1 |
14 /14 |
ACM2_HUMAN ACM2_HUMAN Muscarinic acetylcholine receptor M2 | |
7trq[1] | G |
IUI
5-amino-3,4-dimethyl-N-{[4-(trifluoromethanesulfon.. |
A | 30.8 /30.2 |
13 /13 |
ACM4_HUMAN ACM4_HUMAN Muscarinic acetylcholine receptor M4 | |
7xka[1] | C |
G1I
(5R,6R)-6-(methylamino)-5,6,7,8-tetrahydronaphthal.. |
A | 16.7 /29.3 |
12 /12 |
ENLYS_BPT4 ADRB2_HUMAN ADRB2_HUMAN Endolysin,Beta-2 adrenergic receptor | |
8gdz[71] | E |
G1I
(5R,6R)-6-(methylamino)-5,6,7,8-tetrahydronaphthal.. |
D | 16.7 /30.2 |
6 /9 |
ADRB2_HUMAN Beta-2 adrenergic receptor | |
8uo1[1] | G |
G1I
(5R,6R)-6-(methylamino)-5,6,7,8-tetrahydronaphthal.. |
D | 20.0 /30.2 |
5 /10 |
ADRB2_HUMAN Beta-2 adrenergic receptor | |
7dhi[1] | F |
68H
SALBUTAMOL[17 atoms] |
E | 16.7 /30.2 |
12 /12 |
ADRB2_HUMAN Beta-2 adrenergic receptor | |
6drz[1] | G |
H8J
(8alpha)-N-[(2S)-1-hydroxybutan-2-yl]-1,6-dimethyl.. |
A | 22.2 /30.2 |
9 /16 |
5HT2B_HUMAN C562_ECOLX 5HT2B_HUMAN 5HT2B receptor, BRIL chimera | |
8sai[1] | F |
S12
O-[(S)-hydroxy{[(2S)-2-hydroxy-3-(octadec-9-enoylo.. |
A | 18.8 /30.1 |
16 /16 |
GPR34_HUMAN Probable G-protein coupled receptor 34 | |
8fx5[1] | F |
XNO
xanomeline[19 atoms] |
A | 13.3 /30.0 |
15 /15 |
ACM4_HUMAN ACM4_HUMAN Muscarinic acetylcholine receptor M4 | |
8fx5[1] | G |
XNO
xanomeline[19 atoms] |
A | 40.0 /30.0 |
5 /5 |
ACM4_HUMAN ACM4_HUMAN Muscarinic acetylcholine receptor M4 | |
7trp[1] | F |
IUE
3-amino-5-chloro-N-cyclopropyl-6-methoxy-4-methylt.. |
A | 33.3 /29.9 |
9 /9 |
ACM4_HUMAN ACM4_HUMAN Muscarinic acetylcholine receptor M4 | |
7trs[1] | F |
ACH
ACETYLCHOLINE[10 atoms] |
E | 20.0 /29.9 |
10 /10 |
ACM4_HUMAN ACM4_HUMAN Muscarinic acetylcholine receptor M4 | |
5o9h[2] | C |
9P2
1-(1,3-benzodioxol-5-yl)-~{N}-(1,3-benzodioxol-5-y.. |
A | 25.0 /31.7 |
12 /12 |
C5AR1_HUMAN C5a anaphylatoxin chemotactic receptor 1 | |
5o9h[1] | U |
9P2
1-(1,3-benzodioxol-5-yl)-~{N}-(1,3-benzodioxol-5-y.. |
A | 0.0 /31.7 |
2 /2 |
C5AR1_HUMAN C5a anaphylatoxin chemotactic receptor 1 | |
5o9h[1] | C |
9P2
1-(1,3-benzodioxol-5-yl)-~{N}-(1,3-benzodioxol-5-y.. |
B | 40.0 /30.7 |
5 /5 |
C5AR1_HUMAN C5a anaphylatoxin chemotactic receptor 1 | |
6c1q[1] | C |
9P2
1-(1,3-benzodioxol-5-yl)-~{N}-(1,3-benzodioxol-5-y.. |
A | 25.0 /29.9 |
12 /12 |
C562_ECOLX C5AR1_HUMAN Soluble cytochrome b562, C5a anaphylatoxin chemota.. | |
6c1r[1] | C |
EFD
avacopan[42 atoms] |
A | 25.0 /29.9 |
16 /16 |
C562_ECOLX C5AR1_HUMAN Soluble cytochrome b562, C5a anaphylatoxin chemota.. | |
4pxz[1] | B |
6AD
2-(methylsulfanyl)adenosine 5'-(trihydrogen diphos.. |
A | 33.3 /33.2 |
18 /23 |
P2Y12_HUMAN C562_ECOLX P2Y12_HUMAN P2Y purinoceptor 12, Soluble cytochrome b562 | |
7xxh[1] | F |
6AD
2-(methylsulfanyl)adenosine 5'-(trihydrogen diphos.. |
A | 23.1 /29.8 |
13 /15 |
P2RY1_HUMAN P2Y purinoceptor 1 | |
7xxi[1] | E |
6AD
2-(methylsulfanyl)adenosine 5'-(trihydrogen diphos.. |
A | 31.2 /29.7 |
16 /16 |
P2Y12_HUMAN P2Y purinoceptor 12 | |
7xv3[1] | F |
WJS
(2~{S})-2-$l^{4}-azanyl-3-[[(2~{R})-3-octadecanoyl.. |
A | 13.3 /29.7 |
15 /15 |
GP174_HUMAN Probable G-protein coupled receptor 174 | |
4xnv[1] | B |
BUR
1-[2-(2-tert-butylphenoxy)pyridin-3-yl]-3-[4-(trif.. |
A | 50.0 /29.7 |
10 /10 |
P2RY1_HUMAN RUBR_CLOPA P2RY1_HUMAN P2Y purinoceptor 1, Rubredoxin, P2Y purinoceptor 1.. | |
3sn6[3] | F |
P0G
8-[(1R)-2-{[1,1-dimethyl-2-(2-methylphenyl)ethyl]a.. |
D | 9.1 /29.1 |
11 /17 |
ENLYS_BPT4 ADRB2_HUMAN Endolysin,Beta-2 adrenergic receptor | |
6e67[2] | C |
P0G
8-[(1R)-2-{[1,1-dimethyl-2-(2-methylphenyl)ethyl]a.. |
A | 10.0 /30.4 |
10 /16 |
ADRB2_HUMAN A0A097J809_BPT4 GNAS2_HUMAN ADRB2_HUMAN Beta-2 adrenergic receptor,Endolysin,Guanine nucle.. | |
6ni3[1] | F |
P0G
8-[(1R)-2-{[1,1-dimethyl-2-(2-methylphenyl)ethyl]a.. |
D | 18.2 /29.6 |
11 /16 |
A0A097J809_BPT4 ADRB2_HUMAN Endolysin,Beta-2 adrenergic receptor chimera | |
4xnw[2] | C |
2ID
[(1R,2S,4S,5S)-4-[2-iodo-6-(methylamino)-9H-purin-.. |
A | 13.3 /29.6 |
15 /17 |
P2RY1_HUMAN RUBR_CLOPA P2RY1_HUMAN P2Y purinoceptor 1,Rubredoxin,P2Y purinoceptor 1 | |
6rnk[1] | C |
KAZ
2-[2-[[3-[4-[(4-methylpiperazin-1-yl)methyl]phenyl.. |
A | 20.0 /29.6 |
15 /16 |
SUCR1_RAT Succinate receptor 1 | |
6z10[1] | C |
Q4T
2-[2-[[3-[4-chloranyl-2-fluoranyl-5-[(3~{R})-piper.. |
A | 26.7 /29.6 |
15 /15 |
SUCR1_RAT Succinate receptor 1 | |
6mxt[1] | C |
K5Y
salmeterol[30 atoms] |
A | 25.0 /29.6 |
20 /20 |
D9IEF7_BPT4 ADRB2_HUMAN ADRB2_HUMAN Endolysin, Beta-2 adrenergic receptor chimera | |
6d27[1] | I |
FT4
[(3R)-3-{[(4-fluorophenyl)sulfonyl](methyl)amino}-.. |
A | 20.0 /29.5 |
5 /10 |
PD2R2_HUMAN D9IEF7_BPT4 D9IEF7_BPT4 PD2R2_HUMAN Prostaglandin D2 receptor 2, Endolysin chimera | |
8kh5[1] | G |
LPS
O-{HYDROXY[((2R)-2-HYDROXY-3-{[(1S)-1-HYDROXYPENTA.. |
A | 25.0 /29.4 |
24 /25 |
GP174_HUMAN Probable G-protein coupled receptor 174 | |
7tuz[1] | F |
KJX
(2S,4aS,4bS,7R,8S,8aS,9R,10aR)-7-[(2R,3R)-7-hydrox.. |
A | 20.0 /29.3 |
10 /10 |
GP183_HUMAN G-protein coupled receptor 183 | |
4ldl[1] | C |
XQC
4-[(1R)-1-hydroxy-2-{[1-(4-hydroxyphenyl)-2-methyl.. |
A | 18.8 /29.3 |
16 /16 |
LYS_BPT4 ADRB2_HUMAN ADRB2_HUMAN Lysozyme, Beta-2 adrenergic receptor | |
4ldo[1] | D |
ALE
L-EPINEPHRINE[13 atoms] |
A | 18.2 /29.3 |
11 /11 |
LYS_BPT4 ADRB2_HUMAN ADRB2_HUMAN Lysozyme, Beta-2 adrenergic receptor | |
4qkx[1] | E |
35V
4-[(1R)-1-hydroxy-2-({2-[3-methoxy-4-(2-sulfanylet.. |
A | 21.4 /29.3 |
14 /14 |
D9IEF7_BPT4 ADRB2_HUMAN Beta-2 adrenergic receptor | |
6n48[1] | E |
KBY
N-[(3R)-4-(4-tert-butylphenyl)-3-({2-[(4-methoxyph.. |
A | 22.2 /29.3 |
9 /9 |
A0A097J809_BPT4 ADRB2_HUMAN ADRB2_HUMAN Endolysin,Beta-2 adrenergic receptor,Beta-2 adrene.. | |
7xk9[1] | C |
GJ6
(5R,6R)-6-(propan-2-ylamino)-5,6,7,8-tetrahydronap.. |
A | 15.4 /29.3 |
13 /13 |
ENLYS_BPT4 ADRB2_HUMAN ADRB2_HUMAN Endolysin,Beta-2 adrenergic receptor | |
7l1v[1] | G |
XGD
4'-methoxy-N,N-dimethyl-3'-{[3-(2-{[2-(2H-1,2,3-tr.. |
E | 23.8 /29.1 |
21 /22 |
Q548Y0_HUMAN Hypocretin receptor type 2 | |
4xt1[1] | S |
SIN
SUCCINIC ACID[8 atoms] |
A | 20.0 /30.1 |
5 /5 |
US28_HCMVA G-protein coupled receptor homolog US28 | |
6d26[1] | L |
SIN
SUCCINIC ACID[8 atoms] |
A | 33.3 /28.6 |
6 /6 |
PD2R2_HUMAN D9IEF7_BPT4 D9IEF7_BPT4 PD2R2_HUMAN Prostaglandin D2 receptor 2, Endolysin chimera | |
6d26[1] | N |
SIN
SUCCINIC ACID[8 atoms] |
A | 0.0 /28.6 |
3 /3 |
PD2R2_HUMAN D9IEF7_BPT4 D9IEF7_BPT4 PD2R2_HUMAN Prostaglandin D2 receptor 2, Endolysin chimera | |
6d26[1] | O |
SIN
SUCCINIC ACID[8 atoms] |
A | 33.3 /28.6 |
3 /5 |
PD2R2_HUMAN D9IEF7_BPT4 D9IEF7_BPT4 PD2R2_HUMAN Prostaglandin D2 receptor 2, Endolysin chimera | |
6d26[1] | B |
FSY
fevipiprant[29 atoms] |
A | 23.1 /28.6 |
13 /19 |
PD2R2_HUMAN D9IEF7_BPT4 D9IEF7_BPT4 PD2R2_HUMAN Prostaglandin D2 receptor 2, Endolysin chimera | |
6tot[2] | M |
NRK
(1~{R},2~{S})-2-[(2,4-dimethylpyrimidin-5-yl)oxyme.. |
B | 12.5 /27.8 |
16 /16 |
OX1R_HUMAN Orexin receptor type 1 | |
6vms[1] | F |
08Y
bromoergocryptine[43 atoms] |
E | 15.0 /28.5 |
20 /20 |
D9IEF7_BPT4 DRD2_HUMAN DRD2_HUMAN Endolysin,D(2) dopamine receptor,D(2) dopamine rec.. | |
7vgy[1] | G |
ML2
N-[2-(2-iodo-5-methoxy-1H-indol-3-yl)ethyl]acetami.. |
A | 13.3 /28.2 |
15 /15 |
MTR1A_HUMAN Melatonin receptor type 1A | |
7f9y[1] | G |
OCA
OCTANOIC ACID (CAPRYLIC ACID)[9 atoms] |
F | 14.3 /28.0 |
7 /7 |
Soluble cytochrome b562 | |
7na8[1] | F |
1KD
1-(methanesulfonyl)-1'-(2-methyl-L-alanyl-O-benzyl.. |
E | 0.0 /27.9 |
15 /19 |
GHSR_HUMAN Growth hormone secretagogue receptor type 1 | |
4s0v[1] | B |
SUV
[(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,.. |
A | 10.0 /36.1 |
10 /19 |
OX2R_HUMAN Q9V2J8_PYRAB OX2R_HUMAN Human Orexin receptor type 2 fusion protein to P. .. | |
6to7[1] | C |
SUV
[(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,.. |
A | 11.8 /27.8 |
17 /17 |
OX1R_HUMAN Orexin receptor type 1 | |
6tos[1] | V |
NRE
[(2~{S},5~{S})-2-[[(5-bromanylpyridin-2-yl)amino]m.. |
B | 6.2 /27.8 |
16 /16 |
OX1R_HUMAN Orexin receptor type 1 | |
7ymj[1] | C |
JGX
Tamsulosin[28 atoms] |
A | 21.4 /27.8 |
14 /14 |
alpha1A-adrenergic receptor | |
8hvi[1] | F |
NFI
3-methyl-5-[(4-oxidanylidene-4-phenyl-butanoyl)ami.. |
A | 12.5 /27.8 |
8 /8 |
C562_ECOLX GP132_HUMAN Soluble cytochrome b562,Probable G-protein coupled.. | |
8hqm[1] | F |
140
N-PALMITOYLGLYCINE[22 atoms] |
D | 0.0 /27.7 |
7 /7 |
C562_ECOLX GP132_HUMAN Soluble cytochrome b562,Probable G-protein coupled.. | |
6do1[4] | I |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /98.7 |
2 /2 |
AGTR1_HUMAN C562_ECOLX AGTR1_HUMAN Type-1 angiotensin II receptor,Soluble cytochrome .. | |
7f6g[1] | F |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /99.4 |
3 /3 |
Angiotensin receptor AT1R | |
7srs[1] | G |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
C | 50.0 /27.5 |
2 /2 |
5-hydroxytryptamine receptor 2B | |
7srs[1] | H |
7LD
(8alpha)-N,N-diethyl-6-methyl-9,10-didehydroergoli.. |
C | 16.7 /27.5 |
6 /6 |
5-hydroxytryptamine receptor 2B | |
6to7[5] | BA |
PGW
(1R)-2-{[(S)-{[(2S)-2,3-dihydroxypropyl]oxy}(hydro.. |
A | 0.0 /27.8 |
10 /10 |
OX1R_HUMAN Orexin receptor type 1 | |
6tos[2] | Z |
PGW
(1R)-2-{[(S)-{[(2S)-2,3-dihydroxypropyl]oxy}(hydro.. |
B | 11.8 /27.8 |
17 /17 |
OX1R_HUMAN Orexin receptor type 1 | |
5wqc[2] | B |
7MA
N-ethyl-2-[(6-methoxypyridin-3-yl)-(2-methylphenyl.. |
A | 0.0 /37.0 |
6 /17 |
OX2R_HUMAN Q9V2J8_PYRAB OX2R_HUMAN Orexin receptor type 2,GlgA glycogen synthase,Orex.. | |
6tod[1] | C |
7MA
N-ethyl-2-[(6-methoxypyridin-3-yl)-(2-methylphenyl.. |
A | 11.1 /27.3 |
18 /18 |
OX1R_HUMAN Orexin receptor type 1 | |
8ihi[3] | G |
P9X
(5~{S})-5-methyl-4-oxidanylidene-5-phenyl-furan-2-.. |
E | 15.4 /24.5 |
13 /13 |
C562_ECOLX HCAR2_HUMAN Soluble cytochrome b562,Hydroxycarboxylic acid rec.. | |
6to7[8] | F |
SOG
octyl 1-thio-beta-D-glucopyranoside[20 atoms] |
A | 50.0 /27.8 |
4 /4 |
OX1R_HUMAN Orexin receptor type 1 | |
6to7[16] | G |
SOG
octyl 1-thio-beta-D-glucopyranoside[20 atoms] |
A | 20.0 /27.8 |
5 /5 |
OX1R_HUMAN Orexin receptor type 1 | |
6to7[10] | H |
SOG
octyl 1-thio-beta-D-glucopyranoside[16 atoms] |
A | 20.0 /27.8 |
10 /10 |
OX1R_HUMAN Orexin receptor type 1 | |
6to7[4] | I |
SOG
octyl 1-thio-beta-D-glucopyranoside[14 atoms] |
A | 50.0 /27.8 |
2 /2 |
OX1R_HUMAN Orexin receptor type 1 | |
6to7[2] | N |
SOG
octyl 1-thio-beta-D-glucopyranoside[16 atoms] |
A | 33.3 /27.8 |
6 /6 |
OX1R_HUMAN Orexin receptor type 1 | |
6to7[6] | O |
SOG
octyl 1-thio-beta-D-glucopyranoside[10 atoms] |
A | 0.0 /27.8 |
4 /4 |
OX1R_HUMAN Orexin receptor type 1 | |
6to7[2] | P |
SOG
octyl 1-thio-beta-D-glucopyranoside[9 atoms] |
A | 100.0 /27.8 |
1 /2 |
OX1R_HUMAN Orexin receptor type 1 | |
6to7[1] | Q |
SOG
octyl 1-thio-beta-D-glucopyranoside[8 atoms] |
A | 0.0 /27.8 |
4 /5 |
OX1R_HUMAN Orexin receptor type 1 | |
6tod[1] | DA |
SOG
octyl 1-thio-beta-D-glucopyranoside[7 atoms] |
A | 0.0 /27.3 |
5 /5 |
OX1R_HUMAN Orexin receptor type 1 | |
6tod[6] | P |
SOG
octyl 1-thio-beta-D-glucopyranoside[20 atoms] |
A | 33.3 /27.3 |
6 /7 |
OX1R_HUMAN Orexin receptor type 1 | |
6tod[1] | R |
SOG
octyl 1-thio-beta-D-glucopyranoside[20 atoms] |
A | 80.0 /27.3 |
5 /6 |
OX1R_HUMAN Orexin receptor type 1 | |
6tod[2] | Y |
SOG
octyl 1-thio-beta-D-glucopyranoside[7 atoms] |
A | 0.0 /27.3 |
1 /1 |
OX1R_HUMAN Orexin receptor type 1 | |
6tos[1] | AA |
SOG
octyl 1-thio-beta-D-glucopyranoside[20 atoms] |
B | 0.0 /27.8 |
3 /5 |
OX1R_HUMAN Orexin receptor type 1 | |
6tos[1] | LA |
SOG
octyl 1-thio-beta-D-glucopyranoside[20 atoms] |
B | 0.0 /27.8 |
1 /4 |
OX1R_HUMAN Orexin receptor type 1 | |
6tq9[1] | E |
SOG
octyl 1-thio-beta-D-glucopyranoside[20 atoms] |
A | 0.0 /27.4 |
1 /7 |
OX1R_HUMAN Orexin receptor type 1 | |
6tq9[1] | S |
SOG
octyl 1-thio-beta-D-glucopyranoside[20 atoms] |
B | 0.0 /27.2 |
2 /2 |
OX1R_HUMAN Orexin receptor type 1 | |
6tq9[3] | C |
NVN
1-[6,8-bis(fluoranyl)-2-methyl-quinolin-4-yl]-3-[4.. |
A | 16.7 /27.4 |
12 /14 |
OX1R_HUMAN Orexin receptor type 1 | |
7m8w[1] | B |
YSS
15R-methyl-prostaglandin D2[26 atoms] |
A | 33.3 /27.1 |
12 /17 |
PD2R2_HUMAN D9IEF7_BPT4 D9IEF7_BPT4 PD2R2_HUMAN Prostaglandin D2 receptor 2, Endolysin chimera | |
6ko5[1] | D |
8QX
6-(4-bromanyl-2-fluoranyl-phenoxy)-2-methyl-3-[[(3.. |
A | 20.0 /27.0 |
15 /16 |
C562_ECOLX GHSR_HUMAN Chimera of Soluble cytochrome b562 and Growth horm.. | |
7xk2[2] | F |
FI7
2-[[2,2-dimethyl-3-[3-(5-oxidanylpyridin-2-yl)-1,2.. |
C | 11.8 /25.6 |
17 /17 |
HCAR2_HUMAN Hydroxycarboxylic acid receptor 2 | |
8ihf[1] | G |
FI7
2-[[2,2-dimethyl-3-[3-(5-oxidanylpyridin-2-yl)-1,2.. |
E | 14.3 /24.5 |
21 /21 |
C562_ECOLX HCAR2_HUMAN Soluble cytochrome b562,Hydroxycarboxylic acid rec.. | |
8ijd[2] | F |
FI7
2-[[2,2-dimethyl-3-[3-(5-oxidanylpyridin-2-yl)-1,2.. |
A | 16.7 /24.5 |
18 /18 |
HCAR2_HUMAN Hydroxycarboxylic acid receptor 2 | |
8iyh[1] | F |
FI7
2-[[2,2-dimethyl-3-[3-(5-oxidanylpyridin-2-yl)-1,2.. |
C | 15.4 /25.7 |
13 /13 |
ACM4_HUMAN HCAR2_HUMAN Hydroxycarboxylic acid receptor 2 | |
8jz7[1] | F |
FI7
2-[[2,2-dimethyl-3-[3-(5-oxidanylpyridin-2-yl)-1,2.. |
E | 7.1 /25.6 |
14 /14 |
HCAR2_HUMAN Hydroxycarboxylic acid receptor 2 | |
8j6p[2] | F |
IX8
7-methyl-N-[(2R)-1-phenoxypropan-2-yl]-3-(4-propan.. |
E | 16.7 /24.4 |
12 /12 |
HCAR2_HUMAN Hydroxycarboxylic acid receptor 2 | |
8jhy[2] | F |
IX8
7-methyl-N-[(2R)-1-phenoxypropan-2-yl]-3-(4-propan.. |
E | 16.7 /25.6 |
12 /12 |
HCAR2_HUMAN Hydroxycarboxylic acid receptor 2 | |
8jim[1] | F |
AW9
(2Z)-4-methoxy-4-oxobut-2-enoic acid[9 atoms] |
E | 9.1 /25.6 |
11 /11 |
HCAR2_HUMAN Hydroxycarboxylic acid receptor 2 | |
8h8j[1] | F |
WYB
2,2'-[(2-chloro-5-cyano-1,3-phenylene)bis(azanediy.. |
C | 11.1 /25.0 |
9 /10 |
GPR35_HUMAN G-protein coupled receptor 35 | |
8h2g[2] | F |
NIO
NICOTINIC ACID[9 atoms] |
A | 11.1 /24.5 |
9 /9 |
HCAR2_HUMAN Hydroxy-carboxylic acid receptor 2 | |
8ija[2] | F |
NIO
NICOTINIC ACID[9 atoms] |
A | 22.2 /24.5 |
9 /9 |
HCAR2_HUMAN Hydroxycarboxylic acid receptor 2 | |
8iy9[1] | F |
NIO
NICOTINIC ACID[9 atoms] |
E | 18.2 /24.2 |
11 /11 |
ACM4_HUMAN HCAR2_HUMAN Hydroxycarboxylic acid receptor 2 | |
8j6l[1] | F |
NIO
NICOTINIC ACID[9 atoms] |
E | 20.0 /24.3 |
10 /10 |
HCAR2_HUMAN Hydroxycarboxylic acid receptor 2,hydroxycarboxyli.. | |
8jii[2] | F |
NIO
NICOTINIC ACID[9 atoms] |
E | 14.3 /25.6 |
7 /7 |
HCAR2_HUMAN Hydroxycarboxylic acid receptor 2 | |
8i7v[2] | F |
OJX
5-methyl-4-oxidanyl-pyrazin-4-ium-2-carboxylic aci.. |
A | 15.4 /24.5 |
13 /13 |
HCAR2_HUMAN Human hydroxycarboxylic acid receptor 2,Hydroxycar.. | |
8ijb[1] | F |
OJX
5-methyl-4-oxidanyl-pyrazin-4-ium-2-carboxylic aci.. |
A | 20.0 /24.5 |
10 /10 |
HCAR2_HUMAN Hydroxycarboxylic acid receptor 2 | |
8jer[1] | F |
OJX
5-methyl-4-oxidanyl-pyrazin-4-ium-2-carboxylic aci.. |
C | 18.2 /25.5 |
11 /11 |
ACM4_HUMAN HCAR2_HUMAN Hydroxycarboxylic acid receptor 2 | |
8i7w[2] | F |
OKL
8-chloranyl-3-pentyl-7H-purine-2,6-dione[17 atoms].. |
A | 14.3 /24.5 |
14 /14 |
HCAR2_HUMAN Human hydroxycarboxylic acid receptor 2,Hydroxycar.. | |
8ihb[1] | G |
OKL
8-chloranyl-3-pentyl-7H-purine-2,6-dione[17 atoms].. |
A | 14.3 /24.5 |
14 /14 |
C562_ECOLX HCAR2_HUMAN Soluble cytochrome b562,Hydroxycarboxylic acid rec.. | |
8iyw[1] | F |
OKL
8-chloranyl-3-pentyl-7H-purine-2,6-dione[17 atoms].. |
E | 27.3 /24.3 |
11 /11 |
ACM4_HUMAN HCAR2_HUMAN Hydroxycarboxylic acid receptor 2 | |
8j6j[1] | F |
OKL
8-chloranyl-3-pentyl-7H-purine-2,6-dione[17 atoms].. |
E | 20.0 /24.5 |
15 /15 |
HCAR2_HUMAN Hydroxycarboxylic acid receptor 2,hydroxycarboxyli.. | |
8ihh[1] | G |
P8A
5-butyl-1~{H}-pyrazole-3-carboxylic acid[12 atoms].. |
A | 13.3 /24.5 |
15 /15 |
C562_ECOLX HCAR2_HUMAN Soluble cytochrome b562,Hydroxycarboxylic acid rec.. | |
8jhn[1] | F |
UR9
(E)-4-methoxy-4-oxidanylidene-but-2-enoic acid[9 a.. |
C | 33.3 /24.5 |
9 /9 |
ACM4_HUMAN HCAR2_HUMAN Hydroxycarboxylic acid receptor 2 | |
8j6q[1] | H |
3HR
(3R)-3-hydroxybutanoic acid[7 atoms] |
E | 9.1 /24.4 |
11 /11 |
HCAR2_HUMAN Hydroxycarboxylic acid receptor 2 | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
METAL | |||||||
359 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
5t1a[1] | I |
ZN
ZINC ION[1 atoms] |
A | 66.7 /35.9 |
3 /4 |
CCR2_HUMAN D9IEF7_BPT4 CCR2_HUMAN Chimera protein of CC chemokine receptor type 2 is.. | |
5zkq[2] | H |
ZN
ZINC ION[1 atoms] |
A | 0.0 /32.5 |
3 /5 |
PTAFR_HUMAN ENLYS_BPT4 ENLYS_BPT4 PTAFR_HUMAN Platelet-activating factor receptor,Endolysin,Endo.. | |
6me8[1] | D |
ZN
ZINC ION[1 atoms] |
A | 0.0 /31.2 |
2 /4 |
C562_ECOLX MTR1B_HUMAN RUBR_CLOPA MTR1B_HUMAN Soluble cytochrome b562,Melatonin receptor type 1B.. | |
3vw7[1] | L |
CL
CHLORIDE ION[1 atoms] |
A | 50.0 /36.4 |
2 /3 |
PAR1_HUMAN LYS_BPT4 PAR1_HUMAN Proteinase-activated receptor 1, Lysozyme | |
4dkl[2] | S |
CL
CHLORIDE ION[1 atoms] |
A | 0.0 /36.5 |
1 /3 |
OPRM_MOUSE LYS_BPT4 OPRM_MOUSE Mu-type opioid receptor, lysozyme chimera | |
6do1[2] | J |
CL
CHLORIDE ION[1 atoms] |
A | 100.0 /98.7 |
2 /2 |
AGTR1_HUMAN C562_ECOLX AGTR1_HUMAN Type-1 angiotensin II receptor,Soluble cytochrome .. | |
6do1[1] | K |
CL
CHLORIDE ION[1 atoms] |
A | 100.0 /98.7 |
1 /1 |
AGTR1_HUMAN C562_ECOLX AGTR1_HUMAN Type-1 angiotensin II receptor,Soluble cytochrome .. | |
6do1[2] | L |
CL
CHLORIDE ION[1 atoms] |
A | 100.0 /98.7 |
3 /3 |
AGTR1_HUMAN C562_ECOLX AGTR1_HUMAN Type-1 angiotensin II receptor,Soluble cytochrome .. | |
6do1[1] | P |
CL
CHLORIDE ION[1 atoms] |
B | 100.0 /98.7 |
2 /2 |
AGTR1_HUMAN C562_ECOLX AGTR1_HUMAN Type-1 angiotensin II receptor,Soluble cytochrome .. | |
6z10[1] | Q |
CL
CHLORIDE ION[1 atoms] |
A | 33.3 /29.6 |
3 /3 |
SUCR1_RAT Succinate receptor 1 | |
6mxt[1] | D |
MG
MAGNESIUM ION[1 atoms] |
A | 33.3 /29.6 |
3 /5 |
D9IEF7_BPT4 ADRB2_HUMAN ADRB2_HUMAN Endolysin, Beta-2 adrenergic receptor chimera | |
6mxt[1] | E |
NI
NICKEL (II) ION[1 atoms] |
A | 50.0 /29.6 |
2 /2 |
D9IEF7_BPT4 ADRB2_HUMAN ADRB2_HUMAN Endolysin, Beta-2 adrenergic receptor chimera | |
3vw7[1] | M |
NA
SODIUM ION[1 atoms] |
A | 100.0 /36.4 |
3 /4 |
PAR1_HUMAN LYS_BPT4 PAR1_HUMAN Proteinase-activated receptor 1, Lysozyme | |
4lde[6] | D |
NA
SODIUM ION[1 atoms] |
A | 33.3 /29.3 |
3 /5 |
LYS_BPT4 ADRB2_HUMAN ADRB2_HUMAN Lysozyme, Beta-2 adrenergic receptor | |
4n6h[1] | U |
NA
SODIUM ION[1 atoms] |
A | 100.0 /33.3 |
3 /3 |
C562_ECOLX OPRD_HUMAN Soluble cytochrome b562, Delta-type opioid recepto.. | |
4rwd[3] | F |
NA
SODIUM ION[1 atoms] |
A | 100.0 /33.6 |
3 /3 |
C562_ECOLX Soluble cytochrome b562,Delta-type opioid receptor.. | |
5ndd[2] | C |
NA
SODIUM ION[1 atoms] |
A | 100.0 /33.8 |
3 /5 |
D9IEF7_BPT4 PAR2_HUMAN C562_ECOLX PAR2_HUMAN Lysozyme,Proteinase-activated receptor 2,Soluble c.. | |
6qzh[1] | D |
NA
SODIUM ION[1 atoms] |
A | 100.0 /36.7 |
3 /4 |
CCR7_HUMAN NANA_STREE CCR7_HUMAN C-C chemokine receptor type 7,Sialidase A,C-C chem.. | |
6rz4[3] | C |
NA
SODIUM ION[1 atoms] |
A | 100.0 /40.0 |
2 /5 |
CLTR1_HUMAN C562_ECOLX CLTR1_HUMAN Cysteinyl leukotriene receptor 1,Soluble cytochrom.. | |
6to7[2] | CA |
NA
SODIUM ION[1 atoms] |
A | 66.7 /27.8 |
3 /3 |
OX1R_HUMAN Orexin receptor type 1 | |
7k15[1] | C |
NA
SODIUM ION[1 atoms] |
A | 66.7 /36.4 |
3 /3 |
LT4R1_HUMAN FLAV_DESVH LT4R1_HUMAN Leukotriene B4 receptor 1,Flavodoxin,Leukotriene B.. | |
7m8w[1] | C |
NA
SODIUM ION[1 atoms] |
A | 80.0 /27.1 |
5 /6 |
PD2R2_HUMAN D9IEF7_BPT4 D9IEF7_BPT4 PD2R2_HUMAN Prostaglandin D2 receptor 2, Endolysin chimera | |
8h8j[1] | G |
CA
CALCIUM ION[1 atoms] |
C | 0.0 /25.0 |
2 /2 |
GPR35_HUMAN G-protein coupled receptor 35 | |
7zl9[1] | J |
UNX
UNKNOWN ATOM OR ION[1 atoms] |
A | 0.0 /24.3 |
1 /1 |
HCAR2_HUMAN C562_ECOLX Hydroxycarboxylic acid receptor 2,Soluble cytochro.. | |
7zl9[1] | K |
UNX
UNKNOWN ATOM OR ION[1 atoms] |
A | 33.3 /24.3 |
3 /3 |
HCAR2_HUMAN C562_ECOLX Hydroxycarboxylic acid receptor 2,Soluble cytochro.. | |
7zl9[1] | L |
UNX
UNKNOWN ATOM OR ION[1 atoms] |
A | 0.0 /24.3 |
3 /3 |
HCAR2_HUMAN C562_ECOLX Hydroxycarboxylic acid receptor 2,Soluble cytochro.. | |
7zl9[1] | M |
UNX
UNKNOWN ATOM OR ION[1 atoms] |
A | 0.0 /24.3 |
3 /4 |
HCAR2_HUMAN C562_ECOLX Hydroxycarboxylic acid receptor 2,Soluble cytochro.. | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
OTHERPOLY | |||||||
359 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
7f9z[1] | C | 3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.]PYRAZOLE.. | G | 6.2 /28.0 |
16 /17 |
human ghrelin receptor | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
HOMO | |||||||
359 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
4djh[2] | B | OPRK_HUMAN LYS_BPT4 OPRK_HUMAN Kappa-type opioid receptor, Lysozyme[448 aa] | A | 60.0 /39.0 |
15 /19 |
OPRK_HUMAN LYS_BPT4 OPRK_HUMAN Kappa-type opioid receptor, Lysozyme | |
4djh[2] | B | OPRK_HUMAN LYS_BPT4 OPRK_HUMAN Kappa-type opioid receptor, Lysozyme[448 aa] | A | 25.0 /39.0 |
16 /16 |
OPRK_HUMAN LYS_BPT4 OPRK_HUMAN Kappa-type opioid receptor, Lysozyme | |
5unf[2] | B | C562_ECOLX AGTR2_HUMAN Chimera protein of Type-2 angiotensin II receptor .. | A | 12.5 /37.6 |
16 /18 |
C562_ECOLX AGTR2_HUMAN Chimera protein of Type-2 angiotensin II receptor .. | |
5unf[2] | A | C562_ECOLX AGTR2_HUMAN Chimera protein of Type-2 angiotensin II receptor .. | B | 31.6 /37.9 |
19 /19 |
C562_ECOLX AGTR2_HUMAN Chimera protein of Type-2 angiotensin II receptor .. | |
3odu[10] | B | CXCR4_HUMAN LYS_BPT4 CXCR4_HUMAN C-X-C chemokine receptor type 4, Lysozyme Chimera[.. | A | 14.3 /36.2 |
14 /23 |
CXCR4_HUMAN LYS_BPT4 CXCR4_HUMAN C-X-C chemokine receptor type 4, Lysozyme Chimera | |
3oe8[1] | B | CXCR4_HUMAN LYS_BPT4 CXCR4_HUMAN C-X-C chemokine receptor type 4, Lysozyme Chimera[.. | A | 50.0 /37.1 |
11 /14 |
CXCR4_HUMAN LYS_BPT4 CXCR4_HUMAN C-X-C chemokine receptor type 4, Lysozyme Chimera | |
3oe8[1] | A | CXCR4_HUMAN LYS_BPT4 CXCR4_HUMAN C-X-C chemokine receptor type 4, Lysozyme Chimera[.. | B | 25.0 /35.2 |
8 /13 |
CXCR4_HUMAN LYS_BPT4 CXCR4_HUMAN C-X-C chemokine receptor type 4, Lysozyme Chimera | |
8u4s[7] | F | CXCR4_HUMAN C-X-C chemokine receptor type 4[284 aa] | C | 31.6 /36.5 |
19 /19 |
CXCR4_HUMAN C-X-C chemokine receptor type 4 | |
8u4s[7] | I | CXCR4_HUMAN C-X-C chemokine receptor type 4[284 aa] | C | 37.5 /36.5 |
16 /16 |
CXCR4_HUMAN C-X-C chemokine receptor type 4 | |
4dkl[2] | A | OPRM_MOUSE LYS_BPT4 OPRM_MOUSE Mu-type opioid receptor, lysozyme chimera[442 aa] | A | 17.6 /36.5 |
17 /29 |
OPRM_MOUSE LYS_BPT4 OPRM_MOUSE Mu-type opioid receptor, lysozyme chimera | |
6vi4[2] | B | OPRK_HUMAN Kappa opioid receptor[276 aa] | A | 66.7 /36.0 |
6 /12 |
OPRK_HUMAN Kappa opioid receptor | |
7w0l[4] | E | C562_ECOLX APJ_HUMAN Soluble cytochrome b562,Apelin receptor[298 aa] | D | 66.7 /35.6 |
3 /3 |
C562_ECOLX APJ_HUMAN Soluble cytochrome b562,Apelin receptor | |
7f83[1] | B | GHSR_HUMAN C562_ECOLX GHSR_HUMAN Growth hormone secretagogue receptor type 1,Solubl.. | A | 50.0 /34.7 |
2 /14 |
GHSR_HUMAN C562_ECOLX GHSR_HUMAN Growth hormone secretagogue receptor type 1,Solubl.. | |
7f83[1] | A | GHSR_HUMAN C562_ECOLX GHSR_HUMAN Growth hormone secretagogue receptor type 1,Solubl.. | B | 53.8 /34.7 |
13 /16 |
GHSR_HUMAN C562_ECOLX GHSR_HUMAN Growth hormone secretagogue receptor type 1,Solubl.. | |
8ef5[8] | F | OPRM_HUMAN Mu-type opioid receptor[288 aa] | A | 9.1 /34.4 |
11 /11 |
OPRM_HUMAN Mu-type opioid receptor | |
8f7q[4] | G | OPRM_HUMAN Mu-type opioid receptor[287 aa] | A | 8.3 /34.1 |
12 /12 |
OPRM_HUMAN Mu-type opioid receptor | |
4ea3[1] | A | C562_ECOLX OPRX_HUMAN Fusion protein of Nociceptin receptor and cytochro.. | B | 33.3 /34.6 |
6 /7 |
C562_ECOLX OPRX_HUMAN Fusion protein of Nociceptin receptor and cytochro.. | |
4ea3[3] | A | C562_ECOLX OPRX_HUMAN Fusion protein of Nociceptin receptor and cytochro.. | B | 28.6 /34.6 |
14 /14 |
C562_ECOLX OPRX_HUMAN Fusion protein of Nociceptin receptor and cytochro.. | |
4ea3[1] | A | C562_ECOLX OPRX_HUMAN Fusion protein of Nociceptin receptor and cytochro.. | B | 30.8 /34.6 |
13 /20 |
C562_ECOLX OPRX_HUMAN Fusion protein of Nociceptin receptor and cytochro.. | |
4ea3[1] | B | C562_ECOLX OPRX_HUMAN Fusion protein of Nociceptin receptor and cytochro.. | A | 14.3 /33.6 |
7 /7 |
C562_ECOLX OPRX_HUMAN Fusion protein of Nociceptin receptor and cytochro.. | |
4ea3[3] | B | C562_ECOLX OPRX_HUMAN Fusion protein of Nociceptin receptor and cytochro.. | A | 27.8 /33.6 |
18 /18 |
C562_ECOLX OPRX_HUMAN Fusion protein of Nociceptin receptor and cytochro.. | |
4ea3[1] | B | C562_ECOLX OPRX_HUMAN Fusion protein of Nociceptin receptor and cytochro.. | A | 31.2 /33.6 |
16 /16 |
C562_ECOLX OPRX_HUMAN Fusion protein of Nociceptin receptor and cytochro.. | |
5zkq[1] | A | PTAFR_HUMAN ENLYS_BPT4 ENLYS_BPT4 PTAFR_HUMAN Platelet-activating factor receptor,Endolysin,Endo.. | B | 40.0 /33.1 |
5 /13 |
PTAFR_HUMAN ENLYS_BPT4 ENLYS_BPT4 PTAFR_HUMAN Platelet-activating factor receptor,Endolysin,Endo.. | |
6pt2[2] | A | Delta opioid receptor[397 aa] | B | 46.2 /34.2 |
13 /16 |
Delta opioid receptor | |
6pt2[2] | B | Delta opioid receptor[361 aa] | A | 45.5 /32.5 |
11 /22 |
Delta opioid receptor | |
8f7s[2] | F | OPRD_HUMAN Delta-type opioid receptor[289 aa] | A | 12.0 /32.5 |
25 /27 |
OPRD_HUMAN Delta-type opioid receptor | |
5zkq[1] | B | PTAFR_HUMAN ENLYS_BPT4 ENLYS_BPT4 PTAFR_HUMAN Platelet-activating factor receptor,Endolysin,Endo.. | A | 28.6 /32.5 |
14 /15 |
PTAFR_HUMAN ENLYS_BPT4 ENLYS_BPT4 PTAFR_HUMAN Platelet-activating factor receptor,Endolysin,Endo.. | |
5o9h[2] | B | C5AR1_HUMAN C5a anaphylatoxin chemotactic receptor 1[295 aa] | A | 27.3 /31.7 |
11 /11 |
C5AR1_HUMAN C5a anaphylatoxin chemotactic receptor 1 | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
PRECIPITANT | |||||||
359 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
7jni[1] | J |
FMT
FORMIC ACID[3 atoms] |
A | 44.4 /38.5 |
9 /9 |
C562_ECOLX AGTR2_HUMAN Soluble cytochrome b562,Type-2 angiotensin II rece.. | |
4dkl[4] | R |
1PE
PENTAETHYLENE GLYCOL[16 atoms] |
A | 0.0 /36.5 |
1 /6 |
OPRM_MOUSE LYS_BPT4 OPRM_MOUSE Mu-type opioid receptor, lysozyme chimera | |
4xnv[1] | O |
1PE
PENTAETHYLENE GLYCOL[16 atoms] |
A | 100.0 /29.7 |
1 /1 |
P2RY1_HUMAN RUBR_CLOPA P2RY1_HUMAN P2Y purinoceptor 1, Rubredoxin, P2Y purinoceptor 1.. | |
6rz6[2] | EA |
1PE
PENTAETHYLENE GLYCOL[15 atoms] |
A | 0.0 /37.7 |
3 /7 |
CLTR2_HUMAN C562_ECOLX CLTR2_HUMAN Cysteinyl leukotriene receptor 2,Soluble cytochrom.. | |
3ny8[1] | H |
PGE
TRIETHYLENE GLYCOL[10 atoms] |
A | 50.0 /31.9 |
2 /2 |
ADRB2_HUMAN LYS_BPT4 ADRB2_HUMAN Beta-2 adrenergic receptor, Lysozyme | |
4n6h[2] | N |
PGE
TRIETHYLENE GLYCOL[10 atoms] |
A | 0.0 /33.3 |
3 /3 |
C562_ECOLX OPRD_HUMAN Soluble cytochrome b562, Delta-type opioid recepto.. | |
4n6h[1] | O |
PGE
TRIETHYLENE GLYCOL[10 atoms] |
A | 0.0 /33.3 |
1 /1 |
C562_ECOLX OPRD_HUMAN Soluble cytochrome b562, Delta-type opioid recepto.. | |
6c1r[1] | G |
PGE
TRIETHYLENE GLYCOL[9 atoms] |
A | 28.6 /29.9 |
7 /7 |
C562_ECOLX C5AR1_HUMAN Soluble cytochrome b562, C5a anaphylatoxin chemota.. | |
6d27[1] | M |
PGE
TRIETHYLENE GLYCOL[10 atoms] |
A | 100.0 /29.5 |
2 /2 |
PD2R2_HUMAN D9IEF7_BPT4 D9IEF7_BPT4 PD2R2_HUMAN Prostaglandin D2 receptor 2, Endolysin chimera | |
6rz7[1] | AA |
PGE
TRIETHYLENE GLYCOL[10 atoms] |
A | 0.0 /37.7 |
1 /2 |
CLTR2_HUMAN C562_ECOLX CLTR2_HUMAN Cysteinyl leukotriene receptor 2,Soluble cytochrom.. | |
4n6h[1] | S |
TLA
L(+)-TARTARIC ACID[10 atoms] |
A | 57.1 /33.3 |
7 /7 |
C562_ECOLX OPRD_HUMAN Soluble cytochrome b562, Delta-type opioid recepto.. | |
5o9h[2] | D |
TLA
L(+)-TARTARIC ACID[10 atoms] |
A | 50.0 /31.7 |
4 /9 |
C5AR1_HUMAN C5a anaphylatoxin chemotactic receptor 1 | |
5o9h[1] | E |
TLA
L(+)-TARTARIC ACID[10 atoms] |
A | 14.3 /31.7 |
7 /7 |
C5AR1_HUMAN C5a anaphylatoxin chemotactic receptor 1 | |
6rz6[1] | D |
TLA
L(+)-TARTARIC ACID[10 atoms] |
A | 75.0 /37.7 |
4 /7 |
CLTR2_HUMAN C562_ECOLX CLTR2_HUMAN Cysteinyl leukotriene receptor 2,Soluble cytochrom.. | |
6omm[1] | L |
PLM
PALMITIC ACID[18 atoms] |
A | 0.0 /34.3 |
2 /2 |
FPR2_HUMAN N-formyl peptide receptor 2 | |
6omm[1] | M |
PLM
PALMITIC ACID[18 atoms] |
A | 20.0 /34.3 |
5 /5 |
FPR2_HUMAN N-formyl peptide receptor 2 | |
6omm[1] | N |
PLM
PALMITIC ACID[18 atoms] |
A | 14.3 /34.3 |
7 /7 |
FPR2_HUMAN N-formyl peptide receptor 2 | |
7t6t[1] | F |
PLM
PALMITIC ACID[18 atoms] |
E | 40.0 /35.7 |
5 /5 |
FPR1_HUMAN fMet-Leu-Phe receptor | |
7t6t[1] | G |
PLM
PALMITIC ACID[18 atoms] |
E | 40.0 /35.7 |
10 /10 |
FPR1_HUMAN fMet-Leu-Phe receptor | |
7t6u[3] | G |
PLM
PALMITIC ACID[18 atoms] |
F | 33.3 /34.3 |
3 /3 |
FPR2_HUMAN N-formyl peptide receptor 2 | |
7vfx[1] | J |
PLM
PALMITIC ACID[18 atoms] |
A | 40.0 /35.9 |
5 /5 |
FPR1_HUMAN fMet-Leu-Phe receptor | |
8f7s[2] | K |
PLM
PALMITIC ACID[18 atoms] |
A | 0.0 /32.5 |
2 /3 |
OPRD_HUMAN Delta-type opioid receptor | |
8f7s[2] | L |
PLM
PALMITIC ACID[18 atoms] |
A | 50.0 /32.5 |
4 /4 |
OPRD_HUMAN Delta-type opioid receptor | |
8f7s[2] | M |
PLM
PALMITIC ACID[18 atoms] |
A | 66.7 /32.5 |
3 /3 |
OPRD_HUMAN Delta-type opioid receptor | |
8f7s[3] | N |
PLM
PALMITIC ACID[18 atoms] |
A | 0.0 /32.5 |
2 /2 |
OPRD_HUMAN Delta-type opioid receptor | |
8f7s[1] | O |
PLM
PALMITIC ACID[18 atoms] |
A | 0.0 /32.5 |
8 /8 |
OPRD_HUMAN Delta-type opioid receptor | |
8f7s[3] | P |
PLM
PALMITIC ACID[18 atoms] |
A | 0.0 /32.5 |
1 /1 |
OPRD_HUMAN Delta-type opioid receptor | |
8f7s[2] | Q |
PLM
PALMITIC ACID[18 atoms] |
A | 0.0 /32.5 |
1 /1 |
OPRD_HUMAN Delta-type opioid receptor | |
8f7s[2] | R |
PLM
PALMITIC ACID[18 atoms] |
A | 0.0 /32.5 |
3 /3 |
OPRD_HUMAN Delta-type opioid receptor | |
8f7s[2] | S |
PLM
PALMITIC ACID[18 atoms] |
A | 0.0 /32.5 |
2 /2 |
OPRD_HUMAN Delta-type opioid receptor | |
8f7w[1] | K |
PLM
PALMITIC ACID[18 atoms] |
A | 33.3 /35.3 |
3 /3 |
OPRK_HUMAN Kappa-type opioid receptor | |
8hk2[1] | L |
PLM
PALMITIC ACID[18 atoms] |
A | 40.0 /31.8 |
5 /5 |
C3AR_HUMAN C3a anaphylatoxin chemotactic receptor | |
8hk2[1] | M |
PLM
PALMITIC ACID[18 atoms] |
A | 20.0 /31.8 |
5 /5 |
C3AR_HUMAN C3a anaphylatoxin chemotactic receptor | |
8hk5[1] | G |
PLM
PALMITIC ACID[18 atoms] |
A | 25.0 /29.7 |
4 /4 |
C5AR1_HUMAN C5a anaphylatoxin chemotactic receptor 1 | |
8sg1[1] | I |
PLM
PALMITIC ACID[18 atoms] |
A | 25.0 /36.9 |
8 /8 |
CML1_HUMAN Chemerin-like receptor 1 | |
4dkl[2] | P |
MPG
[(Z)-octadec-9-enyl] (2R)-2,3-bis(oxidanyl)propano.. |
A | 60.0 /36.5 |
5 /5 |
OPRM_MOUSE LYS_BPT4 OPRM_MOUSE Mu-type opioid receptor, lysozyme chimera | |
4dkl[2] | Q |
MPG
[(Z)-octadec-9-enyl] (2R)-2,3-bis(oxidanyl)propano.. |
A | 50.0 /36.5 |
8 /8 |
OPRM_MOUSE LYS_BPT4 OPRM_MOUSE Mu-type opioid receptor, lysozyme chimera | |
8k2w[1] | D |
PCW
1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[54 atoms].. |
B | 46.2 /36.2 |
13 /13 |
C562_ECOLX CXCR3_HUMAN OPRK_HUMAN CXCR3_HUMAN Soluble cytochrome b562,C-X-C chemokine receptor t.. | |
3d4s[1] | E |
OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[25 .. |
A | 0.0 /31.9 |
6 /6 |
ADRB2_HUMAN LYS_BPT4 ADRB2_HUMAN Beta-2 adrenergic receptor/T4-lysozyme chimera | |
3d4s[5] | F |
OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[25 .. |
A | 16.7 /31.9 |
6 /6 |
ADRB2_HUMAN LYS_BPT4 ADRB2_HUMAN Beta-2 adrenergic receptor/T4-lysozyme chimera | |
3d4s[182] | G |
OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[25 .. |
A | 50.0 /31.9 |
4 /5 |
ADRB2_HUMAN LYS_BPT4 ADRB2_HUMAN Beta-2 adrenergic receptor/T4-lysozyme chimera | |
3odu[1] | D |
OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[18 .. |
A | 66.7 /36.2 |
3 /3 |
CXCR4_HUMAN LYS_BPT4 CXCR4_HUMAN C-X-C chemokine receptor type 4, Lysozyme Chimera | |
3odu[1] | F |
OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[16 .. |
A | 36.4 /36.2 |
11 /11 |
CXCR4_HUMAN LYS_BPT4 CXCR4_HUMAN C-X-C chemokine receptor type 4, Lysozyme Chimera | |
3odu[1] | E |
OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[22 .. |
B | 0.0 /36.2 |
1 /1 |
CXCR4_HUMAN LYS_BPT4 CXCR4_HUMAN C-X-C chemokine receptor type 4, Lysozyme Chimera | |
3odu[1] | J |
OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[22 .. |
B | 100.0 /36.2 |
1 /1 |
CXCR4_HUMAN LYS_BPT4 CXCR4_HUMAN C-X-C chemokine receptor type 4, Lysozyme Chimera | |
3oe6[4] | D |
OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[15 .. |
A | 0.0 /39.4 |
3 /3 |
CXCR4_HUMAN LYS_BPT4 CXCR4_HUMAN C-X-C chemokine receptor type 4, Lysozyme Chimera | |
3oe6[2] | E |
OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[16 .. |
A | 60.0 /39.4 |
5 /5 |
CXCR4_HUMAN LYS_BPT4 CXCR4_HUMAN C-X-C chemokine receptor type 4, Lysozyme Chimera | |
3vw7[1] | F |
OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[25 .. |
A | 25.0 /36.4 |
4 /11 |
PAR1_HUMAN LYS_BPT4 PAR1_HUMAN Proteinase-activated receptor 1, Lysozyme | |
3vw7[5] | G |
OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[25 .. |
A | 0.0 /36.4 |
1 /8 |
PAR1_HUMAN LYS_BPT4 PAR1_HUMAN Proteinase-activated receptor 1, Lysozyme | |
4djh[8] | F |
OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[16 .. |
A | 0.0 /39.0 |
4 /4 |
OPRK_HUMAN LYS_BPT4 OPRK_HUMAN Kappa-type opioid receptor, Lysozyme | |
4ea3[3] | G |
OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[16 .. |
A | 25.0 /33.6 |
4 /4 |
C562_ECOLX OPRX_HUMAN Fusion protein of Nociceptin receptor and cytochro.. | |
4ea3[11] | G |
OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[16 .. |
B | 28.6 /34.6 |
7 /7 |
C562_ECOLX OPRX_HUMAN Fusion protein of Nociceptin receptor and cytochro.. | |
4mbs[2] | J |
OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[12 .. |
A | 40.0 /34.0 |
5 /5 |
CCR5_HUMAN RUBR_CLOPA CCR5_HUMAN Chimera protein of C-C chemokine receptor type 5 a.. | |
4mbs[3] | O |
OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[13 .. |
B | 66.7 /34.0 |
3 /3 |
CCR5_HUMAN RUBR_CLOPA CCR5_HUMAN Chimera protein of C-C chemokine receptor type 5 a.. | |
4n6h[1] | H |
OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[13 .. |
A | 50.0 /33.3 |
6 /6 |
C562_ECOLX OPRD_HUMAN Soluble cytochrome b562, Delta-type opioid recepto.. | |
4n6h[1] | I |
OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[18 .. |
A | 20.0 /33.3 |
5 /5 |
C562_ECOLX OPRD_HUMAN Soluble cytochrome b562, Delta-type opioid recepto.. | |
4n6h[1] | M |
OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[16 .. |
A | 50.0 /33.3 |
2 /2 |
C562_ECOLX OPRD_HUMAN Soluble cytochrome b562, Delta-type opioid recepto.. | |
4ntj[1] | F |
OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[21 .. |
A | 40.0 /32.4 |
5 /5 |
P2Y12_HUMAN C562_ECOLX P2Y12_HUMAN P2Y purinoceptor 12,Soluble cytochrome b562,P2Y pu.. | |
4pxz[1] | D |
OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[17 .. |
A | 60.0 /33.2 |
5 /5 |
P2Y12_HUMAN C562_ECOLX P2Y12_HUMAN P2Y purinoceptor 12, Soluble cytochrome b562 | |
4rwd[2] | H |
OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[13 .. |
A | 66.7 /33.6 |
9 /9 |
C562_ECOLX Soluble cytochrome b562,Delta-type opioid receptor.. | |
4xnv[1] | J |
OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[25 .. |
A | 11.1 /29.7 |
9 /9 |
P2RY1_HUMAN RUBR_CLOPA P2RY1_HUMAN P2Y purinoceptor 1, Rubredoxin, P2Y purinoceptor 1.. | |
4xnv[1] | N |
OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[25 .. |
A | 10.0 /29.7 |
10 /10 |
P2RY1_HUMAN RUBR_CLOPA P2RY1_HUMAN P2Y purinoceptor 1, Rubredoxin, P2Y purinoceptor 1.. | |
5c1m[2] | C |
OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[16 .. |
A | 0.0 /34.9 |
2 /2 |
OPRM_MOUSE Mu-type opioid receptor | |
5c1m[2] | D |
OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[18 .. |
A | 75.0 /34.9 |
4 /4 |
OPRM_MOUSE Mu-type opioid receptor | |
5t1a[1] | H |
OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[25 .. |
A | 14.3 /35.9 |
7 /7 |
CCR2_HUMAN D9IEF7_BPT4 CCR2_HUMAN Chimera protein of CC chemokine receptor type 2 is.. | |
5xsz[1] | B |
OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[9 a.. |
A | 40.0 /31.7 |
5 /5 |
Q08BG4_DANRE ENLYS_BPT4 Q08BG4_DANRE Lysophosphatidic acid receptor 6a,Endolysin,Lysoph.. | |
6c1r[1] | H |
OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[25 .. |
A | 33.3 /29.9 |
3 /3 |
C562_ECOLX C5AR1_HUMAN Soluble cytochrome b562, C5a anaphylatoxin chemota.. | |
6ibb[5] | J |
OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[25 .. |
A | 50.0 /32.0 |
4 /9 |
SUCR1_RAT Succinate receptor 1 | |
6ps4[1] | Q |
OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[13 .. |
A | 100.0 /31.9 |
1 /7 |
ADRB2_HUMAN D9IEF7_BPT4 ADRB2_HUMAN Fusion protein of Beta-2 adrenergic receptor and T.. | |
6pt2[2] | M |
OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[19 .. |
B | 50.0 /34.2 |
4 /4 |
Delta opioid receptor | |
6rz4[3] | E |
OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[12 .. |
A | 0.0 /40.0 |
2 /2 |
CLTR1_HUMAN C562_ECOLX CLTR1_HUMAN Cysteinyl leukotriene receptor 1,Soluble cytochrom.. | |
6rz8[1] | E |
OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[21 .. |
A | 0.0 /37.1 |
1 /5 |
CLTR2_HUMAN C562_ECOLX CLTR2_HUMAN Cysteinyl leukotriene receptor 2,Soluble cytochrom.. | |
7f83[1] | I |
OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[25 .. |
A | 66.7 /34.7 |
3 /6 |
GHSR_HUMAN C562_ECOLX GHSR_HUMAN Growth hormone secretagogue receptor type 1,Solubl.. | |
7jni[1] | H |
OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[25 .. |
A | 50.0 /38.5 |
8 /9 |
C562_ECOLX AGTR2_HUMAN Soluble cytochrome b562,Type-2 angiotensin II rece.. | |
4xt3[1] | E |
PO4
PHOSPHATE ION[5 atoms] |
A | 0.0 /29.8 |
2 /2 |
US28_HCMVA G-protein coupled receptor homolog US28 | |
5c1m[2] | F |
PO4
PHOSPHATE ION[5 atoms] |
A | 0.0 /34.9 |
3 /3 |
OPRM_MOUSE Mu-type opioid receptor | |
5c1m[2] | G |
P6G
HEXAETHYLENE GLYCOL[19 atoms] |
A | 0.0 /34.9 |
7 /7 |
OPRM_MOUSE Mu-type opioid receptor | |
5c1m[1] | H |
P6G
HEXAETHYLENE GLYCOL[13 atoms] |
A | 50.0 /34.9 |
4 /4 |
OPRM_MOUSE Mu-type opioid receptor | |
7k15[1] | J |
P6G
HEXAETHYLENE GLYCOL[19 atoms] |
A | 100.0 /36.4 |
1 /9 |
LT4R1_HUMAN FLAV_DESVH LT4R1_HUMAN Leukotriene B4 receptor 1,Flavodoxin,Leukotriene B.. | |
6to7[2] | D |
PG4
TETRAETHYLENE GLYCOL[13 atoms] |
A | 42.9 /27.8 |
7 /7 |
OX1R_HUMAN Orexin receptor type 1 | |
6tod[1] | F |
PG4
TETRAETHYLENE GLYCOL[13 atoms] |
A | 50.0 /27.3 |
6 /6 |
OX1R_HUMAN Orexin receptor type 1 | |
6tod[1] | G |
PG4
TETRAETHYLENE GLYCOL[13 atoms] |
A | 0.0 /27.3 |
4 /4 |
OX1R_HUMAN Orexin receptor type 1 | |
8e0g[1] | H |
PG4
TETRAETHYLENE GLYCOL[13 atoms] |
A | 100.0 /34.9 |
2 /2 |
OPRM_MOUSE Mu-type opioid receptor | |
6akx[2] | D |
NO3
NITRATE ION[4 atoms] |
A | 33.3 /34.8 |
6 /6 |
CCR5_HUMAN RUBR_CLOPA CCR5_HUMAN C-C chemokine receptor type 5,Rubredoxin,C-C chemo.. | |
8efq[1] | F |
ETA
ETHANOLAMINE[4 atoms] |
E | 0.0 /34.7 |
1 /1 |
OPRM_HUMAN Mu-type opioid receptor | |
2rh1[4] | J |
BU1
1,4-BUTANEDIOL[6 atoms] |
A | 50.0 /31.2 |
2 /5 |
ADRB2_HUMAN LYS_BPT4 ADRB2_HUMAN beta-2-adrenergic receptor/T4-lysozyme chimera | |
5d5a[2] | E |
BU1
1,4-BUTANEDIOL[6 atoms] |
A | 0.0 /31.2 |
1 /3 |
ADRB2_HUMAN ENLYS_BPT4 ADRB2_HUMAN Beta-2 adrenergic receptor,Endolysin,Beta-2 adrene.. | |
5x7d[1] | B |
EPE
4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACI.. |
A | 42.9 /31.2 |
7 /7 |
ADRB2_HUMAN D9IEF7_BPT4 ADRB2_HUMAN Chimera protein of Beta-2 adrenergic receptor and .. | |
4ea3[1] | D |
OLB
(2S)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[15 .. |
A | 42.9 /33.6 |
7 /7 |
C562_ECOLX OPRX_HUMAN Fusion protein of Nociceptin receptor and cytochro.. | |
4ea3[1] | D |
OLB
(2S)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[15 .. |
B | 50.0 /34.6 |
2 /2 |
C562_ECOLX OPRX_HUMAN Fusion protein of Nociceptin receptor and cytochro.. | |
6ps2[1] | D |
OLB
(2S)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[18 .. |
A | 0.0 /30.8 |
3 /3 |
ADRB2_HUMAN D9IEF7_BPT4 ADRB2_HUMAN Fusion protein of Beta-2 adrenergic receptor and T.. | |
6ps2[1] | E |
OLB
(2S)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[12 .. |
A | 33.3 /30.8 |
3 /3 |
ADRB2_HUMAN D9IEF7_BPT4 ADRB2_HUMAN Fusion protein of Beta-2 adrenergic receptor and T.. | |
6ps2[1] | F |
OLB
(2S)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[15 .. |
A | 14.3 /30.8 |
7 /7 |
ADRB2_HUMAN D9IEF7_BPT4 ADRB2_HUMAN Fusion protein of Beta-2 adrenergic receptor and T.. | |
6ps2[1] | I |
OLB
(2S)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[13 .. |
A | 100.0 /30.8 |
1 /6 |
ADRB2_HUMAN D9IEF7_BPT4 ADRB2_HUMAN Fusion protein of Beta-2 adrenergic receptor and T.. | |
6ps2[1] | K |
OLB
(2S)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[18 .. |
A | 50.0 /30.8 |
2 /2 |
ADRB2_HUMAN D9IEF7_BPT4 ADRB2_HUMAN Fusion protein of Beta-2 adrenergic receptor and T.. | |
5lwe[2] | T |
MLI
MALONATE ION[7 atoms] |
A | 80.0 /34.8 |
5 /6 |
CCR9_HUMAN C-C chemokine receptor type 9 | |
6c1r[1] | D |
MLI
MALONATE ION[7 atoms] |
A | 20.0 /29.9 |
5 /8 |
C562_ECOLX C5AR1_HUMAN Soluble cytochrome b562, C5a anaphylatoxin chemota.. | |
6c1r[1] | E |
MLI
MALONATE ION[7 atoms] |
A | 33.3 /29.9 |
6 /6 |
C562_ECOLX C5AR1_HUMAN Soluble cytochrome b562, C5a anaphylatoxin chemota.. | |
4xt1[1] | L |
UNL
UNKNOWN LIGAND[7 atoms] |
A | 0.0 /30.1 |
2 /2 |
US28_HCMVA G-protein coupled receptor homolog US28 | |
4xt1[1] | N |
UNL
UNKNOWN LIGAND[10 atoms] |
A | 33.3 /30.1 |
3 /3 |
US28_HCMVA G-protein coupled receptor homolog US28 | |
4xt1[1] | O |
UNL
UNKNOWN LIGAND[12 atoms] |
A | 14.3 /30.1 |
7 /7 |
US28_HCMVA G-protein coupled receptor homolog US28 | |
4xt1[1] | P |
UNL
UNKNOWN LIGAND[10 atoms] |
A | 66.7 /30.1 |
3 /3 |
US28_HCMVA G-protein coupled receptor homolog US28 | |
4xt1[1] | Q |
UNL
UNKNOWN LIGAND[12 atoms] |
A | 33.3 /30.1 |
6 /6 |
US28_HCMVA G-protein coupled receptor homolog US28 | |
4xt3[1] | D |
UNL
UNKNOWN LIGAND[9 atoms] |
A | 0.0 /29.8 |
2 /2 |
US28_HCMVA G-protein coupled receptor homolog US28 | |
5wb2[1] | K |
MES
2-(N-MORPHOLINO)-ETHANESULFONIC ACID[12 atoms] |
A | 50.0 /29.8 |
6 /6 |
Q80KM9_HCMV Envelope protein US28, nanobody 7 fusion protein | |
3oe6[2] | F |
GOL
GLYCEROL[6 atoms] |
A | 75.0 /39.4 |
8 /8 |
CXCR4_HUMAN LYS_BPT4 CXCR4_HUMAN C-X-C chemokine receptor type 4, Lysozyme Chimera | |
6ibb[3] | M |
GOL
GLYCEROL[6 atoms] |
A | 0.0 /32.0 |
5 /8 |
SUCR1_RAT Succinate receptor 1 | |
6d26[1] | S |
PGO
S-1,2-PROPANEDIOL[5 atoms] |
A | 66.7 /28.6 |
3 /3 |
PD2R2_HUMAN D9IEF7_BPT4 D9IEF7_BPT4 PD2R2_HUMAN Prostaglandin D2 receptor 2, Endolysin chimera | |
6d27[1] | P |
PGO
S-1,2-PROPANEDIOL[5 atoms] |
A | 50.0 /29.5 |
4 /4 |
PD2R2_HUMAN D9IEF7_BPT4 D9IEF7_BPT4 PD2R2_HUMAN Prostaglandin D2 receptor 2, Endolysin chimera | |
6d27[1] | Q |
PGO
S-1,2-PROPANEDIOL[5 atoms] |
A | 0.0 /29.5 |
2 /2 |
PD2R2_HUMAN D9IEF7_BPT4 D9IEF7_BPT4 PD2R2_HUMAN Prostaglandin D2 receptor 2, Endolysin chimera | |
6d27[1] | R |
PGO
S-1,2-PROPANEDIOL[5 atoms] |
A | 25.0 /29.5 |
4 /4 |
PD2R2_HUMAN D9IEF7_BPT4 D9IEF7_BPT4 PD2R2_HUMAN Prostaglandin D2 receptor 2, Endolysin chimera | |
4lde[4] | E |
1WV
(2S)-2,3-dihydroxypropyl (7Z)-tetradec-7-enoate[15.. |
A | 16.7 /29.3 |
6 /6 |
LYS_BPT4 ADRB2_HUMAN ADRB2_HUMAN Lysozyme, Beta-2 adrenergic receptor | |
6to7[1] | AA |
SOG
octyl 1-thio-beta-D-glucopyranoside[4 atoms] |
A | 66.7 /27.8 |
3 /3 |
OX1R_HUMAN Orexin receptor type 1 | |
6to7[2] | M |
SOG
octyl 1-thio-beta-D-glucopyranoside[6 atoms] |
A | 0.0 /27.8 |
1 /1 |
OX1R_HUMAN Orexin receptor type 1 | |
6to7[1] | R |
SOG
octyl 1-thio-beta-D-glucopyranoside[5 atoms] |
A | 0.0 /27.8 |
4 /4 |
OX1R_HUMAN Orexin receptor type 1 | |
6to7[1] | T |
SOG
octyl 1-thio-beta-D-glucopyranoside[5 atoms] |
A | 0.0 /27.8 |
4 /4 |
OX1R_HUMAN Orexin receptor type 1 | |
6to7[1] | X |
SOG
octyl 1-thio-beta-D-glucopyranoside[6 atoms] |
A | 0.0 /27.8 |
1 /1 |
OX1R_HUMAN Orexin receptor type 1 | |
6to7[1] | Y |
SOG
octyl 1-thio-beta-D-glucopyranoside[4 atoms] |
A | 0.0 /27.8 |
1 /1 |
OX1R_HUMAN Orexin receptor type 1 | |
6to7[1] | Z |
SOG
octyl 1-thio-beta-D-glucopyranoside[4 atoms] |
A | 0.0 /27.8 |
1 /1 |
OX1R_HUMAN Orexin receptor type 1 | |
6tos[1] | FA |
SOG
octyl 1-thio-beta-D-glucopyranoside[5 atoms] |
B | 20.0 /27.8 |
5 /5 |
OX1R_HUMAN Orexin receptor type 1 | |
6tos[1] | HA |
SOG
octyl 1-thio-beta-D-glucopyranoside[6 atoms] |
B | 50.0 /27.8 |
2 /5 |
OX1R_HUMAN Orexin receptor type 1 | |
6tos[1] | IA |
SOG
octyl 1-thio-beta-D-glucopyranoside[6 atoms] |
B | 0.0 /27.8 |
3 /3 |
OX1R_HUMAN Orexin receptor type 1 | |
8hqn[1] | F |
9HO
(9S,10E,12Z)-9-hydroxyoctadeca-10,12-dienoic acid[.. |
D | 21.4 /27.8 |
14 /14 |
C562_ECOLX GP132_HUMAN Soluble cytochrome b562,Probable G-protein coupled.. | |
5o9h[1] | NA |
CIT
CITRIC ACID[13 atoms] |
B | 0.0 /30.7 |
2 /2 |
C5AR1_HUMAN C5a anaphylatoxin chemotactic receptor 1 | |
6to7[2] | E |
CIT
CITRIC ACID[13 atoms] |
A | 66.7 /27.8 |
6 /6 |
OX1R_HUMAN Orexin receptor type 1 | |
2rh1[4] | C |
SO4
SULFATE ION[5 atoms] |
A | 42.9 /31.2 |
7 /7 |
ADRB2_HUMAN LYS_BPT4 ADRB2_HUMAN beta-2-adrenergic receptor/T4-lysozyme chimera | |
3pds[1] | D |
SO4
SULFATE ION[5 atoms] |
A | 42.9 /31.2 |
7 /7 |
ADRB2_HUMAN LYS_BPT4 ADRB2_HUMAN Fusion protein Beta-2 adrenergic receptor/Lysozyme.. | |
3pds[10] | F |
SO4
SULFATE ION[5 atoms] |
A | 50.0 /31.2 |
2 /2 |
ADRB2_HUMAN LYS_BPT4 ADRB2_HUMAN Fusion protein Beta-2 adrenergic receptor/Lysozyme.. | |
4dkl[2] | C |
SO4
SULFATE ION[5 atoms] |
A | 60.0 /36.5 |
5 /6 |
OPRM_MOUSE LYS_BPT4 OPRM_MOUSE Mu-type opioid receptor, lysozyme chimera | |
4dkl[10] | D |
SO4
SULFATE ION[5 atoms] |
A | 50.0 /36.5 |
4 /4 |
OPRM_MOUSE LYS_BPT4 OPRM_MOUSE Mu-type opioid receptor, lysozyme chimera | |
4dkl[2] | G |
SO4
SULFATE ION[5 atoms] |
A | 0.0 /36.5 |
4 /4 |
OPRM_MOUSE LYS_BPT4 OPRM_MOUSE Mu-type opioid receptor, lysozyme chimera | |
4dkl[2] | N |
SO4
SULFATE ION[5 atoms] |
A | 33.3 /36.5 |
3 /3 |
OPRM_MOUSE LYS_BPT4 OPRM_MOUSE Mu-type opioid receptor, lysozyme chimera | |
5t1a[1] | D |
SO4
SULFATE ION[5 atoms] |
A | 75.0 /35.9 |
4 /4 |
CCR2_HUMAN D9IEF7_BPT4 CCR2_HUMAN Chimera protein of CC chemokine receptor type 2 is.. | |
5t1a[1] | E |
SO4
SULFATE ION[5 atoms] |
A | 100.0 /35.9 |
1 /4 |
CCR2_HUMAN D9IEF7_BPT4 CCR2_HUMAN Chimera protein of CC chemokine receptor type 2 is.. | |
6d26[3] | C |
SO4
SULFATE ION[5 atoms] |
A | 0.0 /28.6 |
1 /8 |
PD2R2_HUMAN D9IEF7_BPT4 D9IEF7_BPT4 PD2R2_HUMAN Prostaglandin D2 receptor 2, Endolysin chimera | |
6d26[2] | F |
SO4
SULFATE ION[5 atoms] |
A | 50.0 /28.6 |
2 /4 |
PD2R2_HUMAN D9IEF7_BPT4 D9IEF7_BPT4 PD2R2_HUMAN Prostaglandin D2 receptor 2, Endolysin chimera | |
6d26[2] | G |
SO4
SULFATE ION[5 atoms] |
A | 60.0 /28.6 |
5 /7 |
PD2R2_HUMAN D9IEF7_BPT4 D9IEF7_BPT4 PD2R2_HUMAN Prostaglandin D2 receptor 2, Endolysin chimera | |
6d26[3] | H |
SO4
SULFATE ION[5 atoms] |
A | 66.7 /28.6 |
3 /7 |
PD2R2_HUMAN D9IEF7_BPT4 D9IEF7_BPT4 PD2R2_HUMAN Prostaglandin D2 receptor 2, Endolysin chimera | |
6d26[2] | I |
SO4
SULFATE ION[5 atoms] |
A | 0.0 /28.6 |
1 /5 |
PD2R2_HUMAN D9IEF7_BPT4 D9IEF7_BPT4 PD2R2_HUMAN Prostaglandin D2 receptor 2, Endolysin chimera | |
6rnk[2] | R |
SO4
SULFATE ION[5 atoms] |
A | 0.0 /29.6 |
3 /3 |
SUCR1_RAT Succinate receptor 1 | |
6tod[5] | D |
SO4
SULFATE ION[5 atoms] |
A | 25.0 /27.3 |
4 /4 |
OX1R_HUMAN Orexin receptor type 1 | |
7m8w[1] | D |
FLC
CITRATE ANION[13 atoms] |
A | 60.0 /27.1 |
5 /7 |
PD2R2_HUMAN D9IEF7_BPT4 D9IEF7_BPT4 PD2R2_HUMAN Prostaglandin D2 receptor 2, Endolysin chimera | |
3ny8[159] | E |
OLA
OLEIC ACID[13 atoms] |
A | 25.0 /31.9 |
4 /4 |
ADRB2_HUMAN LYS_BPT4 ADRB2_HUMAN Beta-2 adrenergic receptor, Lysozyme | |
3odu[1] | M |
OLA
OLEIC ACID[20 atoms] |
B | 25.0 /36.2 |
8 /8 |
CXCR4_HUMAN LYS_BPT4 CXCR4_HUMAN C-X-C chemokine receptor type 4, Lysozyme Chimera | |
3odu[1] | N |
OLA
OLEIC ACID[12 atoms] |
B | 0.0 /36.2 |
4 /4 |
CXCR4_HUMAN LYS_BPT4 CXCR4_HUMAN C-X-C chemokine receptor type 4, Lysozyme Chimera | |
3odu[1] | O |
OLA
OLEIC ACID[13 atoms] |
B | 42.9 /36.2 |
7 /7 |
CXCR4_HUMAN LYS_BPT4 CXCR4_HUMAN C-X-C chemokine receptor type 4, Lysozyme Chimera | |
4n6h[1] | D |
OLA
OLEIC ACID[15 atoms] |
A | 0.0 /33.3 |
3 /3 |
C562_ECOLX OPRD_HUMAN Soluble cytochrome b562, Delta-type opioid recepto.. | |
4n6h[1] | E |
OLA
OLEIC ACID[20 atoms] |
A | 66.7 /33.3 |
6 /6 |
C562_ECOLX OPRD_HUMAN Soluble cytochrome b562, Delta-type opioid recepto.. | |
4n6h[11] | F |
OLA
OLEIC ACID[20 atoms] |
A | 16.7 /33.3 |
6 /7 |
C562_ECOLX OPRD_HUMAN Soluble cytochrome b562, Delta-type opioid recepto.. | |
4n6h[1] | K |
OLA
OLEIC ACID[11 atoms] |
A | 33.3 /33.3 |
3 /3 |
C562_ECOLX OPRD_HUMAN Soluble cytochrome b562, Delta-type opioid recepto.. | |
4rwd[1] | G |
OLA
OLEIC ACID[13 atoms] |
A | 100.0 /33.6 |
1 /1 |
C562_ECOLX Soluble cytochrome b562,Delta-type opioid receptor.. | |
5dhg[9] | I |
OLA
OLEIC ACID[12 atoms] |
B | 33.3 /34.6 |
6 /6 |
C562_ECOLX OPRX_HUMAN Soluble cytochrome b562,Nociceptin receptor | |
5dhh[3] | J |
OLA
OLEIC ACID[7 atoms] |
A | 0.0 /33.8 |
1 /1 |
C562_ECOLX OPRX_HUMAN Soluble cytochrome b562,Nociceptin receptor | |
5lwe[9] | N |
OLA
OLEIC ACID[13 atoms] |
A | 50.0 /34.8 |
2 /2 |
CCR9_HUMAN C-C chemokine receptor type 9 | |
5lwe[1] | HA |
OLA
OLEIC ACID[20 atoms] |
B | 25.0 /34.1 |
4 /5 |
CCR9_HUMAN C-C chemokine receptor type 9 | |
5o9h[1] | H |
OLA
OLEIC ACID[15 atoms] |
A | 0.0 /31.7 |
1 /1 |
C5AR1_HUMAN C5a anaphylatoxin chemotactic receptor 1 | |
5o9h[1] | Q |
OLA
OLEIC ACID[15 atoms] |
A | 25.0 /31.7 |
4 /4 |
C5AR1_HUMAN C5a anaphylatoxin chemotactic receptor 1 | |
5o9h[1] | S |
OLA
OLEIC ACID[20 atoms] |
A | 25.0 /31.7 |
4 /4 |
C5AR1_HUMAN C5a anaphylatoxin chemotactic receptor 1 | |
5o9h[2] | X |
OLA
OLEIC ACID[10 atoms] |
B | 0.0 /30.7 |
2 /2 |
C5AR1_HUMAN C5a anaphylatoxin chemotactic receptor 1 | |
5uiw[1] | J |
OLA
OLEIC ACID[12 atoms] |
A | 0.0 /33.8 |
2 /2 |
CCR5_HUMAN RUBR_CLOPA CCR5_HUMAN C-C chemokine receptor type 5,Rubredoxin chimera | |
5ws3[1] | C |
OLA
OLEIC ACID[15 atoms] |
A | 100.0 /37.0 |
1 /3 |
OX2R_HUMAN Q9V2J8_PYRAB OX2R_HUMAN Orexin receptor type 2,GlgA glycogen synthase,Orex.. | |
6drz[1] | C |
OLA
OLEIC ACID[17 atoms] |
A | 12.5 /30.2 |
8 /8 |
5HT2B_HUMAN C562_ECOLX 5HT2B_HUMAN 5HT2B receptor, BRIL chimera | |
6gpx[3] | D |
OLA
OLEIC ACID[15 atoms] |
A | 33.3 /36.8 |
6 /6 |
CCR2_HUMAN RUBR_CLOPA CCR2_HUMAN C-C chemokine receptor type 2,Rubredoxin,C-C chemo.. | |
6gpx[1] | H |
OLA
OLEIC ACID[15 atoms] |
A | 0.0 /36.8 |
1 /1 |
CCR2_HUMAN RUBR_CLOPA CCR2_HUMAN C-C chemokine receptor type 2,Rubredoxin,C-C chemo.. | |
6gpx[1] | I |
OLA
OLEIC ACID[20 atoms] |
A | 0.0 /36.8 |
7 /10 |
CCR2_HUMAN RUBR_CLOPA CCR2_HUMAN C-C chemokine receptor type 2,Rubredoxin,C-C chemo.. | |
6gpx[1] | K |
OLA
OLEIC ACID[11 atoms] |
A | 0.0 /36.8 |
3 /3 |
CCR2_HUMAN RUBR_CLOPA CCR2_HUMAN C-C chemokine receptor type 2,Rubredoxin,C-C chemo.. | |
6mxt[1] | H |
OLA
OLEIC ACID[20 atoms] |
A | 25.0 /29.6 |
4 /5 |
D9IEF7_BPT4 ADRB2_HUMAN ADRB2_HUMAN Endolysin, Beta-2 adrenergic receptor chimera | |
6pt2[1] | F |
OLA
OLEIC ACID[20 atoms] |
A | 40.0 /32.5 |
5 /5 |
Delta opioid receptor | |
6pt2[2] | G |
OLA
OLEIC ACID[20 atoms] |
A | 33.3 /32.5 |
9 /9 |
Delta opioid receptor | |
6pt2[1] | F |
OLA
OLEIC ACID[20 atoms] |
B | 66.7 /34.2 |
3 /3 |
Delta opioid receptor | |
6pt2[1] | H |
OLA
OLEIC ACID[13 atoms] |
B | 50.0 /34.2 |
2 /2 |
Delta opioid receptor | |
6pt2[1] | L |
OLA
OLEIC ACID[9 atoms] |
B | 33.3 /34.2 |
3 /3 |
Delta opioid receptor | |
6rz5[1] | KA |
OLA
OLEIC ACID[16 atoms] |
B | 100.0 /40.0 |
1 /5 |
CLTR1_HUMAN C562_ECOLX CLTR1_HUMAN Cysteinyl leukotriene receptor 1,Soluble cytochrom.. | |
6rz7[3] | I |
OLA
OLEIC ACID[20 atoms] |
A | 33.3 /37.7 |
6 /7 |
CLTR2_HUMAN C562_ECOLX CLTR2_HUMAN Cysteinyl leukotriene receptor 2,Soluble cytochrom.. | |
6rz7[3] | Q |
OLA
OLEIC ACID[9 atoms] |
A | 50.0 /37.7 |
4 /4 |
CLTR2_HUMAN C562_ECOLX CLTR2_HUMAN Cysteinyl leukotriene receptor 2,Soluble cytochrom.. | |
6rz7[1] | X |
OLA
OLEIC ACID[17 atoms] |
A | 66.7 /37.7 |
3 /5 |
CLTR2_HUMAN C562_ECOLX CLTR2_HUMAN Cysteinyl leukotriene receptor 2,Soluble cytochrom.. | |
6rz7[1] | Z |
OLA
OLEIC ACID[10 atoms] |
A | 0.0 /37.7 |
1 /2 |
CLTR2_HUMAN C562_ECOLX CLTR2_HUMAN Cysteinyl leukotriene receptor 2,Soluble cytochrom.. | |
7k15[1] | E |
OLA
OLEIC ACID[12 atoms] |
A | 33.3 /36.4 |
6 /6 |
LT4R1_HUMAN FLAV_DESVH LT4R1_HUMAN Leukotriene B4 receptor 1,Flavodoxin,Leukotriene B.. | |
7zly[1] | B |
OLA
OLEIC ACID[11 atoms] |
A | 33.3 /24.5 |
3 /3 |
HCAR2_HUMAN C562_ECOLX HCAR2_HUMAN Hydroxycarboxylic acid receptor 2,Soluble cytochro.. | |
4djh[1] | H |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
B | 50.0 /39.0 |
2 /3 |
OPRK_HUMAN LYS_BPT4 OPRK_HUMAN Kappa-type opioid receptor, Lysozyme | |
4djh[1] | I |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
B | 75.0 /39.0 |
4 /6 |
OPRK_HUMAN LYS_BPT4 OPRK_HUMAN Kappa-type opioid receptor, Lysozyme | |
6d27[1] | S |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
A | 0.0 /29.5 |
3 /3 |
PD2R2_HUMAN D9IEF7_BPT4 D9IEF7_BPT4 PD2R2_HUMAN Prostaglandin D2 receptor 2, Endolysin chimera | |
7zl9[1] | H |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
A | 100.0 /24.3 |
1 /2 |
HCAR2_HUMAN C562_ECOLX Hydroxycarboxylic acid receptor 2,Soluble cytochro.. | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. |